ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_FAT	GOTERM_CC_FAT	GOTERM_MF_FAT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	SP_PIR_KEYWORDS	UP_SEQ_FEATURE
37166_at	3-hydroxyanthranilate 3,4-dioxygenase	Homo sapiens						GO:0070050~neuron maintenance,GO:0060249~anatomical structure homeostasis,GO:0055114~oxidation reduction,GO:0051188~cofactor biosynthetic process,GO:0051186~cofactor metabolic process,GO:0046874~quinolinate metabolic process,GO:0046686~response to cadmium ion,GO:0046496~nicotinamide nucleotide metabolic process,GO:0046394~carboxylic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0043648~dicarboxylic acid metabolic process,GO:0043603~cellular amide metabolic process,GO:0042592~homeostatic process,GO:0042364~water-soluble vitamin biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0019805~quinolinate biosynthetic process,GO:0019748~secondary metabolic process,GO:0019725~cellular homeostasis,GO:0019674~NAD metabolic process,GO:0019363~pyridine nucleotide biosynthetic process,GO:0019362~pyridine nucleotide metabolic process,GO:0016053~organic acid biosynthetic process,GO:0010043~response to zinc ion,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0009820~alkaloid metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009110~vitamin biosynthetic process,GO:0009108~coenzyme biosynthetic process,GO:0006769~nicotinamide metabolic process,GO:0006767~water-soluble vitamin metabolic process,GO:0006766~vitamin metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006732~coenzyme metabolic process,												GO:0044429~mitochondrial part,GO:0031975~envelope,GO:0031967~organelle envelope,GO:0031966~mitochondrial membrane,GO:0031090~organelle membrane,GO:0005829~cytosol,GO:0005740~mitochondrial envelope,GO:0005739~mitochondrion,GO:0005625~soluble fraction,GO:0000267~cell fraction,																GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0019825~oxygen binding,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0009055~electron carrier activity,GO:0008198~ferrous iron binding,GO:0005506~iron ion binding,GO:0000334~3-hydroxyanthranilate 3,4-dioxygenase activity,							IPR016700:3-hydroxyanthranilate 3, 4-dioxygenase, metazoan,IPR010329:3-hydroxyanthranilic acid dioxygenase,																				hsa00380:Tryptophan metabolism,					PIRSF017681:3hydroanth_dOase_animal,PIRSF017681:3-hydroxyanthranilate 3,4-dioxygenase, animal type,																						pyridine nucleotide biosynthesis,polymorphism,oxidoreductase,metal-binding,iron,dioxygenase,cytoplasm,complete proteome,alternative splicing,3d-structure,						turn,strand,splice variant,sequence variant,metal ion-binding site:Iron; catalytic,helix,chain:3-hydroxyanthranilate 3,4-dioxygenase,binding site:Substrate,binding site:Dioxygen,										
34467_g_at	5-hydroxytryptamine (serotonin) receptor 4	Homo sapiens						GO:0019935~cyclic-nucleotide-mediated signaling,GO:0019932~second-messenger-mediated signaling,GO:0007242~intracellular signaling cascade,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,GO:0005768~endosome,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,																GO:0008227~amine receptor activity,GO:0004993~serotonin receptor activity,GO:0004935~adrenoceptor activity,							IPR017452:GPCR, rhodopsin-like superfamily,IPR001520:5-Hydroxytryptamine 4 receptor,IPR000276:7TM GPCR, rhodopsin-like,																				hsa04080:Neuroactive ligand-receptor interaction,hsa04020:Calcium signaling pathway,					PIRSF800006:rhodopsin-like G protein-coupled receptors,PIRSF038635:5-hydroxytryptamine receptor 4,																						transmembrane protein,transmembrane,transducer,receptor,polymorphism,palmitate,neurotransmitter receptor,membrane,lipoprotein,glycoprotein,g-protein coupled receptor,G protein-coupled receptor,endosome,disulfide bond,complete proteome,cell membrane,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,sequence variant,lipid moiety-binding region:S-palmitoyl cysteine,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:5-hydroxytryptamine receptor 4,										
39522_at	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	Homo sapiens						GO:0019318~hexose metabolic process,GO:0006003~fructose 2,6-bisphosphate metabolic process,GO:0006000~fructose metabolic process,GO:0005996~monosaccharide metabolic process,												GO:0005829~cytosol,																GO:0042802~identical protein binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0019203~carbohydrate phosphatase activity,GO:0019200~carbohydrate kinase activity,GO:0017076~purine nucleotide binding,GO:0016791~phosphatase activity,GO:0008443~phosphofructokinase activity,GO:0005524~ATP binding,GO:0004331~fructose-2,6-bisphosphate 2-phosphatase activity,GO:0003873~6-phosphofructo-2-kinase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR016260:Bifunctional 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphate 2-phosphatase,IPR013079:6-phosphofructo-2-kinase,IPR013078:Phosphoglycerate mutase,IPR003094:Fructose-2,6-bisphosphatase,IPR001345:Phosphoglycerate/bisphosphoglycerate mutase,																				hsa00051:Fructose and mannose metabolism,					PIRSF000709:bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphate 2-phosphatase,PIRSF000709:6PFK_2-Ptase,																						transferase,placenta,phosphotransferase,phosphoric monoester hydrolase,phosphoprotein,phosphohistidine,nucleotide-binding,multifunctional enzyme,kinase,hydrolase,complete proteome,atp-binding,alternative splicing,3d-structure,						turn,strand,splice variant,sequence conflict,region of interest:Fructose-2,6-bisphosphatase,region of interest:6-phosphofructo-2-kinase,nucleotide phosphate-binding region:ATP,modified residue,helix,chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 3,binding site:Fructose-6-phosphate,active site:Tele-phosphohistidine intermediate,active site:Proton donor,										
41703_r_at	A kinase (PRKA) anchor protein 7	Homo sapiens						GO:0008104~protein localization,GO:0007242~intracellular signaling cascade,GO:0006811~ion transport,												GO:0045177~apical part of cell,GO:0044459~plasma membrane part,GO:0031225~anchored to membrane,GO:0031224~intrinsic to membrane,GO:0016328~lateral plasma membrane,GO:0016324~apical plasma membrane,GO:0005886~plasma membrane,GO:0005829~cytosol,																GO:0051018~protein kinase A binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,							IPR019511:Protein kinase A anchor protein, RI-RII subunit-binding domain,IPR019510:Protein kinase A anchor protein, nuclear localisation signal domain,																					polymorphism,palmitate,myristate,membrane,lipoprotein,kinase,cytoplasm,complete proteome,cell membrane,alternative splicing,						splice variant,sequence variant,region of interest:RII-binding,region of interest:Required for membrane localization,region of interest:Required for apical membrane localization,lipid moiety-binding region:S-palmitoyl cysteine,lipid moiety-binding region:N-myristoyl glycine,chain:A-kinase anchor protein 7 isoforms alpha and beta,chain:A-kinase anchor protein 7 isoform gamma,										
40350_at	ADAM metallopeptidase domain 23	Homo sapiens						GO:0022610~biological adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0007155~cell adhesion,GO:0006508~proteolysis,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,GO:0005576~extracellular region,																GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0032403~protein complex binding,GO:0008270~zinc ion binding,GO:0008237~metallopeptidase activity,GO:0008233~peptidase activity,GO:0005178~integrin binding,GO:0004222~metalloendopeptidase activity,GO:0004175~endopeptidase activity,							IPR018358:Disintegrin, conserved site,IPR013111:EGF, extracellular,IPR013032:EGF-like region, conserved site,IPR006586:ADAM, cysteine-rich,IPR006210:EGF-like,IPR002870:Peptidase M12B, propeptide,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR000742:EGF-like, type 3,																							SM00608:ACR,SM00181:EGF,SM00050:DISIN,											transmembrane,signal,Secreted,Protease,phosphoprotein,metalloprotease,metal-binding,membrane,integrin,hydrolase,glycoprotein,egf-like domain,disulfide bond,complete proteome,cleavage on pair of basic residues,cell membrane,cell adhesion,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,signal peptide,region of interest:May bind the integrin receptor,mutagenesis site,modified residue,glycosylation site:N-linked (GlcNAc...),domain:Peptidase M12B,domain:EGF-like,domain:Disintegrin,disulfide bond,compositionally biased region:Cys-rich,chain:Disintegrin and metalloproteinase domain- containing protein 23,										
1575_at	ATP-binding cassette, sub-family B (MDR/TAP), member 1	Homo sapiens											h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,h_mrpPathway:Multi-Drug Resistance Factors,															Defense mechanisms,						GO:0055085~transmembrane transport,GO:0042493~response to drug,												GO:0070161~anchoring junction,GO:0044459~plasma membrane part,GO:0031224~intrinsic to membrane,GO:0030055~cell-substrate junction,GO:0030054~cell junction,GO:0016323~basolateral plasma membrane,GO:0016021~integral to membrane,GO:0009986~cell surface,GO:0005925~focal adhesion,GO:0005924~cell-substrate adherens junction,GO:0005912~adherens junction,GO:0005886~plasma membrane,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,																GO:0043492~ATPase activity, coupled to movement of substances,GO:0042910~xenobiotic transporter activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042623~ATPase activity, coupled,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015239~multidrug transporter activity,GO:0015238~drug transporter activity,GO:0008559~xenobiotic-transporting ATPase activity,GO:0005524~ATP binding,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR017940:ABC transporter integral membrane type 1,IPR017871:ABC transporter, conserved site,IPR003593:ATPase, AAA+ type, core,IPR003439:ABC transporter-like,IPR001140:ABC transporter, transmembrane region,																				hsa02010:ABC transporters,								Inflammatory bowel disease 13, susceptibility to,Colchicine resistance,										PIRSF002773:multidrug resistance protein,																								SM00382:AAA,											transport,transmembrane protein,transmembrane,repeat,polymorphism,phosphoprotein,P-loop,nucleotide-binding,nucleotide binding,membrane,hydrolase,glycoprotein,duplication,complete proteome,atp-binding,ATP,						transmembrane region,topological domain:Cytoplasmic,sequence variant,sequence conflict,nucleotide phosphate-binding region:ATP 2,nucleotide phosphate-binding region:ATP 1,modified residue,glycosylation site:N-linked (GlcNAc...),domain:ABC transporter 2,domain:ABC transporter 1,domain:ABC transmembrane type-1 2,domain:ABC transmembrane type-1 1,chain:Multidrug resistance protein 1,										
40294_at	ATP-binding cassette, sub-family B (MDR/TAP), member 9	Homo sapiens						GO:0055085~transmembrane transport,GO:0048609~reproductive process in a multicellular organism,GO:0048232~male gamete generation,GO:0045184~establishment of protein localization,GO:0032504~multicellular organism reproduction,GO:0019953~sexual reproduction,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0008104~protein localization,GO:0007283~spermatogenesis,GO:0007276~gamete generation,												GO:0043190~ATP-binding cassette (ABC) transporter complex,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005783~endoplasmic reticulum,GO:0005773~vacuole,GO:0005764~lysosome,GO:0000323~lytic vacuole,																GO:0043492~ATPase activity, coupled to movement of substances,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042623~ATPase activity, coupled,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0005524~ATP binding,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR017940:ABC transporter integral membrane type 1,IPR017871:ABC transporter, conserved site,IPR003593:ATPase, AAA+ type, core,IPR003439:ABC transporter-like,IPR001140:ABC transporter, transmembrane region,																				hsa04142:Lysosome,hsa02010:ABC transporters,																SM00382:AAA,											transport,transmembrane,signal,protein transport,polymorphism,phosphoprotein,peptide transport,nucleotide-binding,membrane,lysosome,endoplasmic reticulum,complete proteome,atp-binding,alternative splicing,						transmembrane region,splice variant,signal peptide,sequence variant,nucleotide phosphate-binding region:ATP,modified residue,domain:ABC transporter,domain:ABC transmembrane type-1,compositionally biased region:Poly-Glu,chain:ATP-binding cassette sub-family B member 9,										
32439_at	ATPase, H+/K+ exchanging, beta polypeptide	Homo sapiens						GO:0046034~ATP metabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0032496~response to lipopolysaccharide,GO:0030001~metal ion transport,GO:0015992~proton transport,GO:0015672~monovalent inorganic cation transport,GO:0010243~response to organic nitrogen,GO:0010033~response to organic substance,GO:0009719~response to endogenous stimulus,GO:0009617~response to bacterium,GO:0009260~ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009141~nucleoside triphosphate metabolic process,GO:0006818~hydrogen transport,GO:0006814~sodium ion transport,GO:0006813~potassium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006754~ATP biosynthetic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006163~purine nucleotide metabolic process,GO:0002237~response to molecule of bacterial origin,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,																GO:0046872~metal ion binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042623~ATPase activity, coupled,GO:0031420~alkali metal ion binding,GO:0030955~potassium ion binding,GO:0022890~inorganic cation transmembrane transporter activity,GO:0016887~ATPase activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0008900~hydrogen:potassium-exchanging ATPase activity,GO:0005391~sodium:potassium-exchanging ATPase activity,							IPR000402:ATPase, P-type cation exchange, beta subunit,																				hsa00190:Oxidative phosphorylation,					PIRSF005757:Na(+)/K(+)-exchanging ATPase beta-3 chain,																						transport,transmembrane protein,transmembrane,Signal-anchor,potassium transport,potassium,membrane,ion transport,hydrolase,Hydrogen ion transport,glycoprotein,disulfide bond,complete proteome,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Potassium-transporting ATPase subunit beta,										
39469_s_at	ATPase, aminophospholipid transporter-like, class I, type 8A, member 2	Homo sapiens						GO:0046034~ATP metabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0015914~phospholipid transport,GO:0010876~lipid localization,GO:0009260~ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009141~nucleoside triphosphate metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0006869~lipid transport,GO:0006754~ATP biosynthetic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006163~purine nucleotide metabolic process,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,																GO:0046872~metal ion binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042623~ATPase activity, coupled,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015247~aminophospholipid transporter activity,GO:0005548~phospholipid transporter activity,GO:0005524~ATP binding,GO:0005319~lipid transporter activity,GO:0004012~phospholipid-translocating ATPase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000287~magnesium ion binding,GO:0000166~nucleotide binding,							IPR018303:ATPase, P-type phosphorylation site,IPR008250:ATPase, P-type, ATPase-associated region,IPR006539:ATPase, P-type, phospholipid-translocating, flippase,IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter,																					transmembrane,polymorphism,phosphoprotein,nucleotide-binding,metal-binding,membrane,magnesium,hydrolase,complete proteome,atp-binding,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,sequence variant,modified residue,metal ion-binding site:Magnesium,chain:Probable phospholipid-transporting ATPase IB,active site:4-aspartylphosphate intermediate,										
33685_at	ATPase, class I, type 8B, member 3	Homo sapiens						GO:0048610~reproductive cellular process,GO:0046034~ATP metabolic process,GO:0045332~phospholipid translocation,GO:0044271~nitrogen compound biosynthetic process,GO:0035036~sperm-egg recognition,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034204~lipid translocation,GO:0019953~sexual reproduction,GO:0016044~membrane organization,GO:0015914~phospholipid transport,GO:0010876~lipid localization,GO:0009988~cell-cell recognition,GO:0009566~fertilization,GO:0009260~ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009141~nucleoside triphosphate metabolic process,GO:0008037~cell recognition,GO:0007339~binding of sperm to zona pellucida,GO:0007338~single fertilization,GO:0006869~lipid transport,GO:0006754~ATP biosynthetic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006163~purine nucleotide metabolic process,												GO:0031988~membrane-bounded vesicle,GO:0031982~vesicle,GO:0031410~cytoplasmic vesicle,GO:0031224~intrinsic to membrane,GO:0030141~secretory granule,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016021~integral to membrane,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0001669~acrosomal vesicle,GO:0000299~integral to membrane of membrane fraction,GO:0000267~cell fraction,																GO:0046872~metal ion binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042623~ATPase activity, coupled,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015247~aminophospholipid transporter activity,GO:0005548~phospholipid transporter activity,GO:0005524~ATP binding,GO:0005319~lipid transporter activity,GO:0004012~phospholipid-translocating ATPase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000287~magnesium ion binding,GO:0000166~nucleotide binding,							IPR018303:ATPase, P-type phosphorylation site,IPR018247:EF-HAND 1,IPR013200:HAD superfamily hydrolase-like, type 3,IPR008250:ATPase, P-type, ATPase-associated region,IPR006539:ATPase, P-type, phospholipid-translocating, flippase,IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter,																					transmembrane,polymorphism,phosphoprotein,nucleotide-binding,metal-binding,membrane,magnesium,hydrolase,complete proteome,atp-binding,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,sequence variant,metal ion-binding site:Magnesium,chain:Probable phospholipid-transporting ATPase IK,active site:4-aspartylphosphate intermediate,										
33027_at	ArfGAP with GTPase domain, ankyrin repeat and PH domain 4; ArfGAP with GTPase domain, ankyrin repeat and PH domain 6	Homo sapiens						GO:0051336~regulation of hydrolase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0032312~regulation of ARF GTPase activity,GO:0032012~regulation of ARF protein signal transduction,															GO:0060589~nucleoside-triphosphatase regulator activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0030695~GTPase regulator activity,GO:0008270~zinc ion binding,GO:0008060~ARF GTPase activator activity,GO:0008047~enzyme activator activity,GO:0005096~GTPase activator activity,GO:0005083~small GTPase regulator activity,							IPR011993:Pleckstrin homology-type,IPR002110:Ankyrin,IPR001849:Pleckstrin homology,IPR001164:Arf GTPase activating protein,																							SM00248:ANK,SM00233:PH,SM00105:ArfGap,											zinc-finger,zinc,repeat,polymorphism,metal-binding,GTPase activation,complete proteome,ank repeat,						zinc finger region:C4-type,sequence variant,repeat:ANK 2,repeat:ANK 1,domain:PH,domain:Arf-GAP,chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6,chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4,										
1910_s_at	B-cell CLL/lymphoma 2	Homo sapiens							99.NF-kB_activation,86.Apoptosis_Nematode&_Vert,83.Growth_factors_Survival_factors_Mitogens,46.P13K_PTEN,38.Cell_cycle_arrest_and_apoptosis_ceramide,152.altered_synaptic_signalling-neurodegenerative_disorders,127.Mito-stress,																	h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_prionPathway:Prion Pathway,h_p53Pathway:p53 Signaling Pathway,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_melanocytepathway:Melanocyte Development and Pigmentation Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_il7Pathway:IL-7 Signal Transduction,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_hsp27Pathway:Stress Induction of HSP Regulation,h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_ceramidePathway:Ceramide Signaling Pathway,h_badPathway:Regulation of BAD phosphorylation,								GO:0070661~leukocyte proliferation,GO:0070482~response to oxygen levels,GO:0070059~apoptosis in response to endoplasmic reticulum stress,GO:0060675~ureteric bud morphogenesis,GO:0060562~epithelial tube morphogenesis,GO:0060548~negative regulation of cell death,GO:0060485~mesenchyme development,GO:0060429~epithelium development,GO:0060348~bone development,GO:0060284~regulation of cell development,GO:0060249~anatomical structure homeostasis,GO:0055123~digestive system development,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055065~metal ion homeostasis,GO:0051960~regulation of nervous system development,GO:0051926~negative regulation of calcium ion transport,GO:0051924~regulation of calcium ion transport,GO:0051902~negative regulation of mitochondrial depolarization,GO:0051900~regulation of mitochondrial depolarization,GO:0051899~membrane depolarization,GO:0051881~regulation of mitochondrial membrane potential,GO:0051789~response to protein stimulus,GO:0051726~regulation of cell cycle,GO:0051607~defense response to virus,GO:0051593~response to folic acid,GO:0051412~response to corticosterone stimulus,GO:0051402~neuron apoptosis,GO:0051385~response to mineralocorticoid stimulus,GO:0051384~response to glucocorticoid stimulus,GO:0051329~interphase of mitotic cell cycle,GO:0051325~interphase,GO:0051272~positive regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051270~regulation of cell motion,GO:0051247~positive regulation of protein metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051098~regulation of binding,GO:0051094~positive regulation of developmental process,GO:0051051~negative regulation of transport,GO:0050942~positive regulation of pigment cell differentiation,GO:0050932~regulation of pigment cell differentiation,GO:0050931~pigment cell differentiation,GO:0050801~ion homeostasis,GO:0050792~regulation of viral reproduction,GO:0050767~regulation of neurogenesis,GO:0048878~chemical homeostasis,GO:0048873~homeostasis of number of cells within a tissue,GO:0048872~homeostasis of number of cells,GO:0048871~multicellular organismal homeostasis,GO:0048858~cell projection morphogenesis,GO:0048857~neural nucleus development,GO:0048812~neuron projection morphogenesis,GO:0048762~mesenchymal cell differentiation,GO:0048754~branching morphogenesis of a tube,GO:0048753~pigment granule organization,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0048742~regulation of skeletal muscle fiber development,GO:0048732~gland development,GO:0048730~epidermis morphogenesis,GO:0048729~tissue morphogenesis,GO:0048678~response to axon injury,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048641~regulation of skeletal muscle tissue development,GO:0048636~positive regulation of muscle development,GO:0048634~regulation of muscle development,GO:0048610~reproductive cellular process,GO:0048609~reproductive process in a multicellular organism,GO:0048608~reproductive structure development,GO:0048599~oocyte development,GO:0048589~developmental growth,GO:0048565~gut development,GO:0048547~gut morphogenesis,GO:0048546~digestive tract morphogenesis,GO:0048545~response to steroid hormone stimulus,GO:0048538~thymus development,GO:0048536~spleen development,GO:0048534~hemopoietic or lymphoid organ development,GO:0048511~rhythmic process,GO:0048477~oogenesis,GO:0048087~positive regulation of pigmentation during development,GO:0048070~regulation of pigmentation during development,GO:0048066~pigmentation during development,GO:0048041~focal adhesion formation,GO:0046907~intracellular transport,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046688~response to copper ion,GO:0046671~negative regulation of retinal cell programmed cell death,GO:0046668~regulation of retinal cell programmed cell death,GO:0046661~male sex differentiation,GO:0046660~female sex differentiation,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0046632~alpha-beta T cell differentiation,GO:0046631~alpha-beta T cell activation,GO:0046546~development of primary male sexual characteristics,GO:0046545~development of primary female sexual characteristics,GO:0045937~positive regulation of phosphate metabolic process,GO:0045930~negative regulation of mitotic cell cycle,GO:0045927~positive regulation of growth,GO:0045926~negative regulation of growth,GO:0045844~positive regulation of striated muscle development,GO:0045792~negative regulation of cell size,GO:0045786~negative regulation of cell cycle,GO:0045664~regulation of neuron differentiation,GO:0045636~positive regulation of melanocyte differentiation,GO:0045634~regulation of melanocyte differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045471~response to ethanol,GO:0045321~leukocyte activation,GO:0045165~cell fate commitment,GO:0045137~development of primary sexual characteristics,GO:0045069~regulation of viral genome replication,GO:0045058~T cell selection,GO:0044093~positive regulation of molecular function,GO:0043627~response to estrogen stimulus,GO:0043583~ear development,GO:0043524~negative regulation of neuron apoptosis,GO:0043523~regulation of neuron apoptosis,GO:0043497~regulation of protein heterodimerization activity,GO:0043496~regulation of protein homodimerization activity,GO:0043473~pigmentation,GO:0043434~response to peptide hormone stimulus,GO:0043393~regulation of protein binding,GO:0043375~CD8-positive, alpha-beta T cell lineage commitment,GO:0043374~CD8-positive, alpha-beta T cell differentiation,GO:0043369~CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,GO:0043368~positive T cell selection,GO:0043279~response to alkaloid,GO:0043271~negative regulation of ion transport,GO:0043269~regulation of ion transport,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043029~T cell homeostasis,GO:0042981~regulation of apoptosis,GO:0042698~ovulation cycle,GO:0042633~hair cycle,GO:0042596~fear response,GO:0042592~homeostatic process,GO:0042542~response to hydrogen peroxide,GO:0042493~response to drug,GO:0042440~pigment metabolic process,GO:0042391~regulation of membrane potential,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042303~molting cycle,GO:0042127~regulation of cell proliferation,GO:0042113~B cell activation,GO:0042110~T cell activation,GO:0042100~B cell proliferation,GO:0040018~positive regulation of multicellular organism growth,GO:0040017~positive regulation of locomotion,GO:0040014~regulation of multicellular organism growth,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040008~regulation of growth,GO:0040007~growth,GO:0035295~tube development,GO:0035265~organ growth,GO:0035239~tube morphogenesis,GO:0035094~response to nicotine,GO:0034330~cell junction organization,GO:0034329~cell junction assembly,GO:0034097~response to cytokine stimulus,GO:0033689~negative regulation of osteoblast proliferation,GO:0033688~regulation of osteoblast proliferation,GO:0033555~multicellular organismal response to stress,GO:0033554~cellular response to stress,GO:0033273~response to vitamin,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033077~T cell differentiation in the thymus,GO:0033059~cellular pigmentation,GO:0033033~negative regulation of myeloid cell apoptosis,GO:0033032~regulation of myeloid cell apoptosis,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032943~mononuclear cell proliferation,GO:0032880~regulation of protein localization,GO:0032848~negative regulation of cellular pH reduction,GO:0032847~regulation of cellular pH reduction,GO:0032845~negative regulation of homeostatic process,GO:0032844~regulation of homeostatic process,GO:0032835~glomerulus development,GO:0032535~regulation of cellular component size,GO:0032504~multicellular organism reproduction,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031960~response to corticosteroid stimulus,GO:0031667~response to nutrient levels,GO:0031647~regulation of protein stability,GO:0031589~cell-substrate adhesion,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031175~neuron projection development,GO:0031103~axon regeneration,GO:0031102~neuron projection regeneration,GO:0031099~regeneration,GO:0031069~hair follicle morphogenesis,GO:0031000~response to caffeine,GO:0030902~hindbrain development,GO:0030336~negative regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030318~melanocyte differentiation,GO:0030308~negative regulation of cell growth,GO:0030279~negative regulation of ossification,GO:0030278~regulation of ossification,GO:0030217~T cell differentiation,GO:0030183~B cell differentiation,GO:0030182~neuron differentiation,GO:0030155~regulation of cell adhesion,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0030036~actin cytoskeleton organization,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030003~cellular cation homeostasis,GO:0022612~gland morphogenesis,GO:0022610~biological adhesion,GO:0022602~ovulation cycle process,GO:0022405~hair cycle process,GO:0022404~molting cycle process,GO:0022403~cell cycle phase,GO:0022402~cell cycle process,GO:0022037~metencephalon development,GO:0021747~cochlear nucleus development,GO:0021548~pons development,GO:0019953~sexual reproduction,GO:0019748~secondary metabolic process,GO:0019725~cellular homeostasis,GO:0019220~regulation of phosphate metabolic process,GO:0018210~peptidyl-threonine modification,GO:0018209~peptidyl-serine modification,GO:0018107~peptidyl-threonine phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0016337~cell-cell adhesion,GO:0016311~dephosphorylation,GO:0016310~phosphorylation,GO:0016265~death,GO:0016202~regulation of striated muscle tissue development,GO:0016050~vesicle organization,GO:0016049~cell growth,GO:0016044~membrane organization,GO:0014911~positive regulation of smooth muscle cell migration,GO:0014910~regulation of smooth muscle cell migration,GO:0014074~response to purine,GO:0014070~response to organic cyclic substance,GO:0014042~positive regulation of neuron maturation,GO:0014041~regulation of neuron maturation,GO:0014031~mesenchymal cell development,GO:0012501~programmed cell death,GO:0010959~regulation of metal ion transport,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010810~regulation of cell-substrate adhesion,GO:0010720~positive regulation of cell development,GO:0010608~posttranscriptional regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010523~negative regulation of calcium ion transport into cytosol,GO:0010522~regulation of calcium ion transport into cytosol,GO:0010332~response to gamma radiation,GO:0010224~response to UV-B,GO:0010212~response to ionizing radiation,GO:0010044~response to aluminum ion,GO:0010039~response to iron ion,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0010033~response to organic substance,GO:0009994~oocyte differentiation,GO:0009991~response to extracellular stimulus,GO:0009791~post-embryonic development,GO:0009725~response to hormone stimulus,GO:0009719~response to endogenous stimulus,GO:0009636~response to toxin,GO:0009628~response to abiotic stimulus,GO:0009615~response to virus,GO:0009611~response to wounding,GO:0009416~response to light stimulus,GO:0009411~response to UV,GO:0009408~response to heat,GO:0009314~response to radiation,GO:0009266~response to temperature stimulus,GO:0008637~apoptotic mitochondrial changes,GO:0008633~activation of pro-apoptotic gene products,GO:0008585~female gonad development,GO:0008584~male gonad development,GO:0008544~epidermis development,GO:0008406~gonad development,GO:0008361~regulation of cell size,GO:0008285~negative regulation of cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007610~behavior,GO:0007584~response to nutrient,GO:0007569~cell aging,GO:0007568~aging,GO:0007565~female pregnancy,GO:0007548~sex differentiation,GO:0007423~sensory organ development,GO:0007409~axonogenesis,GO:0007398~ectoderm development,GO:0007346~regulation of mitotic cell cycle,GO:0007292~female gamete generation,GO:0007281~germ cell development,GO:0007276~gamete generation,GO:0007160~cell-matrix adhesion,GO:0007155~cell adhesion,GO:0007049~cell cycle,GO:0007044~cell-substrate junction assembly,GO:0007015~actin filament organization,GO:0007010~cytoskeleton organization,GO:0007006~mitochondrial membrane organization,GO:0007005~mitochondrion organization,GO:0006979~response to oxidative stress,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006952~defense response,GO:0006916~anti-apoptosis,GO:0006915~apoptosis,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006839~mitochondrial transport,GO:0006808~regulation of nitrogen utilization,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006582~melanin metabolic process,GO:0006470~protein amino acid dephosphorylation,GO:0006468~protein amino acid phosphorylation,GO:0003014~renal system process,GO:0003006~reproductive developmental process,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002360~T cell lineage commitment,GO:0002326~B cell lineage commitment,GO:0002320~lymphoid progenitor cell differentiation,GO:0002260~lymphocyte homeostasis,GO:0002252~immune effector process,GO:0002244~hemopoietic progenitor cell differentiation,GO:0002209~behavioral defense response,GO:0002009~morphogenesis of an epithelium,GO:0001952~regulation of cell-matrix adhesion,GO:0001942~hair follicle development,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001894~tissue homeostasis,GO:0001836~release of cytochrome c from mitochondria,GO:0001822~kidney development,GO:0001782~B cell homeostasis,GO:0001776~leukocyte homeostasis,GO:0001775~cell activation,GO:0001763~morphogenesis of a branching structure,GO:0001666~response to hypoxia,GO:0001662~behavioral fear response,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001657~ureteric bud development,GO:0001656~metanephros development,GO:0001655~urogenital system development,GO:0001558~regulation of cell growth,GO:0001541~ovarian follicle development,GO:0001503~ossification,GO:0001501~skeletal system development,GO:0001101~response to acid,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,GO:0000302~response to reactive oxygen species,GO:0000278~mitotic cell cycle,GO:0000082~G1/S transition of mitotic cell cycle,												GO:0044432~endoplasmic reticulum part,GO:0044429~mitochondrial part,GO:0043209~myelin sheath,GO:0042598~vesicular fraction,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0031975~envelope,GO:0031968~organelle outer membrane,GO:0031967~organelle envelope,GO:0031966~mitochondrial membrane,GO:0031965~nuclear membrane,GO:0031224~intrinsic to membrane,GO:0031090~organelle membrane,GO:0019867~outer membrane,GO:0016021~integral to membrane,GO:0012505~endomembrane system,GO:0008287~protein serine/threonine phosphatase complex,GO:0005955~calcineurin complex,GO:0005829~cytosol,GO:0005792~microsome,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005741~mitochondrial outer membrane,GO:0005740~mitochondrial envelope,GO:0005739~mitochondrion,GO:0005635~nuclear envelope,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,GO:0000159~protein phosphatase type 2A complex,																GO:0070513~death domain binding,GO:0051434~BH3 domain binding,GO:0051400~BH domain binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0030528~transcription regulator activity,GO:0019904~protein domain specific binding,GO:0019899~enzyme binding,GO:0016563~transcription activator activity,GO:0008134~transcription factor binding,GO:0002020~protease binding,							IPR013278:Apoptosis regulator, Bcl-2,IPR004725:Apoptosis regulator Bcl-X protein,IPR003093:Apoptosis regulator Bcl-2 protein, BH4,IPR002475:BCL2-like apoptosis inhibitor,IPR000712:Apoptosis regulator Bcl-2, BH,																				hsa05222:Small cell lung cancer,hsa05215:Prostate cancer,hsa05210:Colorectal cancer,hsa05200:Pathways in cancer,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa04722:Neurotrophin signaling pathway,hsa04510:Focal adhesion,hsa04210:Apoptosis,								Leukemia/lymphoma, B-cell, 2,																					SM00337:BCL,SM00265:BH4,											transmembrane,Proto-oncogene,polymorphism,phosphoprotein,nucleus,mitochondrion outer membrane,mitochondrion,membrane,endoplasmic reticulum,disease mutation,complete proteome,chromosomal rearrangement,Apoptosis,alternative splicing,3d-structure,						turn,transmembrane region,strand,splice variant,site:Cleavage; by caspase-3,short sequence motif:BH4,short sequence motif:BH3,short sequence motif:BH2,short sequence motif:BH1,sequence variant,sequence conflict,mutagenesis site,modified residue,helix,chain:Apoptosis regulator Bcl-2,										
822_s_at	CASP2 and RIPK1 domain containing adaptor with death domain	Homo sapiens											h_tnfr1Pathway:TNFR1 Signaling Pathway,h_stressPathway:TNF/Stress Related Signaling,h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF,								GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043065~positive regulation of apoptosis,GO:0042981~regulation of apoptosis,GO:0016265~death,GO:0012502~induction of programmed cell death,GO:0012501~programmed cell death,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0008219~cell death,GO:0006917~induction of apoptosis,GO:0006915~apoptosis,GO:0006508~proteolysis,															GO:0070513~death domain binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0030693~caspase activity,GO:0030674~protein binding, bridging,GO:0019904~protein domain specific binding,GO:0019899~enzyme binding,GO:0008234~cysteine-type peptidase activity,GO:0008233~peptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004175~endopeptidase activity,GO:0002020~protease binding,							IPR011029:DEATH-like,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR002398:Peptidase C14, caspase precursor p45,IPR001315:Caspase Recruitment,IPR000488:Death,															Many sequence variants affecting diversity of adult human height,										PIRSF037760:death domain-containing protein CRADD,																								SM00114:CARD,SM00005:DEATH,											complete proteome,Apoptosis,3d-structure,						turn,strand,helix,domain:Death,domain:CARD,chain:Death domain-containing protein CRADD,										
35595_at	CGRP receptor component	Homo sapiens						GO:0048610~reproductive cellular process,GO:0046903~secretion,GO:0032940~secretion by cell,GO:0032774~RNA biosynthetic process,GO:0019953~sexual reproduction,GO:0017156~calcium ion-dependent exocytosis,GO:0016192~vesicle-mediated transport,GO:0009566~fertilization,GO:0007340~acrosome reaction,GO:0007338~single fertilization,GO:0006887~exocytosis,GO:0006383~transcription from RNA polymerase III promoter,GO:0006351~transcription, DNA-dependent,GO:0006350~transcription,												GO:0044459~plasma membrane part,GO:0042575~DNA polymerase complex,GO:0009898~internal side of plasma membrane,GO:0009360~DNA polymerase III complex,GO:0005886~plasma membrane,																GO:0034062~RNA polymerase activity,GO:0016779~nucleotidyltransferase activity,GO:0004948~calcitonin receptor activity,GO:0003899~DNA-directed RNA polymerase activity,GO:0000166~nucleotide binding,							IPR019000:RNA polymerase III, subunit C17,IPR006590:RNA polymerase II, Rpb4, core,												PIRSF022700:PIRSF022700,																								SM00657:RPOL4c,											Transcription,receptor,phosphoprotein,nucleus,membrane,innate immunity,immune response,dna-directed rna polymerase,complete proteome,cell membrane,Antiviral defense,alternative splicing,						splice variant,modified residue,chain:DNA-directed RNA polymerase III subunit RPC9,										
37814_g_at	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51	Homo sapiens						GO:0042254~ribosome biogenesis,GO:0034660~ncRNA metabolic process,GO:0034470~ncRNA processing,GO:0022613~ribonucleoprotein complex biogenesis,GO:0016072~rRNA metabolic process,GO:0006396~RNA processing,GO:0006364~rRNA processing,												GO:0070013~intracellular organelle lumen,GO:0043233~organelle lumen,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0005730~nucleolus,																GO:0070035~purine NTP-dependent helicase activity,GO:0042623~ATPase activity, coupled,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0008026~ATP-dependent helicase activity,GO:0005524~ATP binding,GO:0004386~helicase activity,GO:0003723~RNA binding,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR014021:Helicase, superfamily 1 and 2, ATP-binding,IPR014001:DEAD-like helicase, N-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR001650:DNA/RNA helicase, C-terminal,IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,																							SM00490:HELICc,SM00487:DEXDc,											rrna processing,rna-binding,ribosome biogenesis,polymorphism,phosphoprotein,nucleus,nucleotide-binding,hydrolase,helicase,complete proteome,atp-binding,						short sequence motif:Q motif,short sequence motif:DEAD box,sequence variant,sequence conflict,nucleotide phosphate-binding region:ATP,modified residue,domain:Helicase C-terminal,domain:Helicase ATP-binding,compositionally biased region:Arg-rich,chain:ATP-dependent RNA helicase DDX51,										
936_s_at	DNA segment on chromosome 4 (unique) 234 expressed sequence	Homo sapiens						GO:0007212~dopamine receptor signaling pathway,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005794~Golgi apparatus,																GO:0050780~dopamine receptor binding,							IPR009431:D1 dopamine receptor-interacting, calcyon,												PIRSF002383:neuron specific protein/calcyon,PIRSF002383:Calcyon,																						transmembrane,Signal-anchor,membrane,golgi apparatus,complete proteome,						transmembrane region,topological domain:Lumenal,topological domain:Cytoplasmic,chain:Neuron-specific protein family member 1,										
32148_at	FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)	Homo sapiens						GO:0051056~regulation of small GTPase mediated signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,												GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0019898~extrinsic to membrane,GO:0005856~cytoskeleton,																GO:0060589~nucleoside-triphosphatase regulator activity,GO:0030695~GTPase regulator activity,GO:0008092~cytoskeletal protein binding,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005083~small GTPase regulator activity,							IPR019750:Band 4.1 subgroup,IPR019749:Band 4.1 domain,IPR019748:FERM central domain,IPR019747:FERM conserved site,IPR018980:FERM, C-terminal PH-like domain,IPR018979:FERM, N-terminal,IPR014847:FERM adjacent (FA),IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR011993:Pleckstrin homology-type,IPR001849:Pleckstrin homology,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR000798:Ezrin/radixin/moesin ERM,IPR000299:FERM domain,IPR000219:Dbl homology (DH) domain,																							SM00325:RhoGEF,SM00295:B41,SM00233:PH,											repeat,polymorphism,phosphoprotein,guanine-nucleotide releasing factor,complete proteome,alternative splicing,						splice variant,sequence variant,sequence conflict,modified residue,domain:PH 2,domain:PH 1,domain:FERM,domain:DH,compositionally biased region:Poly-Glu,chain:FERM, RhoGEF and pleckstrin domain- containing protein 1,										
33293_at	Fas apoptotic inhibitory molecule 2	Homo sapiens						GO:0060548~negative regulation of cell death,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptosis,GO:0042981~regulation of apoptosis,GO:0016265~death,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0008219~cell death,GO:0006916~anti-apoptosis,GO:0006915~apoptosis,												GO:0045211~postsynaptic membrane,GO:0045202~synapse,GO:0044459~plasma membrane part,GO:0044456~synapse part,GO:0031224~intrinsic to membrane,GO:0030054~cell junction,GO:0016021~integral to membrane,GO:0005886~plasma membrane,										IPR006214:Uncharacterised protein family UPF0005,															Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity,																			transmembrane,synapse,postsynaptic cell membrane,phosphoprotein,membrane,glycoprotein,complete proteome,cell membrane,cell junction,Apoptosis,						transmembrane region,sequence conflict,modified residue,glycosylation site:N-linked (GlcNAc...),compositionally biased region:Poly-Ser,chain:Fas apoptotic inhibitory molecule 2,										
38103_at	GRB10 interacting GYF protein 2	Homo sapiens		IPR003169:GYF,															Parkinson disease 11,																					SM00444:GYF,											polymorphism,phosphoprotein,parkinson disease,disease mutation,complete proteome,alternative splicing,						splice variant,sequence variant,sequence conflict,region of interest:Required for GRB10-binding,modified residue,domain:GYF,compositionally biased region:Pro-rich,compositionally biased region:Poly-Gly,compositionally biased region:Glu-rich,compositionally biased region:Gln-rich,compositionally biased region:Arg-rich,chain:PERQ amino acid-rich with GYF domain- containing protein 2,										
39698_at	HOP homeobox	Homo sapiens											h_hopPathway:Hop Pathway in Cardiac Development,								GO:0060541~respiratory system development,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051094~positive regulation of developmental process,GO:0048639~positive regulation of developmental growth,GO:0048638~regulation of developmental growth,GO:0048286~lung alveolus development,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045927~positive regulation of growth,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045597~positive regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045449~regulation of transcription,GO:0043416~regulation of skeletal muscle regeneration,GO:0043415~positive regulation of skeletal muscle regeneration,GO:0043009~chordate embryonic development,GO:0040008~regulation of growth,GO:0035295~tube development,GO:0032101~regulation of response to external stimulus,GO:0031327~negative regulation of cellular biosynthetic process,GO:0030324~lung development,GO:0030323~respiratory tube development,GO:0016481~negative regulation of transcription,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0007507~heart development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,GO:0001829~trophectodermal cell differentiation,GO:0001825~blastocyst formation,GO:0001824~blastocyst development,GO:0001701~in utero embryonic development,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,															GO:0043565~sequence-specific DNA binding,GO:0030528~transcription regulator activity,GO:0016564~transcription repressor activity,GO:0003700~transcription factor activity,GO:0003677~DNA binding,							IPR017970:Homeobox, conserved site,IPR012287:Homeodomain-related,IPR001356:Homeobox,																							SM00389:HOX,											transcription regulation,Transcription,repressor,Proto-oncogene,nucleus,Homeobox,developmental protein,complete proteome,alternative splicing,						splice variant,sequence conflict,DNA-binding region:Homeobox; atypical,chain:Homeodomain-only protein,										
34618_at	Indian hedgehog homolog (Drosophila)	Homo sapiens						GO:0060548~negative regulation of cell death,GO:0060348~bone development,GO:0060135~maternal process involved in female pregnancy,GO:0051604~protein maturation,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051094~positive regulation of developmental process,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0048754~branching morphogenesis of a tube,GO:0048609~reproductive process in a multicellular organism,GO:0048545~response to steroid hormone stimulus,GO:0048514~blood vessel morphogenesis,GO:0048469~cell maturation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045941~positive regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045597~positive regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045449~regulation of transcription,GO:0043627~response to estrogen stimulus,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptosis,GO:0042981~regulation of apoptosis,GO:0042127~regulation of cell proliferation,GO:0035295~tube development,GO:0035239~tube morphogenesis,GO:0032504~multicellular organism reproduction,GO:0032355~response to estradiol stimulus,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032330~regulation of chondrocyte differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031016~pancreas development,GO:0030908~protein splicing,GO:0021700~developmental maturation,GO:0016539~intein-mediated protein splicing,GO:0016485~protein processing,GO:0010941~regulation of cell death,GO:0010648~negative regulation of cell communication,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010033~response to organic substance,GO:0009968~negative regulation of signal transduction,GO:0009891~positive regulation of biosynthetic process,GO:0009725~response to hormone stimulus,GO:0009719~response to endogenous stimulus,GO:0008284~positive regulation of cell proliferation,GO:0007565~female pregnancy,GO:0007389~pattern specification process,GO:0007267~cell-cell signaling,GO:0006508~proteolysis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0001944~vasculature development,GO:0001763~morphogenesis of a branching structure,GO:0001649~osteoblast differentiation,GO:0001569~patterning of blood vessels,GO:0001568~blood vessel development,GO:0001525~angiogenesis,GO:0001503~ossification,GO:0001501~skeletal system development,												GO:0044459~plasma membrane part,GO:0044421~extracellular region part,GO:0009986~cell surface,GO:0009897~external side of plasma membrane,GO:0005886~plasma membrane,GO:0005615~extracellular space,GO:0005576~extracellular region,																GO:0032934~sterol binding,GO:0015485~cholesterol binding,GO:0008289~lipid binding,GO:0008233~peptidase activity,GO:0005496~steroid binding,GO:0005113~patched binding,							IPR006141:Intein splicing site,IPR003587:Hedgehog/intein hint, N-terminal,IPR003586:Hedgehog/intein hint domain, C-terminal,IPR001767:Peptidase C46, hedgehog protein, hint region,IPR001657:Peptidase C46, hedgehog protein,IPR000320:Hedgehog amino-terminal signaling region,																				hsa04340:Hedgehog signaling pathway,								Many sequence variants affecting diversity of adult human height,Genome-wide association analysis identifies 20 loci that influence adult height,Brachydactyly, type A1,Acrocapitofemoral dysplasia,										PIRSF009400:Peptidase_C46,PIRSF009400:hedgehog protein,																								SM00306:HintN,SM00305:HintC,											signal,Secreted,Protease,palmitate,membrane,lipoprotein,hydrolase,glycoprotein,disease mutation,developmental protein,complete proteome,cell membrane,autocatalytic cleavage,						site:Involved in cholesterol transfer,site:Involved in auto-cleavage,site:Essential for auto-cleavage,site:Cleavage; by autolysis,signal peptide,sequence variant,sequence conflict,lipid moiety-binding region:N-palmitoyl cysteine,lipid moiety-binding region:Cholesterol glycine ester,glycosylation site:N-linked (GlcNAc...),chain:Indian hedgehog protein N-product,chain:Indian hedgehog protein C-product,chain:Indian hedgehog protein,										
1645_at	KiSS-1 metastasis-suppressor	Homo sapiens						GO:0007010~cytoskeleton organization,												GO:0005576~extracellular region,																		signal,Secreted,polymorphism,phosphoprotein,direct protein sequencing,complete proteome,cleavage on pair of basic residues,amidation,						site:Cleavage; by MMP2 and MMP9,signal peptide,sequence variant,sequence conflict,region of interest:Essential for receptor binding and receptor activation,peptide:Metastin,peptide:Kisspeptin-14,peptide:Kisspeptin-13,peptide:Kisspeptin-10,modified residue,chain:Metastasis-suppressor KiSS-1,										
38128_at	N-acetyltransferase 8 (GCN5-related, putative); N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene)	Homo sapiens						GO:0048598~embryonic morphogenesis,GO:0042493~response to drug,GO:0007369~gastrulation,GO:0001702~gastrulation with mouth forming second,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,																GO:0016410~N-acyltransferase activity,GO:0016407~acetyltransferase activity,GO:0008080~N-acetyltransferase activity,							IPR016181:Acyl-CoA N-acyltransferase,IPR000182:GCN5-related N-acetyltransferase,												PIRSF027824:PIRSF027824,																						transmembrane,transferase,polymorphism,membrane,gastrulation,developmental protein,complete proteome,Acyltransferase,						transmembrane region,sequence variant,sequence conflict,domain:N-acetyltransferase,chain:Probable N-acetyltransferase 8B,chain:Probable N-acetyltransferase 8,										
40058_s_at	PDZ and LIM domain 5	Homo sapiens					GO:0044449~contractile fiber part,GO:0043292~contractile fiber,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0031674~I band,GO:0030018~Z disc,GO:0030017~sarcomere,GO:0030016~myofibril,GO:0015629~actin cytoskeleton,GO:0005856~cytoskeleton,GO:0005829~cytosol,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,																GO:0047485~protein N-terminus binding,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042805~actinin binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0008270~zinc ion binding,GO:0008092~cytoskeletal protein binding,GO:0005080~protein kinase C binding,GO:0003779~actin binding,							IPR001781:Zinc finger, LIM-type,IPR001478:PDZ/DHR/GLGF,																							SM00228:PDZ,SM00132:LIM,											zinc,repeat,polymorphism,phosphoprotein,metal-binding,LIM domain,direct protein sequencing,complete proteome,acetylation,3d-structure,						turn,strand,sequence variant,modified residue,helix,domain:PDZ,domain:LIM zinc-binding 3,domain:LIM zinc-binding 2,domain:LIM zinc-binding 1,chain:PDZ and LIM domain protein 5,										
33922_at	PR domain containing 2, with ZNF domain	Homo sapiens						GO:0051252~regulation of RNA metabolic process,GO:0045449~regulation of transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,												GO:0005794~Golgi apparatus,																GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042054~histone methyltransferase activity,GO:0030528~transcription regulator activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0008270~zinc ion binding,GO:0008170~N-methyltransferase activity,GO:0003700~transcription factor activity,GO:0003677~DNA binding,							IPR015880:Zinc finger, C2H2-like,IPR009170:Predicted retinoblastoma binding protein (RIZ),IPR007087:Zinc finger, C2H2-type,IPR001214:SET,												PIRSF002395:RIZ_SET,PIRSF002395:retinoblastoma binding protein (RIZ),																								SM00355:ZnF_C2H2,SM00317:SET,											zinc-finger,zinc finger,zinc,transferase,transcription regulation,Transcription,s-adenosyl-l-methionine,repeat,polymorphism,phosphoprotein,nucleus,methyltransferase,metal-binding,dna-binding,complete proteome,alternative splicing,alternative initiation,activator,3d-structure,						zinc finger region:C2H2-type 8; atypical,zinc finger region:C2H2-type 7; atypical,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 1,turn,strand,splice variant,short sequence motif:SH3-binding,sequence variant,sequence conflict,region of interest:Retinoblastoma protein binding,mutagenesis site,modified residue,helix,domain:SET,compositionally biased region:Pro-rich,compositionally biased region:Poly-Ser,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Arg/Lys-rich (basic),chain:PR domain zinc finger protein 2,										
35069_at	PRAME family member 2	Homo sapiens	PIRSF038286:preferentially expressed antigen of melanoma (PRAME) family protein,																						repeat,polymorphism,leucine-rich repeat,complete proteome,						sequence variant,repeat:LRR 3,repeat:LRR 2,repeat:LRR 1,chain:PRAME family member 2,										
33371_s_at	RAB31, member RAS oncogene family	Homo sapiens						GO:0045184~establishment of protein localization,GO:0015031~protein transport,GO:0008104~protein localization,GO:0007264~small GTPase mediated signal transduction,GO:0007242~intracellular signaling cascade,												GO:0044459~plasma membrane part,GO:0009898~internal side of plasma membrane,GO:0005886~plasma membrane,																GO:0032561~guanyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0005525~GTP binding,GO:0003924~GTPase activity,GO:0000166~nucleotide binding,							IPR015594:Rab22-related,IPR013753:Ras,IPR005225:Small GTP-binding protein,IPR003579:Ras small GTPase, Rab type,IPR001806:Ras GTPase,																				hsa04144:Endocytosis,																SM00175:RAB,											prenylation,phosphoprotein,P-loop,nucleotide-binding,nucleotide binding,membrane,lipoprotein,gtp-binding,GTP binding,complete proteome,cell membrane,3d-structure,						turn,strand,short sequence motif:Effector region,sequence conflict,nucleotide phosphate-binding region:GTP,mutagenesis site,modified residue,lipid moiety-binding region:S-geranylgeranyl cysteine,helix,chain:Ras-related protein Rab-31,										
966_at	RAD54-like (S. cerevisiae)	Homo sapiens						GO:0051327~M phase of meiotic cell cycle,GO:0051321~meiotic cell cycle,GO:0051276~chromosome organization,GO:0042493~response to drug,GO:0033554~cellular response to stress,GO:0022403~cell cycle phase,GO:0022402~cell cycle process,GO:0010212~response to ionizing radiation,GO:0009628~response to abiotic stimulus,GO:0009314~response to radiation,GO:0007126~meiosis,GO:0007049~cell cycle,GO:0006974~response to DNA damage stimulus,GO:0006310~DNA recombination,GO:0006302~double-strand break repair,GO:0006281~DNA repair,GO:0006259~DNA metabolic process,GO:0000725~recombinational repair,GO:0000724~double-strand break repair via homologous recombination,GO:0000279~M phase,															GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0005524~ATP binding,GO:0004386~helicase activity,GO:0003677~DNA binding,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR014021:Helicase, superfamily 1 and 2, ATP-binding,IPR014001:DEAD-like helicase, N-terminal,IPR001650:DNA/RNA helicase, C-terminal,IPR000330:SNF2-related,																				hsa03440:Homologous recombination,								Lymphoma, non-Hodgkin,Colon adenocarcinoma,Breast cancer, invasive intraductal,																					SM00490:HELICc,SM00487:DEXDc,											Proto-oncogene,polymorphism,nucleus,nucleotide-binding,hydrolase,helicase,dna-binding,dna repair,DNA damage,disease mutation,complete proteome,atp-binding,						short sequence motif:DEGH box,sequence variant,sequence conflict,nucleotide phosphate-binding region:ATP,mutagenesis site,domain:Helicase C-terminal,domain:Helicase ATP-binding,chain:DNA repair and recombination protein RAD54-like,										
33080_s_at	RAP1 GTPase activating protein	Homo sapiens						GO:0051056~regulation of small GTPase mediated signal transduction,												GO:0019898~extrinsic to membrane,GO:0005829~cytosol,GO:0005794~Golgi apparatus,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,																GO:0060589~nucleoside-triphosphatase regulator activity,GO:0030695~GTPase regulator activity,GO:0008047~enzyme activator activity,GO:0005096~GTPase activator activity,GO:0003924~GTPase activity,							IPR003109:GoLoco motif,IPR000331:Rap/ran-GAP,															Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes,										PIRSF019623:Rap1 GTPase-activating protein,																								SM00390:GoLoco,											polymorphism,phosphoprotein,membrane,GTPase activation,golgi apparatus,complete proteome,alternative splicing,acetylation,3d-structure,						turn,strand,splice variant,sequence variant,modified residue,helix,domain:Rap-GAP,domain:GoLoco,chain:Rap1 GTPase-activating protein 1,										
606_at	Rho family GTPase 2	Homo sapiens						GO:0007264~small GTPase mediated signal transduction,GO:0007242~intracellular signaling cascade,												GO:0044459~plasma membrane part,GO:0009898~internal side of plasma membrane,GO:0005886~plasma membrane,GO:0005769~early endosome,GO:0005768~endosome,																GO:0047485~protein N-terminus binding,GO:0032561~guanyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0005525~GTP binding,GO:0003924~GTPase activity,GO:0000166~nucleotide binding,							IPR013753:Ras,IPR005225:Small GTP-binding protein,IPR003578:Ras small GTPase, Rho type,IPR001806:Ras GTPase,												PIRSF037169:small GTPase, Rho type,																								SM00174:RHO,											prenylation,nucleotide-binding,methylation,membrane,lipoprotein,gtp-binding,cytoplasmic vesicle,complete proteome,						short sequence motif:Effector region,propeptide:Removed in mature form,nucleotide phosphate-binding region:GTP,modified residue,lipid moiety-binding region:S-geranylgeranyl cysteine,chain:Rho-related GTP-binding protein RhoN,										
39908_at	TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa	Homo sapiens													Transcription,						GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0051276~chromosome organization,GO:0051252~regulation of RNA metabolic process,GO:0051101~regulation of DNA binding,GO:0051098~regulation of binding,GO:0051090~regulation of transcription factor activity,GO:0045449~regulation of transcription,GO:0043966~histone H3 acetylation,GO:0043933~macromolecular complex subunit organization,GO:0043543~protein amino acid acylation,GO:0032774~RNA biosynthetic process,GO:0016573~histone acetylation,GO:0016570~histone modification,GO:0016569~covalent chromatin modification,GO:0016568~chromatin modification,GO:0006473~protein amino acid acetylation,GO:0006461~protein complex assembly,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006351~transcription, DNA-dependent,GO:0006350~transcription,GO:0006338~chromatin remodeling,GO:0006325~chromatin organization,												GO:0070461~SAGA-type complex,GO:0070013~intracellular organelle lumen,GO:0044451~nucleoplasm part,GO:0043233~organelle lumen,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0030914~STAGA complex,GO:0016585~chromatin remodeling complex,GO:0005654~nucleoplasm,GO:0000123~histone acetyltransferase complex,GO:0000118~histone deacetylase complex,																GO:0030528~transcription regulator activity,GO:0016563~transcription activator activity,GO:0016410~N-acyltransferase activity,GO:0016407~acetyltransferase activity,GO:0008134~transcription factor binding,GO:0008080~N-acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0004402~histone acetyltransferase activity,GO:0003713~transcription coactivator activity,GO:0003712~transcription cofactor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003677~DNA binding,							IPR011442:Protein of unknown function DUF1546,IPR009072:Histone-fold,IPR004823:TATA box binding protein associated factor (TAF),																				hsa03022:Basal transcription factors,																SM00803:TAF,											transcription regulation,Transcription,phosphoprotein,nucleus,direct protein sequencing,complete proteome,						modified residue,chain:TAF6-like RNA polymerase II p300/CBP- associated factor-associated factor 65 kDa subunit 6L,										
32680_at	TRAF2 and NCK interacting kinase	Homo sapiens						GO:0033554~cellular response to stress,GO:0031098~stress-activated protein kinase signaling pathway,GO:0016310~phosphorylation,GO:0007254~JNK cascade,GO:0007243~protein kinase cascade,GO:0007242~intracellular signaling cascade,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein amino acid phosphorylation,GO:0000165~MAPKKK cascade,															GO:0060589~nucleoside-triphosphatase regulator activity,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030695~GTPase regulator activity,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0005524~ATP binding,GO:0005083~small GTPase regulator activity,GO:0004674~protein serine/threonine kinase activity,GO:0004672~protein kinase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR017442:Serine/threonine protein kinase-related,IPR017441:Protein kinase, ATP binding site,IPR008271:Serine/threonine protein kinase, active site,IPR002290:Serine/threonine protein kinase,IPR001180:Citron-like,IPR000719:Protein kinase, core,															A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype,																					SM00220:S_TKc,SM00036:CNH,											wnt signaling pathway,transferase,serine/threonine-protein kinase,polymorphism,phosphoprotein,nucleus,nucleotide-binding,kinase,cytoplasm,complete proteome,atp-binding,alternative splicing,						splice variant,sequence variant,nucleotide phosphate-binding region:ATP,mutagenesis site,modified residue,domain:Protein kinase,domain:CNH,chain:Traf2 and NCK-interacting protein kinase,binding site:ATP,active site:Proton acceptor,										
35213_at	WW domain binding protein 4 (formin binding protein 21)	Homo sapiens						GO:0016071~mRNA metabolic process,GO:0008380~RNA splicing,GO:0006397~mRNA processing,GO:0006396~RNA processing,												GO:0070013~intracellular organelle lumen,GO:0044451~nucleoplasm part,GO:0043233~organelle lumen,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0030529~ribonucleoprotein complex,GO:0016607~nuclear speck,GO:0016604~nuclear body,GO:0005681~spliceosome,GO:0005654~nucleoplasm,																GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0008270~zinc ion binding,							IPR013085:Zinc finger, U1-C type,IPR003604:Zinc finger, U1-type,IPR001202:WW/Rsp5/WWP,IPR000690:Zinc finger, C2H2-type matrin,																							SM00456:WW,SM00451:ZnF_U1,											zinc-finger,zinc,Spliceosome,repeat,polymorphism,nucleus,mrna splicing,mrna processing,metal-binding,complete proteome,3d-structure,						zinc finger region:Matrin-type,strand,sequence variant,mutagenesis site,domain:WW 2,domain:WW 1,compositionally biased region:Lys-rich,chain:WW domain-binding protein 4,										
40089_at	Williams Beuren syndrome chromosome region 22	Homo sapiens		IPR013216:Methyltransferase type 11,																				hsa00450:Selenoamino acid metabolism,hsa00350:Tyrosine metabolism,hsa00340:Histidine metabolism,hsa00150:Androgen and estrogen metabolism,					PIRSF016329:PIRSF016329,																						williams-beuren syndrome,transferase,nucleus,methyltransferase,complete proteome,alternative splicing,						splice variant,chain:Uncharacterized methyltransferase WBSCR22,										
34606_s_at	activating transcription factor 7	Homo sapiens						GO:0051252~regulation of RNA metabolic process,GO:0045449~regulation of transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,															GO:0046983~protein dimerization activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043565~sequence-specific DNA binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0030528~transcription regulator activity,GO:0008270~zinc ion binding,GO:0003700~transcription factor activity,GO:0003677~DNA binding,							IPR020003:ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain, active site,IPR016378:Transcription factor, cyclic AMP-dependent,IPR015880:Zinc finger, C2H2-like,IPR011616:bZIP transcription factor, bZIP-1,IPR007087:Zinc finger, C2H2-type,IPR004827:Basic-leucine zipper (bZIP) transcription factor,												PIRSF003153:cyclic AMP-dependent transcription factor, CRE-BP1 type,PIRSF003153:ATF2_CRE-BP1,																								SM00355:ZnF_C2H2,SM00338:BRLZ,											zinc-finger,zinc,transcription regulation,Transcription,phosphoprotein,nucleus,metal-binding,leucine zipper,dna-binding,DNA binding,complete proteome,alternative splicing,activator,						zinc finger region:C2H2-type,splice variant,modified residue,domain:Leucine-zipper,DNA-binding region:Basic motif,chain:Cyclic AMP-dependent transcription factor ATF-7,										
40317_at	amiloride-sensitive cation channel 1, neuronal	Homo sapiens						GO:0050877~neurological system process,GO:0030001~metal ion transport,GO:0019226~transmission of nerve impulse,GO:0015672~monovalent inorganic cation transport,GO:0007422~peripheral nervous system development,GO:0007268~synaptic transmission,GO:0007267~cell-cell signaling,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,																GO:0046873~metal ion transmembrane transporter activity,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0031420~alkali metal ion binding,GO:0031402~sodium ion binding,GO:0022838~substrate specific channel activity,GO:0022836~gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022803~passive transmembrane transporter activity,GO:0015276~ligand-gated ion channel activity,GO:0015267~channel activity,GO:0005272~sodium channel activity,GO:0005261~cation channel activity,GO:0005216~ion channel activity,							IPR004724:Epithelial sodium channel,IPR001873:Na+ channel, amiloride-sensitive,																				hsa04742:Taste transduction,														transport,transmembrane,Sodium transport,sodium channel,Sodium,polymorphism,membrane,ionic channel,ion transport,glycoprotein,disulfide bond,complete proteome,cell membrane,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,sequence variant,sequence conflict,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Amiloride-sensitive cation channel 1, neuronal,										
37953_s_at	amiloride-sensitive cation channel 2, neuronal	Homo sapiens						GO:0030001~metal ion transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0015672~monovalent inorganic cation transport,GO:0009628~response to abiotic stimulus,GO:0009268~response to pH,GO:0006816~calcium ion transport,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,																GO:0046873~metal ion transmembrane transporter activity,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0031420~alkali metal ion binding,GO:0031402~sodium ion binding,GO:0022838~substrate specific channel activity,GO:0022836~gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022803~passive transmembrane transporter activity,GO:0015276~ligand-gated ion channel activity,GO:0015267~channel activity,GO:0005509~calcium ion binding,GO:0005272~sodium channel activity,GO:0005261~cation channel activity,GO:0005216~ion channel activity,							IPR004724:Epithelial sodium channel,IPR001873:Na+ channel, amiloride-sensitive,																					transport,transmembrane,Sodium transport,sodium channel,Sodium,phosphoprotein,membrane,ionic channel,ion transport,glycoprotein,disulfide bond,complete proteome,cell membrane,calcium transport,calcium,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,mutagenesis site,modified residue,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Amiloride-sensitive cation channel 2, neuronal,										
37983_at	angiotensin II receptor, type 1	Homo sapiens											h_At1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,								GO:0060193~positive regulation of lipase activity,GO:0060191~regulation of lipase activity,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055065~metal ion homeostasis,GO:0051482~elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating),GO:0051480~cytosolic calcium ion homeostasis,GO:0051353~positive regulation of oxidoreductase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051341~regulation of oxidoreductase activity,GO:0051336~regulation of hydrolase activity,GO:0051247~positive regulation of protein metabolic process,GO:0051094~positive regulation of developmental process,GO:0051046~regulation of secretion,GO:0050886~endocrine process,GO:0050880~regulation of blood vessel size,GO:0050801~ion homeostasis,GO:0050729~positive regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0048878~chemical homeostasis,GO:0048584~positive regulation of response to stimulus,GO:0048015~phosphoinositide-mediated signaling,GO:0045940~positive regulation of steroid metabolic process,GO:0045834~positive regulation of lipid metabolic process,GO:0045597~positive regulation of cell differentiation,GO:0044093~positive regulation of molecular function,GO:0044062~regulation of excretion,GO:0044057~regulation of system process,GO:0043933~macromolecular complex subunit organization,GO:0043085~positive regulation of catalytic activity,GO:0042592~homeostatic process,GO:0042312~regulation of vasodilation,GO:0042127~regulation of cell proliferation,GO:0040008~regulation of growth,GO:0035150~regulation of tube size,GO:0034374~low-density lipoprotein particle remodeling,GO:0034369~plasma lipoprotein particle remodeling,GO:0034368~protein-lipid complex remodeling,GO:0034367~macromolecular complex remodeling,GO:0033864~positive regulation of NAD(P)H oxidase activity,GO:0033860~regulation of NAD(P)H oxidase activity,GO:0032844~regulation of homeostatic process,GO:0032430~positive regulation of phospholipase A2 activity,GO:0032429~regulation of phospholipase A2 activity,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031349~positive regulation of defense response,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030003~cellular cation homeostasis,GO:0019932~second-messenger-mediated signaling,GO:0019725~cellular homeostasis,GO:0019722~calcium-mediated signaling,GO:0019229~regulation of vasoconstriction,GO:0019218~regulation of steroid metabolic process,GO:0019216~regulation of lipid metabolic process,GO:0010873~positive regulation of cholesterol esterification,GO:0010872~regulation of cholesterol esterification,GO:0010863~positive regulation of phospholipase C activity,GO:0010744~positive regulation of foam cell differentiation,GO:0010743~regulation of foam cell differentiation,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010518~positive regulation of phospholipase activity,GO:0010517~regulation of phospholipase activity,GO:0008217~regulation of blood pressure,GO:0008015~blood circulation,GO:0007242~intracellular signaling cascade,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007202~activation of phospholipase C activity,GO:0007200~activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0003078~regulation of natriuresis,GO:0003073~regulation of systemic arterial blood pressure,GO:0003072~renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,GO:0003071~renal system process involved in regulation of systemic arterial blood pressure,GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0003018~vascular process in circulatory system,GO:0003014~renal system process,GO:0003013~circulatory system process,GO:0002034~regulation of blood vessel size by renin-angiotensin,GO:0002018~renin-angiotensin regulation of aldosterone production,GO:0002016~regulation of blood volume by renin-angiotensin,GO:0001990~regulation of systemic arterial blood pressure by hormone,GO:0001822~kidney development,GO:0001655~urogenital system development,GO:0001558~regulation of cell growth,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,																GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0042277~peptide binding,GO:0031711~bradykinin receptor binding,GO:0019958~C-X-C chemokine binding,GO:0019956~chemokine binding,GO:0019955~cytokine binding,GO:0016494~C-X-C chemokine receptor activity,GO:0010698~acetyltransferase activator activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0008047~enzyme activator activity,GO:0004950~chemokine receptor activity,GO:0004947~bradykinin receptor activity,GO:0001653~peptide receptor activity,GO:0001595~angiotensin receptor activity,							IPR017452:GPCR, rhodopsin-like superfamily,IPR000276:7TM GPCR, rhodopsin-like,IPR000248:Angiotensin II receptor,IPR000190:AT1 angiotensin II receptor,																				hsa04614:Renin-angiotensin system,hsa04270:Vascular smooth muscle contraction,hsa04080:Neuroactive ligand-receptor interaction,hsa04020:Calcium signaling pathway,								Renal tubular dysgenesis,Hypertension, essential,										PIRSF800006:rhodopsin-like G protein-coupled receptors,PIRSF501034:angiotensin II receptor 1,PIRSF038557:angiotensin II receptor,																						transmembrane protein,transmembrane,transducer,receptor,polymorphism,phosphoprotein,palmitate,membrane,lipoprotein,hormone receptor,glycoprotein,g-protein coupled receptor,G protein-coupled receptor,disulfide bond,disease mutation,complete proteome,cell membrane,3d-structure,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,sequence variant,sequence conflict,lipid moiety-binding region:S-palmitoyl cysteine,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Type-1 angiotensin II receptor,										
37954_at	annexin A8-like 2	Homo sapiens						GO:0050878~regulation of body fluid levels,GO:0050817~coagulation,GO:0042060~wound healing,GO:0009611~response to wounding,GO:0007599~hemostasis,GO:0007596~blood coagulation,															GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0008289~lipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005543~phospholipid binding,GO:0005509~calcium ion binding,							IPR018502:Annexin repeat,IPR018252:Annexin repeat, conserved site,IPR009115:Annexin, type VIII,IPR001464:Annexin,												PIRSF002359:annexin I,																								SM00335:ANX,											repeat,polymorphism,phospholipid binding,endonexin fold,duplication,complete proteome,calcium/phospholipid-binding,calcium binding,calcium,blood coagulation,annexin,alternative splicing,3d-structure,						turn,strand,splice variant,sequence variant,sequence conflict,repeat:Annexin 4,repeat:Annexin 3,repeat:Annexin 2,repeat:Annexin 1,helix,chain:Annexin A8-like protein 2,chain:Annexin A8,										
34636_at	arachidonate 15-lipoxygenase	Homo sapiens						GO:0060348~bone development,GO:0055114~oxidation reduction,GO:0046456~icosanoid biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0043450~alkene biosynthetic process,GO:0043449~cellular alkene metabolic process,GO:0033559~unsaturated fatty acid metabolic process,GO:0031214~biomineral formation,GO:0030282~bone mineralization,GO:0019370~leukotriene biosynthetic process,GO:0016053~organic acid biosynthetic process,GO:0009611~response to wounding,GO:0008610~lipid biosynthetic process,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006691~leukotriene metabolic process,GO:0006690~icosanoid metabolic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0006633~fatty acid biosynthetic process,GO:0006631~fatty acid metabolic process,GO:0001503~ossification,GO:0001501~skeletal system development,GO:0000038~very-long-chain fatty acid metabolic process,												GO:0005829~cytosol,																GO:0050473~arachidonate 15-lipoxygenase activity,GO:0047977~hepoxilin-epoxide hydrolase activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0016803~ether hydrolase activity,GO:0016801~hydrolase activity, acting on ether bonds,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016165~lipoxygenase activity,GO:0005506~iron ion binding,							IPR013819:Lipoxygenase, C-terminal,IPR001885:Lipoxygenase, mammalian,IPR001024:Lipoxygenase, LH2,IPR000907:Lipoxygenase,																				hsa00591:Linoleic acid metabolism,hsa00590:Arachidonic acid metabolism,					PIRSF000316:arachidonate 5-lipoxygenase,																								SM00308:LH2,											polymorphism,oxidoreductase,metalloprotein,metal-binding,leukotriene biosynthesis,iron,fatty acid oxidation,direct protein sequencing,dioxygenase,cytoplasm,complete proteome,3d-structure,						sequence variant,sequence conflict,mutagenesis site,metal ion-binding site:Iron; via carboxylate; catalytic,metal ion-binding site:Iron; catalytic,domain:PLAT,domain:Lipoxygenase,chain:Arachidonate 15-lipoxygenase,										
35648_at	autism susceptibility candidate 2	Homo sapiens										polymorphism,phosphoprotein,complete proteome,chromosomal rearrangement,alternative splicing,						splice variant,sequence variant,sequence conflict,modified residue,compositionally biased region:Ser-rich,compositionally biased region:His-rich,chain:Autism susceptibility gene 2 protein,										
33963_at	azurocidin 1	Homo sapiens						GO:0060627~regulation of vesicle-mediated transport,GO:0060548~negative regulation of cell death,GO:0060326~cell chemotaxis,GO:0051674~localization of cell,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051174~regulation of phosphorus metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051050~positive regulation of transport,GO:0050930~induction of positive chemotaxis,GO:0050927~positive regulation of positive chemotaxis,GO:0050926~regulation of positive chemotaxis,GO:0050921~positive regulation of chemotaxis,GO:0050920~regulation of chemotaxis,GO:0050900~leukocyte migration,GO:0050829~defense response to Gram-negative bacterium,GO:0050795~regulation of behavior,GO:0050766~positive regulation of phagocytosis,GO:0050764~regulation of phagocytosis,GO:0050754~positive regulation of fractalkine biosynthetic process,GO:0050752~regulation of fractalkine biosynthetic process,GO:0050725~positive regulation of interleukin-1 beta biosynthetic process,GO:0050722~regulation of interleukin-1 beta biosynthetic process,GO:0048870~cell motility,GO:0048584~positive regulation of response to stimulus,GO:0048520~positive regulation of behavior,GO:0048246~macrophage chemotaxis,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045807~positive regulation of endocytosis,GO:0045785~positive regulation of cell adhesion,GO:0045362~positive regulation of interleukin-1 biosynthetic process,GO:0045360~regulation of interleukin-1 biosynthetic process,GO:0045348~positive regulation of MHC class II biosynthetic process,GO:0045346~regulation of MHC class II biosynthetic process,GO:0045321~leukocyte activation,GO:0045123~cellular extravasation,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045073~regulation of chemokine biosynthetic process,GO:0044093~positive regulation of molecular function,GO:0043549~regulation of kinase activity,GO:0043114~regulation of vascular permeability,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptosis,GO:0042981~regulation of apoptosis,GO:0042742~defense response to bacterium,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0042534~regulation of tumor necrosis factor biosynthetic process,GO:0042330~taxis,GO:0042325~regulation of phosphorylation,GO:0042117~monocyte activation,GO:0042116~macrophage activation,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042063~gliogenesis,GO:0042035~regulation of cytokine biosynthetic process,GO:0040017~positive regulation of locomotion,GO:0040012~regulation of locomotion,GO:0033674~positive regulation of kinase activity,GO:0032680~regulation of tumor necrosis factor production,GO:0032652~regulation of interleukin-1 production,GO:0032651~regulation of interleukin-1 beta production,GO:0032644~regulation of fractalkine production,GO:0032642~regulation of chemokine production,GO:0032147~activation of protein kinase activity,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031328~positive regulation of cellular biosynthetic process,GO:0030595~leukocyte chemotaxis,GO:0030155~regulation of cell adhesion,GO:0030100~regulation of endocytosis,GO:0019220~regulation of phosphate metabolic process,GO:0016477~cell migration,GO:0010941~regulation of cell death,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009617~response to bacterium,GO:0009611~response to wounding,GO:0008347~glial cell migration,GO:0008015~blood circulation,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0007205~activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~cell motion,GO:0006916~anti-apoptosis,GO:0006508~proteolysis,GO:0003018~vascular process in circulatory system,GO:0003013~circulatory system process,GO:0002274~myeloid leukocyte activation,GO:0001817~regulation of cytokine production,GO:0001775~cell activation,GO:0001774~microglial cell activation,												GO:0042582~azurophil granule,GO:0031988~membrane-bounded vesicle,GO:0031982~vesicle,GO:0031410~cytoplasmic vesicle,GO:0030141~secretory granule,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005764~lysosome,GO:0005576~extracellular region,GO:0000323~lytic vacuole,																GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0030247~polysaccharide binding,GO:0030246~carbohydrate binding,GO:0017171~serine hydrolase activity,GO:0015643~toxin binding,GO:0008236~serine-type peptidase activity,GO:0008233~peptidase activity,GO:0008201~heparin binding,GO:0005539~glycosaminoglycan binding,GO:0004252~serine-type endopeptidase activity,GO:0004175~endopeptidase activity,GO:0001871~pattern binding,							IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site,IPR001314:Peptidase S1A, chymotrypsin,IPR001254:Peptidase S1 and S6, chymotrypsin/Hap,												PIRSF001135:trypsin,																								SM00020:Tryp_SPc,											signal,Serine protease homolog,polymorphism,inflammation,heparin-binding,glycoprotein,disulfide bond,direct protein sequencing,complete proteome,chemotaxis,Antimicrobial,antibiotic,3d-structure,						turn,strand,signal peptide,sequence variant,sequence conflict,region of interest:Possesses antibiotic activity,region of interest:Hydrophobic,mutagenesis site,helix,glycosylation site:N-linked (GlcNAc...); partial,glycosylation site:N-linked (GlcNAc...),domain:Peptidase S1,disulfide bond,chain:Azurocidin,										
40790_at	basic helix-loop-helix family, member e40	Homo sapiens						GO:0051969~regulation of transmission of nerve impulse,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0050804~regulation of synaptic transmission,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048167~regulation of synaptic plasticity,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0044057~regulation of system process,GO:0042752~regulation of circadian rhythm,GO:0031644~regulation of neurological system process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0016481~negative regulation of transcription,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009649~entrainment of circadian clock,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,															GO:0030528~transcription regulator activity,GO:0016564~transcription repressor activity,GO:0003700~transcription factor activity,GO:0003677~DNA binding,							IPR018352:Orange subgroup,IPR011598:Helix-loop-helix DNA-binding,IPR003650:Orange,IPR001092:Basic helix-loop-helix dimerisation region bHLH,																				hsa04710:Circadian rhythm,					PIRSF027808:PIRSF027808,																								SM00511:ORANGE,SM00353:HLH,											ubl conjugation,transcription regulation,Transcription,phosphoprotein,nucleus,dna-binding,complete proteome,						modified residue,domain:Orange,domain:Helix-loop-helix motif,DNA-binding region:Basic motif,chain:Class E basic helix-loop-helix protein 40,										
38201_at	branched chain aminotransferase 1, cytosolic	Homo sapiens						GO:0051329~interphase of mitotic cell cycle,GO:0051325~interphase,GO:0046395~carboxylic acid catabolic process,GO:0046394~carboxylic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0022403~cell cycle phase,GO:0022402~cell cycle process,GO:0016054~organic acid catabolic process,GO:0016053~organic acid biosynthetic process,GO:0009310~amine catabolic process,GO:0009309~amine biosynthetic process,GO:0009083~branched chain family amino acid catabolic process,GO:0009082~branched chain family amino acid biosynthetic process,GO:0009081~branched chain family amino acid metabolic process,GO:0009063~cellular amino acid catabolic process,GO:0008652~cellular amino acid biosynthetic process,GO:0008283~cell proliferation,GO:0007049~cell cycle,GO:0000278~mitotic cell cycle,GO:0000082~G1/S transition of mitotic cell cycle,												GO:0005829~cytosol,																GO:0042802~identical protein binding,GO:0016769~transferase activity, transferring nitrogenous groups,GO:0008483~transaminase activity,GO:0004084~branched-chain-amino-acid transaminase activity,							IPR018300:Aminotransferase, class IV, conserved site,IPR005786:Branched-chain amino acid aminotransferase II,IPR001544:Aminotransferase, class IV,																				hsa00770:Pantothenate and CoA biosynthesis,hsa00290:Valine, leucine and isoleucine biosynthesis,hsa00280:Valine, leucine and isoleucine degradation,					PIRSF006468:branched-chain amino acid aminotransferase, BCAT1 type,PIRSF006468:BCAT1,																						transferase,pyridoxal phosphate,polymorphism,cytoplasm,complete proteome,branched-chain amino acid biosynthesis,Aminotransferase,amino-acid biosynthesis,acetylation,3d-structure,						turn,strand,sequence variant,sequence conflict,modified residue,helix,chain:Branched-chain-amino-acid aminotransferase, cytosolic,										
39094_at	bromodomain containing 4	Homo sapiens						GO:0051101~regulation of DNA binding,GO:0051099~positive regulation of binding,GO:0051098~regulation of binding,GO:0044093~positive regulation of molecular function,GO:0043388~positive regulation of DNA binding,GO:0016310~phosphorylation,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein amino acid phosphorylation,												GO:0070013~intracellular organelle lumen,GO:0043233~organelle lumen,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0005730~nucleolus,																GO:0003677~DNA binding,							IPR018359:Bromodomain, conserved site,IPR001487:Bromodomain,																							SM00297:BROMO,											repeat,polymorphism,phosphoprotein,nucleus,complete proteome,chromosomal rearrangement,bromodomain,alternative splicing,acetylation,3d-structure,						turn,splice variant,site:Breakpoint for translocation to form BDR4-NUT fusion protein,sequence variant,modified residue,helix,domain:Bromo 2,domain:Bromo 1,compositionally biased region:Ser-rich,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Pro,compositionally biased region:Poly-His,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Ala,compositionally biased region:Lys-rich,chain:Bromodomain-containing protein 4,										
1786_at	c-mer proto-oncogene tyrosine kinase	Homo sapiens						GO:0050953~sensory perception of light stimulus,GO:0050890~cognition,GO:0050877~neurological system process,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0016044~membrane organization,GO:0010324~membrane invagination,GO:0007601~visual perception,GO:0007600~sensory perception,GO:0007267~cell-cell signaling,GO:0007166~cell surface receptor linked signal transduction,GO:0006909~phagocytosis,GO:0006897~endocytosis,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein amino acid phosphorylation,												GO:0044459~plasma membrane part,GO:0042995~cell projection,GO:0031513~nonmotile primary cilium,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005929~cilium,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,GO:0005625~soluble fraction,GO:0001750~photoreceptor outer segment,GO:0000267~cell fraction,																GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0005524~ATP binding,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004672~protein kinase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR017441:Protein kinase, ATP binding site,IPR013783:Immunoglobulin-like fold,IPR013151:Immunoglobulin,IPR008957:Fibronectin, type III-like fold,IPR008266:Tyrosine protein kinase, active site,IPR007110:Immunoglobulin-like,IPR003961:Fibronectin, type III,IPR003599:Immunoglobulin subtype,IPR001245:Tyrosine protein kinase,IPR000719:Protein kinase, core,															Retinitis pigmentosa-38,Retinitis pigmentosa, MERTK-related,										PIRSF500787:proto-oncogene tyrosine-protein kinase MER,PIRSF000629:tyrosine-protein kinase receptor TYRO3/UFO/MER type,																								SM00409:IG,SM00219:TyrKc,SM00060:FN3,											vision,tyrosine-protein kinase,transmembrane,transferase,signal,sensory transduction,retinitis pigmentosa,repeat,receptor,Proto-oncogene,polymorphism,phosphoprotein,nucleotide-binding,membrane,kinase,Immunoglobulin domain,glycoprotein,disulfide bond,disease mutation,complete proteome,atp-binding,3d-structure,						turn,transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,strand,signal peptide,sequence variant,sequence conflict,nucleotide phosphate-binding region:ATP,modified residue,helix,glycosylation site:N-linked (GlcNAc...),domain:Protein kinase,domain:Ig-like C2-type 2,domain:Ig-like C2-type 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 1,disulfide bond,chain:Proto-oncogene tyrosine-protein kinase Mer,binding site:ATP,active site:Proton acceptor,										
37172_at	carboxypeptidase B2 (plasma)	Homo sapiens						GO:0051241~negative regulation of multicellular organismal process,GO:0050819~negative regulation of coagulation,GO:0050818~regulation of coagulation,GO:0042730~fibrinolysis,GO:0032101~regulation of response to external stimulus,GO:0030195~negative regulation of blood coagulation,GO:0030193~regulation of blood coagulation,GO:0006508~proteolysis,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,																GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0008270~zinc ion binding,GO:0008238~exopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008233~peptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0004180~carboxypeptidase activity,							IPR003146:Proteinase inhibitor, carboxypeptidase propeptide,IPR000834:Peptidase M14, carboxypeptidase A,																				hsa04610:Complement and coagulation cascades,					PIRSF001128:carboxypeptidase,																								SM00631:Zn_pept,											zymogen,zinc,signal,Secreted,Protease,polymorphism,metalloprotease,metallo-carboxypeptidase,metal-binding,hydrolase,glycoprotein,disulfide bond,direct protein sequencing,complete proteome,carboxypeptidase,alternative splicing,3d-structure,						turn,strand,splice variant,signal peptide,sequence variant,sequence conflict,propeptide:Activation peptide,metal ion-binding site:Zinc,helix,glycosylation site:N-linked (GlcNAc...); partial,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Carboxypeptidase B2,active site:Nucleophile,										
32469_at	carcinoembryonic antigen-related cell adhesion molecule 3	Homo sapiens					GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,										IPR013783:Immunoglobulin-like fold,IPR013106:Immunoglobulin V-set,IPR003599:Immunoglobulin subtype,																							SM00409:IG,											transmembrane protein,transmembrane,signal,polymorphism,phosphoprotein,membrane,Immunoglobulin domain,glycoprotein,complete proteome,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,signal peptide,sequence variant,sequence conflict,mutagenesis site,glycosylation site:N-linked (GlcNAc...),domain:Ig-like V-type,chain:Carcinoembryonic antigen-related cell adhesion molecule 3,										
33530_at	carcinoembryonic antigen-related cell adhesion molecule 8	Homo sapiens						GO:0006955~immune response,												GO:0044459~plasma membrane part,GO:0044421~extracellular region part,GO:0031226~intrinsic to plasma membrane,GO:0031225~anchored to membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,GO:0005615~extracellular space,GO:0005576~extracellular region,										IPR013783:Immunoglobulin-like fold,IPR013151:Immunoglobulin,IPR013106:Immunoglobulin V-set,IPR007110:Immunoglobulin-like,IPR003599:Immunoglobulin subtype,																							SM00409:IG,											signal,repeat,polymorphism,phosphatidylinositol linkage,membrane,lipoprotein,Immunoglobulin domain,gpi-anchor,glycoprotein,disulfide bond,complete proteome,cell membrane,3d-structure,						turn,strand,signal peptide,sequence variant,propeptide:Removed in mature form,lipid moiety-binding region:GPI-anchor amidated aspartate,helix,glycosylation site:N-linked (GlcNAc...),domain:Ig-like V-type,domain:Ig-like C2-type 2,domain:Ig-like C2-type 1,disulfide bond,chain:Carcinoembryonic antigen-related cell adhesion molecule 8,										
679_at	cathepsin G	Homo sapiens						GO:0042742~defense response to bacterium,GO:0009617~response to bacterium,GO:0006955~immune response,GO:0006952~defense response,GO:0006508~proteolysis,												GO:0009986~cell surface,GO:0005886~plasma membrane,																GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0017171~serine hydrolase activity,GO:0008236~serine-type peptidase activity,GO:0008233~peptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0004175~endopeptidase activity,							IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site,IPR001314:Peptidase S1A, chymotrypsin,IPR001254:Peptidase S1 and S6, chymotrypsin/Hap,																				hsa05322:Systemic lupus erythematosus,hsa04614:Renin-angiotensin system,hsa04142:Lysosome,hsa04080:Neuroactive ligand-receptor interaction,					PIRSF001135:trypsin,																								SM00020:Tryp_SPc,											zymogen,signal,serine proteinase,Serine protease,Protease,polymorphism,lysosome,hydrolase,glycoprotein,disulfide bond,direct protein sequencing,complete proteome,Antimicrobial,antibiotic,3d-structure,						turn,strand,signal peptide,sequence variant,propeptide:Activation peptide,helix,glycosylation site:N-linked (GlcNAc...),domain:Peptidase S1,disulfide bond,chain:Cathepsin G,active site:Charge relay system,										
36421_at	cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)	Homo sapiens						GO:0070647~protein modification by small protein conjugation or removal,GO:0051276~chromosome organization,GO:0033523~histone H2B ubiquitination,GO:0032446~protein modification by small protein conjugation,GO:0016574~histone ubiquitination,GO:0016570~histone modification,GO:0016569~covalent chromatin modification,GO:0016568~chromatin modification,GO:0016567~protein ubiquitination,GO:0010390~histone monoubiquitination,GO:0007049~cell cycle,GO:0006513~protein monoubiquitination,GO:0006350~transcription,GO:0006325~chromatin organization,												GO:0070013~intracellular organelle lumen,GO:0044451~nucleoplasm part,GO:0043233~organelle lumen,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0016593~Cdc73/Paf1 complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0008023~transcription elongation factor complex,GO:0005654~nucleoplasm,										IPR007852:RNA polymerase II accessory factor, Cdc73,															Parathyroid carcinoma,Parathyroid adenoma with cystic changes,Hyperparathyroidism-jaw tumor syndrome,Hyperparathyroidism, familial primary,										PIRSF037563:PIRSF037563,																						tumor suppressor,Transcription,phosphoprotein,nucleus,disease mutation,direct protein sequencing,complete proteome,cell cycle,acetylation,						short sequence motif:Nuclear localization signal,sequence variant,sequence conflict,modified residue,compositionally biased region:Poly-Ile,chain:Parafibromin,										
37454_at	chemokine (C-C motif) ligand 13	Homo sapiens							109.Chemokine_families,												GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055065~metal ion homeostasis,GO:0050801~ion homeostasis,GO:0048878~chemical homeostasis,GO:0042592~homeostatic process,GO:0042330~taxis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030003~cellular cation homeostasis,GO:0019725~cellular homeostasis,GO:0009611~response to wounding,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0007267~cell-cell signaling,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,																GO:0042379~chemokine receptor binding,GO:0008009~chemokine activity,GO:0005125~cytokine activity,							IPR001811:Small chemokine, interleukin-8-like,IPR000827:Small chemokine, C-C group, conserved site,																				hsa04621:NOD-like receptor signaling pathway,hsa04062:Chemokine signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,					PIRSF500572:small inducible cytokine, A2 type,PIRSF001950:small inducible chemokine, C/CC types,																								SM00199:SCY,											signal,Secreted,Pyrrolidone carboxylic acid,polymorphism,inflammatory response,disulfide bond,direct protein sequencing,cytokine,complete proteome,chemotaxis,3d-structure,						strand,signal peptide,sequence variant,sequence conflict,modified residue,helix,disulfide bond,chain:C-C motif chemokine 13, short chain,chain:C-C motif chemokine 13, medium chain,chain:C-C motif chemokine 13, long chain,										
36703_at	chemokine (C-C motif) ligand 25	Homo sapiens						GO:0051674~localization of cell,GO:0050900~leukocyte migration,GO:0048870~cell motility,GO:0042330~taxis,GO:0016477~cell migration,GO:0009611~response to wounding,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~cell motion,												GO:0044421~extracellular region part,GO:0005625~soluble fraction,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000267~cell fraction,																GO:0042379~chemokine receptor binding,GO:0008009~chemokine activity,GO:0005179~hormone activity,GO:0005125~cytokine activity,							IPR001811:Small chemokine, interleukin-8-like,IPR000827:Small chemokine, C-C group, conserved site,																				hsa04672:Intestinal immune network for IgA production,hsa04062:Chemokine signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,					PIRSF001950:small inducible chemokine, C/CC types,																								SM00199:SCY,											signal,Secreted,polymorphism,inflammatory response,disulfide bond,cytokine,complete proteome,chemotaxis,alternative splicing,						splice variant,signal peptide,sequence variant,disulfide bond,chain:C-C motif chemokine 25,										
1403_s_at	chemokine (C-C motif) ligand 5	Homo sapiens							34.Chemokines_in_EAE,33.GProt-coupled_Rec_T_Cell_med_Inflamm,22.Cytokine-chemokine_CNS,18.Cytokine_astocytes,109.Chemokine_families,																	h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy,								GO:0060326~cell chemotaxis,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055065~metal ion homeostasis,GO:0051674~localization of cell,GO:0051384~response to glucocorticoid stimulus,GO:0051240~positive regulation of multicellular organismal process,GO:0051094~positive regulation of developmental process,GO:0050900~leukocyte migration,GO:0050801~ion homeostasis,GO:0050792~regulation of viral reproduction,GO:0050729~positive regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0048878~chemical homeostasis,GO:0048870~cell motility,GO:0048584~positive regulation of response to stimulus,GO:0048545~response to steroid hormone stimulus,GO:0048525~negative regulation of viral reproduction,GO:0048247~lymphocyte chemotaxis,GO:0046903~secretion,GO:0045672~positive regulation of osteoclast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045071~negative regulation of viral genome replication,GO:0045069~regulation of viral genome replication,GO:0043434~response to peptide hormone stimulus,GO:0042592~homeostatic process,GO:0042493~response to drug,GO:0042330~taxis,GO:0034612~response to tumor necrosis factor,GO:0034097~response to cytokine stimulus,GO:0032940~secretion by cell,GO:0032868~response to insulin stimulus,GO:0032846~positive regulation of homeostatic process,GO:0032844~regulation of homeostatic process,GO:0032496~response to lipopolysaccharide,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031960~response to corticosteroid stimulus,GO:0031652~positive regulation of heat generation,GO:0031650~regulation of heat generation,GO:0031622~positive regulation of fever,GO:0031620~regulation of fever,GO:0031349~positive regulation of defense response,GO:0030595~leukocyte chemotaxis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030003~cellular cation homeostasis,GO:0022610~biological adhesion,GO:0019725~cellular homeostasis,GO:0016477~cell migration,GO:0016192~vesicle-mediated transport,GO:0010033~response to organic substance,GO:0009725~response to hormone stimulus,GO:0009719~response to endogenous stimulus,GO:0009617~response to bacterium,GO:0009615~response to virus,GO:0009611~response to wounding,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0007568~aging,GO:0007267~cell-cell signaling,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0007155~cell adhesion,GO:0006979~response to oxidative stress,GO:0006968~cellular defense response,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~cell motion,GO:0006887~exocytosis,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002675~positive regulation of acute inflammatory response,GO:0002673~regulation of acute inflammatory response,GO:0002544~chronic inflammatory response,GO:0002237~response to molecule of bacterial origin,												GO:0044421~extracellular region part,GO:0005625~soluble fraction,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000267~cell fraction,																GO:0042379~chemokine receptor binding,GO:0042056~chemoattractant activity,GO:0008009~chemokine activity,GO:0005125~cytokine activity,							IPR001811:Small chemokine, interleukin-8-like,IPR000827:Small chemokine, C-C group, conserved site,																				hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05020:Prion diseases,hsa04623:Cytosolic DNA-sensing pathway,hsa04621:NOD-like receptor signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04062:Chemokine signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,								HIV-1 disease, rapid progression of,HIV-1 disease, delayed progression of,										PIRSF500570:small inducible cytokine A5,PIRSF001950:small inducible chemokine, C/CC types,																								SM00199:SCY,											T-cell,signal,Secreted,polymorphism,inflammatory response,inflammation,immediate-early protein,glycoprotein,disulfide bond,direct protein sequencing,cytokine,complete proteome,chemotaxis,3d-structure,						strand,site:Susceptible to oxidation,site:Cleavage; by DPP4,signal peptide,sequence variant,sequence conflict,helix,glycosylation site:O-linked (GalNAc...); partial,disulfide bond,chain:RANTES(4-68),chain:RANTES(3-68),chain:C-C motif chemokine 5,										
37061_at	chitinase 1 (chitotriosidase)	Homo sapiens						GO:0016052~carbohydrate catabolic process,GO:0009617~response to bacterium,GO:0009057~macromolecule catabolic process,GO:0006955~immune response,GO:0006032~chitin catabolic process,GO:0006030~chitin metabolic process,GO:0006026~aminoglycan catabolic process,GO:0006022~aminoglycan metabolic process,GO:0005976~polysaccharide metabolic process,GO:0000272~polysaccharide catabolic process,												GO:0044421~extracellular region part,GO:0005773~vacuole,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,																GO:0043169~cation binding,GO:0043167~ion binding,GO:0030247~polysaccharide binding,GO:0030246~carbohydrate binding,GO:0008061~chitin binding,GO:0004568~chitinase activity,GO:0001871~pattern binding,							IPR013781:Glycoside hydrolase, subgroup, catalytic core,IPR011583:Chitinase II,IPR002557:Chitin binding protein, peritrophin-A,IPR001579:Glycoside hydrolase, chitinase active site,IPR001223:Glycoside hydrolase, family 18, catalytic domain,																				hsa00520:Amino sugar and nucleotide sugar metabolism,								Chitotriosidase deficiency,										PIRSF001061:chitinase-like protein,																								SM00636:Glyco_18,SM00494:ChtBD2,											signal,Secreted,polysaccharide degradation,polymorphism,lysosome,hydrolase,glycosidase,disulfide bond,direct protein sequencing,complete proteome,Chitin-binding,Chitin degradation,carbohydrate metabolism,alternative splicing,3d-structure,						turn,strand,splice variant,signal peptide,sequence variant,helix,domain:Chitin-binding type-2,disulfide bond,chain:Chitotriosidase-1,active site:Proton donor,										
32010_at	chromosome 22 open reading frame 33	Homo sapiens										complete proteome,alternative splicing,						splice variant,chain:Protein EAN57,										
38482_at	claudin 7	Homo sapiens						GO:0022610~biological adhesion,GO:0016338~calcium-independent cell-cell adhesion,GO:0016337~cell-cell adhesion,GO:0007155~cell adhesion,												GO:0070160~occluding junction,GO:0044459~plasma membrane part,GO:0043296~apical junction complex,GO:0031224~intrinsic to membrane,GO:0030054~cell junction,GO:0016327~apicolateral plasma membrane,GO:0016021~integral to membrane,GO:0005923~tight junction,GO:0005911~cell-cell junction,GO:0005886~plasma membrane,																GO:0042802~identical protein binding,GO:0005198~structural molecule activity,							IPR017974:Claudin, conserved site,IPR006187:Claudin,IPR004031:PMP-22/EMP/MP20/Claudin,IPR003552:Claudin-7,																				hsa04670:Leukocyte transendothelial migration,hsa04530:Tight junction,hsa04514:Cell adhesion molecules (CAMs),														transmembrane,Tight junction,polymorphism,membrane,complete proteome,cell membrane,cell junction,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,sequence variant,sequence conflict,region of interest:Interactions with TJP1, TJP2 and TJP3,chain:Claudin-7,										
35169_at	collagen, type XVI, alpha 1	Homo sapiens						GO:0022610~biological adhesion,GO:0007565~female pregnancy,GO:0007229~integrin-mediated signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0007155~cell adhesion,												GO:0044421~extracellular region part,GO:0044420~extracellular matrix part,GO:0031012~extracellular matrix,GO:0030934~anchoring collagen,GO:0005597~collagen type XVI,GO:0005593~FACIT collagen,GO:0005581~collagen,GO:0005578~proteinaceous extracellular matrix,GO:0005576~extracellular region,																GO:0032403~protein complex binding,GO:0005198~structural molecule activity,GO:0005178~integrin binding,							IPR008160:Collagen triple helix repeat,IPR003129:Laminin G, thrombospondin-type, N-terminal,												PIRSF002258:collagen alpha 1(IV) chain,																								SM00210:TSPN,											triple helix,trimer,signal,Secreted,repeat,polymorphism,hydroxyproline,hydroxylysine,hydroxylation,glycoprotein,extracellular matrix,direct protein sequencing,complete proteome,collagen,coiled coil,cell binding,cell adhesion,alternative splicing,						splice variant,signal peptide,short sequence motif:Cell attachment site,sequence variant,sequence conflict,region of interest:Triple-helical region 9 (COL9) with 3 imperfections,region of interest:Triple-helical region 8 (COL8) with 1 imperfection,region of interest:Triple-helical region 7 (COL7) with 1 imperfection,region of interest:Triple-helical region 6 (COL6) with 1 imperfection,region of interest:Triple-helical region 5 (COL5) with 3 imperfections,region of interest:Triple-helical region 4 (COL4) with 2 imperfections,region of interest:Triple-helical region 3 (COL3),region of interest:Triple-helical region 2 (COL2) with 2 imperfections,region of interest:Triple-helical region 1 (COL1) with 2 imperfections,region of interest:Nonhelical region 9 (NC9),region of interest:Nonhelical region 8 (NC8),region of interest:Nonhelical region 7 (NC7),region of interest:Nonhelical region 6 (NC6),region of interest:Nonhelical region 5 (NC5),region of interest:Nonhelical region 4 (NC4),region of interest:Nonhelical region 3 (NC3),region of interest:Nonhelical region 2 (NC2),region of interest:Nonhelical region 10 (NC10),region of interest:Nonhelical region 1 (NC1),glycosylation site:N-linked (GlcNAc...),domain:TSP N-terminal,chain:Collagen alpha-1(XVI) chain,										
32250_at	complement factor H	Homo sapiens						GO:0051605~protein maturation by peptide bond cleavage,GO:0051604~protein maturation,GO:0050778~positive regulation of immune response,GO:0048584~positive regulation of response to stimulus,GO:0045087~innate immune response,GO:0016485~protein processing,GO:0009611~response to wounding,GO:0006959~humoral immune response,GO:0006957~complement activation, alternative pathway,GO:0006956~complement activation,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006508~proteolysis,GO:0002684~positive regulation of immune system process,GO:0002541~activation of plasma proteins involved in acute inflammatory response,GO:0002526~acute inflammatory response,GO:0002253~activation of immune response,GO:0002252~immune effector process,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,										IPR016060:Complement control module,IPR000436:Sushi/SCR/CCP,																				hsa04610:Complement and coagulation cascades,								Myocardial infarction, susceptibility to,Membranoproliferative glomerulonephritis with CFH deficiency,Macular degeneration, age-related, 4,Hemolytic-uremic syndrome,Factor H and factor H-like 1,Complement factor H polymorphism in age-related macular degeneration,Complement factor H deficiency,Basal laminar drusen,										PIRSF002482:complement factor H,																								SM00032:CCP,											sushi,signal,Secreted,repeat,polymorphism,innate immunity,immune response,glycoprotein,disulfide bond,disease mutation,direct protein sequencing,complete proteome,complement alternate pathway,alternative splicing,age-related macular degeneration,3d-structure,						turn,strand,splice variant,site:Not glycosylated,signal peptide,sequence variant,sequence conflict,helix,glycosylation site:N-linked (GlcNAc...),domain:Sushi 9,domain:Sushi 8,domain:Sushi 7,domain:Sushi 6,domain:Sushi 5,domain:Sushi 4,domain:Sushi 3,domain:Sushi 20,domain:Sushi 2,domain:Sushi 19,domain:Sushi 18,domain:Sushi 17,domain:Sushi 16,domain:Sushi 15,domain:Sushi 14,domain:Sushi 13,domain:Sushi 12,domain:Sushi 11,domain:Sushi 10,domain:Sushi 1,disulfide bond,chain:Complement factor H,										
36317_at	coronin, actin binding protein, 2A	Homo sapiens						GO:0007242~intracellular signaling cascade,												GO:0070013~intracellular organelle lumen,GO:0044451~nucleoplasm part,GO:0043233~organelle lumen,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0017053~transcriptional repressor complex,GO:0005654~nucleoplasm,																GO:0008092~cytoskeletal protein binding,GO:0003779~actin binding,							IPR019782:WD40 repeat 2,IPR019781:WD40 repeat, subgroup,IPR019775:WD40 repeat, conserved site,IPR017986:WD40 repeat, region,IPR015943:WD40/YVTN repeat-like,IPR015505:Coronin,IPR015049:Region of unknown function DUF1900,IPR015048:Region of unknown function DUF1899,IPR008147:Glutamine synthetase, beta-Grasp,IPR001680:WD40 repeat,																							SM00320:WD40,											wd repeat,repeat,polymorphism,complete proteome,coiled coil,actin-binding,						sequence variant,sequence conflict,repeat:WD 5,repeat:WD 4,repeat:WD 3,repeat:WD 2,repeat:WD 1,chain:Coronin-2A,										
1983_at	cyclin D2	Homo sapiens											h_cellcyclePathway:Cyclins and Cell Cycle Regulation,								GO:0060284~regulation of cell development,GO:0051960~regulation of nervous system development,GO:0051726~regulation of cell cycle,GO:0051591~response to cAMP,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051329~interphase of mitotic cell cycle,GO:0051325~interphase,GO:0051301~cell division,GO:0051247~positive regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0050767~regulation of neurogenesis,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0048609~reproductive process in a multicellular organism,GO:0048608~reproductive structure development,GO:0048545~response to steroid hormone stimulus,GO:0048511~rhythmic process,GO:0048232~male gamete generation,GO:0046660~female sex differentiation,GO:0046545~development of primary female sexual characteristics,GO:0045937~positive regulation of phosphate metabolic process,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045787~positive regulation of cell cycle,GO:0045737~positive regulation of cyclin-dependent protein kinase activity,GO:0045664~regulation of neuron differentiation,GO:0045471~response to ethanol,GO:0045137~development of primary sexual characteristics,GO:0044093~positive regulation of molecular function,GO:0043627~response to estrogen stimulus,GO:0043549~regulation of kinase activity,GO:0043434~response to peptide hormone stimulus,GO:0043085~positive regulation of catalytic activity,GO:0042698~ovulation cycle,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042127~regulation of cell proliferation,GO:0033674~positive regulation of kinase activity,GO:0033574~response to testosterone stimulus,GO:0032870~cellular response to hormone stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032868~response to insulin stimulus,GO:0032504~multicellular organism reproduction,GO:0032355~response to estradiol stimulus,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0022602~ovulation cycle process,GO:0022403~cell cycle phase,GO:0022402~cell cycle process,GO:0019953~sexual reproduction,GO:0019220~regulation of phosphate metabolic process,GO:0014070~response to organic cyclic substance,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010033~response to organic substance,GO:0009725~response to hormone stimulus,GO:0009719~response to endogenous stimulus,GO:0008585~female gonad development,GO:0008406~gonad development,GO:0008284~positive regulation of cell proliferation,GO:0007548~sex differentiation,GO:0007283~spermatogenesis,GO:0007276~gamete generation,GO:0007049~cell cycle,GO:0003006~reproductive developmental process,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001889~liver development,GO:0001541~ovarian follicle development,GO:0000278~mitotic cell cycle,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000079~regulation of cyclin-dependent protein kinase activity,												GO:0000307~cyclin-dependent protein kinase holoenzyme complex,																GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,							IPR015451:Cyclin D,IPR014400:Cyclin, A/B/D/E,IPR013763:Cyclin-related,IPR006671:Cyclin, N-terminal,IPR006670:Cyclin,IPR004367:Cyclin, C-terminal,																				hsa04630:Jak-STAT signaling pathway,hsa04510:Focal adhesion,hsa04310:Wnt signaling pathway,hsa04115:p53 signaling pathway,hsa04110:Cell cycle,					PIRSF001771:Cyclin_A_B_D_E,PIRSF001771:cyclin, A/B/D/E types,																								SM00385:CYCLIN,											polymorphism,cyclin,complete proteome,cell division,cell cycle control,cell cycle,						sequence variant,sequence conflict,chain:G1/S-specific cyclin-D2,										
34453_at	cytochrome P450, family 2, subfamily B, polypeptide 7 pseudogene 1	Homo sapiens						GO:0055114~oxidation reduction,															GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0020037~heme binding,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0009055~electron carrier activity,GO:0005506~iron ion binding,							IPR017973:Cytochrome P450, C-terminal region,IPR008068:Cytochrome P450, E-class, group I, CYP2B-like,IPR002401:Cytochrome P450, E-class, group I,IPR001128:Cytochrome P450,																					oxidoreductase,Monooxygenase,metal-binding,iron,heme,			
38229_at	cytochrome P450, family 3, subfamily A, polypeptide 5	Homo sapiens													Secondary metabolites biosynthesis, transport, and catabolism,						GO:0055114~oxidation reduction,GO:0008202~steroid metabolic process,												GO:0044432~endoplasmic reticulum part,GO:0042598~vesicular fraction,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0031090~organelle membrane,GO:0019898~extrinsic to membrane,GO:0012505~endomembrane system,GO:0005792~microsome,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,																GO:0070330~aromatase activity,GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0009055~electron carrier activity,GO:0005506~iron ion binding,							IPR017973:Cytochrome P450, C-terminal region,IPR017972:Cytochrome P450, conserved site,IPR008072:Cytochrome P450, E-class, CYP3A,IPR002403:Cytochrome P450, E-class, group IV,IPR002402:Cytochrome P450, E-class, group II,IPR002401:Cytochrome P450, E-class, group I,IPR001128:Cytochrome P450,																				hsa00983:Drug metabolism,hsa00982:Drug metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00830:Retinol metabolism,hsa00591:Linoleic acid metabolism,hsa00140:Steroid hormone biosynthesis,								Hypertension, salt-sensitive essential, susceptibility to,										PIRSF000051:cytochrome P450 CYP3A5,																						transmembrane protein,polymorphism,oxidoreductase,Monooxygenase,microsome,metalloprotein,metal-binding,membrane,iron,heme,endoplasmic reticulum,electron transfer,complete proteome,chromoprotein,						sequence variant,sequence conflict,metal ion-binding site:Iron (heme axial ligand),chain:Cytochrome P450 3A5,										
1391_s_at	cytochrome P450, family 4, subfamily A, polypeptide 11	Homo sapiens											h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,															Secondary metabolites biosynthesis, transport, and catabolism,						GO:0055114~oxidation reduction,GO:0006631~fatty acid metabolic process,												GO:0044432~endoplasmic reticulum part,GO:0042598~vesicular fraction,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0031090~organelle membrane,GO:0019898~extrinsic to membrane,GO:0012505~endomembrane system,GO:0005792~microsome,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,																GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0018685~alkane 1-monooxygenase activity,GO:0016713~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,GO:0009055~electron carrier activity,GO:0005506~iron ion binding,							IPR017973:Cytochrome P450, C-terminal region,IPR017972:Cytochrome P450, conserved site,IPR002401:Cytochrome P450, E-class, group I,IPR001128:Cytochrome P450,																				hsa04270:Vascular smooth muscle contraction,hsa03320:PPAR signaling pathway,hsa00830:Retinol metabolism,hsa00590:Arachidonic acid metabolism,hsa00071:Fatty acid metabolism,					PIRSF000050:cytochrome P450 CYP4B1,																						transmembrane protein,polymorphism,oxidoreductase,Monooxygenase,microsome,metalloprotein,metal-binding,membrane,iron,heme,fatty acid oxidation,endoplasmic reticulum,electron transfer,direct protein sequencing,complete proteome,chromoprotein,alternative splicing,						splice variant,sequence variant,sequence conflict,mutagenesis site,metal ion-binding site:Iron (heme axial ligand),compositionally biased region:Poly-Leu,chain:Cytochrome P450 4A11,binding site:Heme (covalent; via 1 link),										
31793_at	defensin, alpha 1	Homo sapiens						GO:0050832~defense response to fungus,GO:0042742~defense response to bacterium,GO:0042330~taxis,GO:0031640~killing of cells of another organism,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0009615~response to virus,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0006955~immune response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0001906~cell killing,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,										IPR016327:Alpha-defensin,IPR006081:Alpha defensin,IPR006080:Mammalian defensin,IPR002366:Defensin propeptide,												PIRSF001875:alpha-defensin,																								SM00048:DEFSN,											signal,Secreted,phosphoprotein,homodimer,fungicide,disulfide bond,direct protein sequencing,defensin,complete proteome,Antiviral defense,Antimicrobial,antibiotic,3d-structure,						strand,signal peptide,peptide:Neutrophil defensin 2,peptide:Neutrophil defensin 1,modified residue,disulfide bond,chain:HP 1-56,										
34546_at	defensin, alpha 4, corticostatin	Homo sapiens						GO:0050832~defense response to fungus,GO:0042742~defense response to bacterium,GO:0031640~killing of cells of another organism,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0006952~defense response,GO:0001906~cell killing,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,										IPR016327:Alpha-defensin,IPR006081:Alpha defensin,IPR006080:Mammalian defensin,IPR002366:Defensin propeptide,												PIRSF001875:alpha-defensin,																								SM00048:DEFSN,											signal,Secreted,polymorphism,homodimer,fungicide,disulfide bond,direct protein sequencing,defensin,complete proteome,Antimicrobial,antibiotic,3d-structure,						strand,signal peptide,sequence variant,peptide:Neutrophil defensin 4,disulfide bond,										
34623_at	defensin, alpha 5, Paneth cell-specific	Homo sapiens						GO:0050832~defense response to fungus,GO:0042742~defense response to bacterium,GO:0031640~killing of cells of another organism,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0006952~defense response,GO:0001906~cell killing,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,										IPR016327:Alpha-defensin,IPR006081:Alpha defensin,IPR006080:Mammalian defensin,IPR002366:Defensin propeptide,												PIRSF001875:alpha-defensin,																								SM00048:DEFSN,											signal,Secreted,polymorphism,homodimer,fungicide,disulfide bond,defensin,complete proteome,Antimicrobial,antibiotic,3d-structure,						strand,signal peptide,sequence variant,peptide:Defensin-5,disulfide bond,										
40186_at	dual specificity phosphatase 9	Homo sapiens											h_dspPathway:Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases,								GO:0051348~negative regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051174~regulation of phosphorus metabolic process,GO:0045859~regulation of protein kinase activity,GO:0044092~negative regulation of molecular function,GO:0043549~regulation of kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043405~regulation of MAP kinase activity,GO:0043086~negative regulation of catalytic activity,GO:0042325~regulation of phosphorylation,GO:0033673~negative regulation of kinase activity,GO:0033554~cellular response to stress,GO:0031098~stress-activated protein kinase signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0016311~dephosphorylation,GO:0007254~JNK cascade,GO:0007243~protein kinase cascade,GO:0007242~intracellular signaling cascade,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006470~protein amino acid dephosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0000188~inactivation of MAPK activity,GO:0000165~MAPKKK cascade,												GO:0005783~endoplasmic reticulum,																GO:0033549~MAP kinase phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0004721~phosphoprotein phosphatase activity,							IPR016130:Protein-tyrosine phosphatase, active site,IPR014393:Dual specificity protein phosphatase (MAP kinase phosphatase),IPR008343:MAP kinase phosphatase,IPR001763:Rhodanese-like,IPR000387:Protein-tyrosine phosphatase,IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region,IPR000340:Protein-tyrosine phosphatase, dual specificity,IPR000340:Dual specificity phosphatase, catalytic domain,																				hsa04010:MAPK signaling pathway,					PIRSF000939:MAPK_Ptase,PIRSF000939:dual specificity protein phosphatase (MAP kinase phosphatase),																								SM00450:RHOD,SM00195:DSPc,											protein phosphatase,hydrolase,cytoplasm,complete proteome,3d-structure,						turn,strand,helix,domain:Tyrosine-protein phosphatase,domain:Rhodanese,chain:Dual specificity protein phosphatase 9,active site:Phosphocysteine intermediate,										
34972_s_at	dynein, axonemal, heavy chain 17	Homo sapiens						GO:0051674~localization of cell,GO:0048870~cell motility,GO:0007018~microtubule-based movement,GO:0007017~microtubule-based process,GO:0006928~cell motion,GO:0001539~ciliary or flagellar motility,												GO:0044463~cell projection part,GO:0044447~axoneme part,GO:0044441~cilium part,GO:0044430~cytoskeletal part,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0042995~cell projection,GO:0035085~cilium axoneme,GO:0030286~dynein complex,GO:0015630~microtubule cytoskeleton,GO:0005930~axoneme,GO:0005929~cilium,GO:0005875~microtubule associated complex,GO:0005874~microtubule,GO:0005858~axonemal dynein complex,GO:0005856~cytoskeleton,																GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0005524~ATP binding,GO:0003777~microtubule motor activity,GO:0003774~motor activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR013602:Dynein heavy chain, N-terminal region 2,IPR013594:Dynein heavy chain, N-terminal region 1,IPR011704:ATPase associated with various cellular activities, AAA-5,IPR004273:Dynein heavy chain,												PIRSF002308:dynein heavy chain, ciliary,																						tpr repeat,repeat,polymorphism,nucleotide-binding,motor protein,microtubule,leucine-rich repeat,dynein,cytoskeleton,cytoplasm,complete proteome,coiled coil,cilium,cell projection,atp-binding,alternative splicing,						splice variant,sequence variant,sequence conflict,repeat:TPR 3,repeat:TPR 2,repeat:TPR 1,repeat:LRR 9,repeat:LRR 8,repeat:LRR 7,repeat:LRR 6,repeat:LRR 5,repeat:LRR 4,repeat:LRR 3,repeat:LRR 2,repeat:LRR 13,repeat:LRR 12,repeat:LRR 11,repeat:LRR 10,repeat:LRR 1,region of interest:Stem,region of interest:Stalk,region of interest:AAA 6,region of interest:AAA 5,region of interest:AAA 4,region of interest:AAA 3,region of interest:AAA 2,region of interest:AAA 1,nucleotide phosphate-binding region:ATP,chain:Dynein heavy chain 17, axonemal,										
37096_at	elastase, neutrophil expressed	Homo sapiens						GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055065~metal ion homeostasis,GO:0051674~localization of cell,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051174~regulation of phosphorus metabolic process,GO:0050922~negative regulation of chemotaxis,GO:0050920~regulation of chemotaxis,GO:0050900~leukocyte migration,GO:0050801~ion homeostasis,GO:0050795~regulation of behavior,GO:0050728~negative regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0048878~chemical homeostasis,GO:0048870~cell motility,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048585~negative regulation of response to stimulus,GO:0048521~negative regulation of behavior,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045416~positive regulation of interleukin-8 biosynthetic process,GO:0045415~negative regulation of interleukin-8 biosynthetic process,GO:0045414~regulation of interleukin-8 biosynthetic process,GO:0045079~negative regulation of chemokine biosynthetic process,GO:0045073~regulation of chemokine biosynthetic process,GO:0044093~positive regulation of molecular function,GO:0043549~regulation of kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043405~regulation of MAP kinase activity,GO:0043085~positive regulation of catalytic activity,GO:0042592~homeostatic process,GO:0042325~regulation of phosphorylation,GO:0042127~regulation of cell proliferation,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042036~negative regulation of cytokine biosynthetic process,GO:0042035~regulation of cytokine biosynthetic process,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0033674~positive regulation of kinase activity,GO:0032677~regulation of interleukin-8 production,GO:0032642~regulation of chemokine production,GO:0032102~negative regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031348~negative regulation of defense response,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0030163~protein catabolic process,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030003~cellular cation homeostasis,GO:0019725~cellular homeostasis,GO:0019220~regulation of phosphate metabolic process,GO:0016477~cell migration,GO:0016192~vesicle-mediated transport,GO:0016044~membrane organization,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010324~membrane invagination,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009628~response to abiotic stimulus,GO:0009416~response to light stimulus,GO:0009411~response to UV,GO:0009314~response to radiation,GO:0009057~macromolecule catabolic process,GO:0008284~positive regulation of cell proliferation,GO:0006928~cell motion,GO:0006909~phagocytosis,GO:0006897~endocytosis,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006508~proteolysis,GO:0001817~regulation of cytokine production,												GO:0009986~cell surface,GO:0005576~extracellular region,																GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0019955~cytokine binding,GO:0017171~serine hydrolase activity,GO:0008367~bacterial binding,GO:0008236~serine-type peptidase activity,GO:0008233~peptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0004175~endopeptidase activity,							IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site,IPR001314:Peptidase S1A, chymotrypsin,IPR001254:Peptidase S1 and S6, chymotrypsin/Hap,																				hsa05322:Systemic lupus erythematosus,								Neutropenia, congenital,Hematopoiesis, cyclic,																					SM00020:Tryp_SPc,											zymogen,signal,Serine protease,Protease,polymorphism,hydrolase,glycoprotein,disulfide bond,disease mutation,direct protein sequencing,complete proteome,3d-structure,						turn,strand,signal peptide,sequence variant,helix,glycosylation site:N-linked (GlcNAc...),domain:Peptidase S1,disulfide bond,chain:Neutrophil elastase,active site:Charge relay system,										
31621_s_at	elastin	Homo sapiens						GO:0060538~skeletal muscle organ development,GO:0060537~muscle tissue development,GO:0051493~regulation of cytoskeleton organization,GO:0051017~actin filament bundle formation,GO:0044087~regulation of cellular component biogenesis,GO:0043254~regulation of protein complex assembly,GO:0043149~stress fiber formation,GO:0043062~extracellular structure organization,GO:0033043~regulation of organelle organization,GO:0032970~regulation of actin filament-based process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032535~regulation of cellular component size,GO:0032271~regulation of protein polymerization,GO:0030833~regulation of actin filament polymerization,GO:0030832~regulation of actin filament length,GO:0030198~extracellular matrix organization,GO:0030036~actin cytoskeleton organization,GO:0030029~actin filament-based process,GO:0014706~striated muscle tissue development,GO:0008283~cell proliferation,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008015~blood circulation,GO:0007585~respiratory gaseous exchange,GO:0007519~skeletal muscle tissue development,GO:0007517~muscle organ development,GO:0007015~actin filament organization,GO:0007010~cytoskeleton organization,GO:0003013~circulatory system process,												GO:0044421~extracellular region part,GO:0031012~extracellular matrix,GO:0005578~proteinaceous extracellular matrix,GO:0005576~extracellular region,																GO:0050840~extracellular matrix binding,GO:0030023~extracellular matrix constituent conferring elasticity,GO:0005201~extracellular matrix structural constituent,GO:0005198~structural molecule activity,							IPR004036:Endonuclease III, conserved site-2,IPR003979:Tropoelastin,															Williams-Beuren syndrome,Supravalvar aortic stenosis,Cutis laxa, AD,																			williams-beuren syndrome,signal,Secreted,repeat,polymorphism,hydroxylation,extracellular matrix,disulfide bond,complete proteome,alternative splicing,						splice variant,signal peptide,sequence variant,sequence conflict,modified residue,disulfide bond,compositionally biased region:Poly-Ala,compositionally biased region:Ala-rich,chain:Elastin,										
34249_at	epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)	Homo sapiens						GO:0044264~cellular polysaccharide metabolic process,GO:0044042~glucan metabolic process,GO:0019318~hexose metabolic process,GO:0016311~dephosphorylation,GO:0015980~energy derivation by oxidation of organic compounds,GO:0007610~behavior,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006470~protein amino acid dephosphorylation,GO:0006112~energy reserve metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006073~cellular glucan metabolic process,GO:0006006~glucose metabolic process,GO:0005996~monosaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005976~polysaccharide metabolic process,												GO:0030529~ribonucleoprotein complex,GO:0005886~plasma membrane,GO:0005844~polysome,GO:0005829~cytosol,GO:0005783~endoplasmic reticulum,																GO:0030246~carbohydrate binding,GO:0016791~phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004721~phosphoprotein phosphatase activity,							IPR016130:Protein-tyrosine phosphatase, active site,IPR002044:Glycoside hydrolase, carbohydrate-binding,IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region,IPR000340:Dual specificity phosphatase, catalytic domain,															Epilepsy, myoclonic, Lafora type,																			protein phosphatase,polymorphism,nucleus,membrane,hydrolase,glycogen metabolism,epilepsy,endoplasmic reticulum,disease mutation,cytoplasm,complete proteome,cell membrane,carbohydrate metabolism,alternative splicing,						splice variant,sequence variant,sequence conflict,mutagenesis site,domain:Tyrosine-protein phosphatase,domain:CBM20,chain:Laforin,										
1855_at	fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog)	Homo sapiens						GO:0051781~positive regulation of cell division,GO:0051302~regulation of cell division,GO:0048538~thymus development,GO:0048534~hemopoietic or lymphoid organ development,GO:0045168~cell-cell signaling involved in cell fate specification,GO:0045165~cell fate commitment,GO:0031128~developmental induction,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0002520~immune system development,GO:0001759~induction of an organ,GO:0001708~cell fate specification,												GO:0005794~Golgi apparatus,GO:0005576~extracellular region,																GO:0008083~growth factor activity,							IPR002348:Interleukin 1/heparin-binding growth factor,IPR002209:Heparin-binding growth factor/Fibroblast growth factor,																				hsa05218:Melanoma,hsa05200:Pathways in cancer,hsa04810:Regulation of actin cytoskeleton,hsa04010:MAPK signaling pathway,								Deafness, congenital with inner ear agenesis, microtia, and microdontia,A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs),										PIRSF001783:fibroblast growth factor,																								SM00442:FGF,											signal,Proto-oncogene,mitogen,growth factor,glycoprotein,disease mutation,complete proteome,						signal peptide,sequence variant,glycosylation site:N-linked (GlcNAc...),chain:INT-2 proto-oncogene protein,										
32279_at	glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)	Homo sapiens													Amino acid transport and metabolism,						GO:0050877~neurological system process,GO:0046395~carboxylic acid catabolic process,GO:0043648~dicarboxylic acid metabolic process,GO:0042136~neurotransmitter biosynthetic process,GO:0042133~neurotransmitter metabolic process,GO:0019226~transmission of nerve impulse,GO:0016054~organic acid catabolic process,GO:0009310~amine catabolic process,GO:0009065~glutamine family amino acid catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009063~cellular amino acid catabolic process,GO:0007268~synaptic transmission,GO:0007267~cell-cell signaling,GO:0006540~glutamate decarboxylation to succinate,GO:0006538~glutamate catabolic process,GO:0006536~glutamate metabolic process,GO:0006105~succinate metabolic process,GO:0001505~regulation of neurotransmitter levels,												GO:0048471~perinuclear region of cytoplasm,GO:0045202~synapse,GO:0044459~plasma membrane part,GO:0044456~synapse part,GO:0044433~cytoplasmic vesicle part,GO:0043005~neuron projection,GO:0042995~cell projection,GO:0031988~membrane-bounded vesicle,GO:0031982~vesicle,GO:0031410~cytoplasmic vesicle,GO:0031225~anchored to membrane,GO:0031224~intrinsic to membrane,GO:0031090~organelle membrane,GO:0030672~synaptic vesicle membrane,GO:0030665~clathrin coated vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030424~axon,GO:0030136~clathrin-coated vesicle,GO:0030135~coated vesicle,GO:0030054~cell junction,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0012506~vesicle membrane,GO:0012505~endomembrane system,GO:0009898~internal side of plasma membrane,GO:0008021~synaptic vesicle,GO:0005886~plasma membrane,GO:0005829~cytosol,GO:0005794~Golgi apparatus,																GO:0070279~vitamin B6 binding,GO:0048037~cofactor binding,GO:0030170~pyridoxal phosphate binding,GO:0019842~vitamin binding,GO:0016831~carboxy-lyase activity,GO:0004351~glutamate decarboxylase activity,							IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR002129:Pyridoxal phosphate-dependent decarboxylase,																				hsa04940:Type I diabetes mellitus,hsa00650:Butanoate metabolism,hsa00430:Taurine and hypotaurine metabolism,hsa00410:beta-Alanine metabolism,hsa00250:Alanine, aspartate and glutamate metabolism,					PIRSF001333:glutamate decarboxylase,																						synapse,pyridoxal phosphate,polymorphism,phosphoprotein,palmitate,Neurotransmitter biosynthesis,membrane,lyase,lipoprotein,golgi apparatus,decarboxylase,cytoplasmic vesicle,cytoplasm,complete proteome,cell membrane,cell junction,carboxy-lyase,carbon-carbon lyase,3d-structure,						turn,strand,sequence variant,region of interest:Substrate binding,modified residue,lipid moiety-binding region:S-palmitoyl cysteine,helix,chain:Glutamate decarboxylase 2,binding site:Substrate,										
38236_at	glutamate receptor, ionotropic, N-methyl D-aspartate 2A	Homo sapiens						GO:0060079~regulation of excitatory postsynaptic membrane potential,GO:0060078~regulation of postsynaptic membrane potential,GO:0055082~cellular chemical homeostasis,GO:0051969~regulation of transmission of nerve impulse,GO:0051931~regulation of sensory perception,GO:0051930~regulation of sensory perception of pain,GO:0051899~membrane depolarization,GO:0051248~negative regulation of protein metabolic process,GO:0050905~neuromuscular process,GO:0050890~cognition,GO:0050877~neurological system process,GO:0050804~regulation of synaptic transmission,GO:0050801~ion homeostasis,GO:0048878~chemical homeostasis,GO:0048511~rhythmic process,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048167~regulation of synaptic plasticity,GO:0045471~response to ethanol,GO:0044057~regulation of system process,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043065~positive regulation of apoptosis,GO:0042981~regulation of apoptosis,GO:0042592~homeostatic process,GO:0042493~response to drug,GO:0042434~indole derivative metabolic process,GO:0042430~indole and derivative metabolic process,GO:0042428~serotonin metabolic process,GO:0042417~dopamine metabolic process,GO:0042391~regulation of membrane potential,GO:0042177~negative regulation of protein catabolic process,GO:0042176~regulation of protein catabolic process,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0034311~diol metabolic process,GO:0033058~directional locomotion,GO:0031644~regulation of neurological system process,GO:0030431~sleep,GO:0030001~metal ion transport,GO:0019725~cellular homeostasis,GO:0019233~sensory perception of pain,GO:0019226~transmission of nerve impulse,GO:0018958~phenol metabolic process,GO:0015674~di-, tri-valent inorganic cation transport,GO:0014075~response to amine stimulus,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010243~response to organic nitrogen,GO:0010033~response to organic substance,GO:0009895~negative regulation of catabolic process,GO:0009894~regulation of catabolic process,GO:0009719~response to endogenous stimulus,GO:0009712~catechol metabolic process,GO:0009628~response to abiotic stimulus,GO:0009611~response to wounding,GO:0009416~response to light stimulus,GO:0009314~response to radiation,GO:0008542~visual learning,GO:0008104~protein localization,GO:0007632~visual behavior,GO:0007613~memory,GO:0007612~learning,GO:0007611~learning or memory,GO:0007610~behavior,GO:0007600~sensory perception,GO:0007268~synaptic transmission,GO:0007267~cell-cell signaling,GO:0007215~glutamate signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0006873~cellular ion homeostasis,GO:0006816~calcium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006586~indolalkylamine metabolic process,GO:0006584~catecholamine metabolic process,GO:0006576~biogenic amine metabolic process,GO:0006575~cellular amino acid derivative metabolic process,GO:0001975~response to amphetamine,GO:0001964~startle response,GO:0001508~regulation of action potential,												GO:0045211~postsynaptic membrane,GO:0045202~synapse,GO:0044459~plasma membrane part,GO:0044456~synapse part,GO:0044430~cytoskeletal part,GO:0043235~receptor complex,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0043005~neuron projection,GO:0042995~cell projection,GO:0042734~presynaptic membrane,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0030054~cell junction,GO:0019717~synaptosome,GO:0017146~N-methyl-D-aspartate selective glutamate receptor complex,GO:0016021~integral to membrane,GO:0014069~postsynaptic density,GO:0008328~ionotropic glutamate receptor complex,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,GO:0005856~cytoskeleton,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,																GO:0050839~cell adhesion molecule binding,GO:0046873~metal ion transmembrane transporter activity,GO:0046872~metal ion binding,GO:0043176~amine binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042165~neurotransmitter binding,GO:0031406~carboxylic acid binding,GO:0022843~voltage-gated cation channel activity,GO:0022838~substrate specific channel activity,GO:0022836~gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022832~voltage-gated channel activity,GO:0022803~passive transmembrane transporter activity,GO:0016597~amino acid binding,GO:0016595~glutamate binding,GO:0015276~ligand-gated ion channel activity,GO:0015267~channel activity,GO:0008066~glutamate receptor activity,GO:0005509~calcium ion binding,GO:0005262~calcium channel activity,GO:0005261~cation channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005216~ion channel activity,GO:0004970~ionotropic glutamate receptor activity,GO:0000287~magnesium ion binding,							IPR019594:Glutamate receptor, L-glutamate/glycine-binding,IPR018884:Glutamate [NMDA] receptor, epsilon subunit, C-terminal,IPR015683:Glutamate receptor-related,IPR001828:Extracellular ligand-binding receptor,IPR001508:NMDA receptor,IPR001320:Ionotropic glutamate receptor,																				hsa05322:Systemic lupus erythematosus,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05010:Alzheimer's disease,hsa04720:Long-term potentiation,hsa04080:Neuroactive ligand-receptor interaction,hsa04020:Calcium signaling pathway,					PIRSF002440:N-methyl-D-aspartate receptor 2A,																								SM00079:PBPe,											transport,transmembrane,synapse,signal,receptor,postsynaptic cell membrane,polymorphism,phosphoprotein,membrane,magnesium,ionic channel,ion transport,glycoprotein,complete proteome,cell membrane,cell junction,calcium,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,site:Functional determinant of NMDA receptors,signal peptide,short sequence motif:PDZ-binding,sequence variant,region of interest:Glutamate binding,modified residue,glycosylation site:N-linked (GlcNAc...),chain:Glutamate [NMDA] receptor subunit epsilon-1,binding site:Glutamate; via amide nitrogen,binding site:Glutamate,										
36479_at	growth arrest-specific 8	Homo sapiens						GO:0051674~localization of cell,GO:0048870~cell motility,GO:0042127~regulation of cell proliferation,GO:0030317~sperm motility,GO:0008285~negative regulation of cell proliferation,GO:0006928~cell motion,												GO:0044463~cell projection part,GO:0044430~cytoskeletal part,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0042995~cell projection,GO:0019861~flagellum,GO:0015630~microtubule cytoskeleton,GO:0009434~microtubule-based flagellum,GO:0005932~microtubule basal body,GO:0005929~cilium,GO:0005874~microtubule,GO:0005856~cytoskeleton,GO:0005815~microtubule organizing center,GO:0005794~Golgi apparatus,																		polymorphism,microtubule,golgi apparatus,flagellum,cytoskeleton,cytoplasm,complete proteome,coiled coil,cilium,cell projection,						sequence variant,region of interest:Regulates microtubule-binding,region of interest:Microtubule-binding,chain:Growth arrest-specific protein 8,										
1890_at	growth differentiation factor 15	Homo sapiens						GO:0007267~cell-cell signaling,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,																GO:0008083~growth factor activity,GO:0005125~cytokine activity,							IPR017948:Transforming growth factor beta, conserved site,IPR001839:Transforming growth factor beta,																							SM00204:TGFB,											signal,Secreted,polymorphism,growth factor,glycoprotein,disulfide bond,cytokine,complete proteome,cleavage on pair of basic residues,						signal peptide,sequence variant,sequence conflict,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Growth/differentiation factor 15,										
919_at	guanine nucleotide binding protein (G protein) alpha 12	Homo sapiens											h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,								GO:0060173~limb development,GO:0050878~regulation of body fluid levels,GO:0050817~coagulation,GO:0048736~appendage development,GO:0048598~embryonic morphogenesis,GO:0043009~chordate embryonic development,GO:0042733~embryonic digit morphogenesis,GO:0042060~wound healing,GO:0035113~embryonic appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035107~appendage morphogenesis,GO:0030326~embryonic limb morphogenesis,GO:0022604~regulation of cell morphogenesis,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009611~response to wounding,GO:0008360~regulation of cell shape,GO:0007599~hemostasis,GO:0007596~blood coagulation,GO:0007266~Rho protein signal transduction,GO:0007265~Ras protein signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007243~protein kinase cascade,GO:0007242~intracellular signaling cascade,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0001701~in utero embryonic development,												GO:0042995~cell projection,GO:0031225~anchored to membrane,GO:0031224~intrinsic to membrane,GO:0005903~brush border,GO:0005886~plasma membrane,																GO:0050780~dopamine receptor binding,GO:0032561~guanyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0005525~GTP binding,GO:0003924~GTPase activity,GO:0000166~nucleotide binding,							IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR000469:G-protein alpha subunit, group 12,																				hsa04810:Regulation of actin cytoskeleton,hsa04730:Long-term depression,hsa04270:Vascular smooth muscle contraction,hsa04010:MAPK signaling pathway,								Many sequence variants affecting diversity of adult human height,										PIRSF002400:GTP-binding regulatory protein Gs alpha chain,																						transducer,polymorphism,phosphoprotein,palmitate,nucleotide-binding,membrane,lipoprotein,gtp-binding,complete proteome,						sequence variant,sequence conflict,nucleotide phosphate-binding region:GTP,modified residue,lipid moiety-binding region:S-palmitoyl cysteine,chain:Guanine nucleotide-binding protein subunit alpha-12,										
37905_r_at	guanine nucleotide binding protein-like 1	Homo sapiens													General function prediction only,						GO:0033554~cellular response to stress,GO:0006974~response to DNA damage stimulus,GO:0006955~immune response,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002456~T cell mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002443~leukocyte mediated immunity,GO:0002252~immune effector process,GO:0002250~adaptive immune response,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,																GO:0032561~guanyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0005525~GTP binding,GO:0005198~structural molecule activity,GO:0000166~nucleotide binding,							IPR002917:GTP-binding protein, HSR1-related,																					phosphoprotein,P-loop,nucleotide-binding,nucleotide binding,gtp-binding,GTP binding,complete proteome,alternative splicing,						splice variant,sequence conflict,nucleotide phosphate-binding region:GTP,modified residue,compositionally biased region:Asp/Glu-rich (highly acidic),chain:Guanine nucleotide-binding protein-like 1,										
31525_s_at	hemoglobin, alpha 2; hemoglobin, alpha 1	Homo sapiens						GO:0015671~oxygen transport,GO:0015669~gas transport,												GO:0044445~cytosolic part,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0033279~ribosomal subunit,GO:0030529~ribonucleoprotein complex,GO:0022627~cytosolic small ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0015935~small ribosomal subunit,GO:0005840~ribosome,GO:0005833~hemoglobin complex,GO:0005829~cytosol,																GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0005506~iron ion binding,GO:0005344~oxygen transporter activity,							IPR018331:Haemoglobin alpha chain,IPR012292:Globin,IPR002339:Haemoglobin, pi,IPR002338:Haemoglobin, alpha,IPR000971:Globin, subset,															Thalassemias, alpha-,Thalassemia, alpha-,Methemoglobinemias, alpha-,Hypochromic microcytic anemia,Hemoglobin H disease,Heinz body anemias, alpha-,Heinz body anemia,Erythrocytosis,Erythremias, alpha-,										PIRSF500045:hemoglobin, vertebrate type,PIRSF036518:globin,																						transport,polymorphism,phosphoprotein,oxygen transport,oxygen carrier,opioid peptide,metalloprotein,metal-binding,iron,heterotetramer,heme,glycoprotein,glycation,erythrocyte,disease mutation,direct protein sequencing,complete proteome,chromoprotein,blood,acetylation,3d-structure,						turn,site:Not glycated,sequence variant,sequence conflict,modified residue,metal ion-binding site:Iron (heme proximal ligand),metal ion-binding site:Iron (heme distal ligand),helix,glycosylation site:N-linked (Glc) (glycation),chain:Hemoglobin subunit alpha,										
31687_f_at	hemoglobin, beta	Homo sapiens											h_ahspPathway:Hemoglobin's Chaperone,								GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0050880~regulation of blood vessel size,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045428~regulation of nitric oxide biosynthetic process,GO:0035150~regulation of tube size,GO:0031328~positive regulation of cellular biosynthetic process,GO:0030185~nitric oxide transport,GO:0015671~oxygen transport,GO:0015669~gas transport,GO:0009891~positive regulation of biosynthetic process,GO:0008217~regulation of blood pressure,GO:0008015~blood circulation,GO:0003018~vascular process in circulatory system,GO:0003013~circulatory system process,												GO:0044445~cytosolic part,GO:0005833~hemoglobin complex,GO:0005829~cytosol,																GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0030492~hemoglobin binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0005506~iron ion binding,GO:0005344~oxygen transporter activity,							IPR012292:Globin,IPR002337:Haemoglobin, beta,IPR000971:Globin, subset,															Thalassemias, beta-,Thalassemia-beta, dominant inclusion-body,Sickle cell anemia,Methemoglobinemias, beta-,HPFH, deletion type,Hereditary persistence of fetal hemoglobin,Heinz body anemias, beta-,Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia,Erythremias, beta-,A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15,										PIRSF500045:hemoglobin, vertebrate type,PIRSF036518:globin,																						vasoactive,transport,s-nitrosylation,pyruvate,polymorphism,phosphoprotein,oxygen transport,oxygen carrier,opioid peptide,metalloprotein,metal-binding,iron,hypotensive agent,homotetramer,heterotetramer,hereditary hemolytic anemia,heme,glycoprotein,glycation,erythrocyte,disease mutation,direct protein sequencing,congenital dyserythropoietic anemia,complete proteome,chromoprotein,blood,blocked amino end,acetylation,3d-structure,						turn,site:Susceptible to oxidation; associated with variant Atlanta, variant non-spherocytic haemolytic anemia and variant Christchurch,site:Not glycated,site:Aspirin-acetylated lysine,sequence variant,sequence conflict,peptide:LVV-hemorphin-7,modified residue,metal ion-binding site:Iron (heme proximal ligand),metal ion-binding site:Iron (heme distal ligand),helix,glycosylation site:N-linked (Glc) (glycation); in Hb A1c,glycosylation site:N-linked (Glc) (glycation),chain:Hemoglobin subunit beta,binding site:2,3-bisphosphoglycerate; via amino nitrogen,binding site:2,3-bisphosphoglycerate,										
33516_at	hemoglobin, delta	Homo sapiens						GO:0015671~oxygen transport,GO:0015669~gas transport,												GO:0044445~cytosolic part,GO:0005833~hemoglobin complex,GO:0005829~cytosol,																GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0005506~iron ion binding,GO:0005344~oxygen transporter activity,							IPR012292:Globin,IPR002337:Haemoglobin, beta,IPR000971:Globin, subset,															Thalassemia, delta-,Thalassemia due to Hb Lepore,										PIRSF500045:hemoglobin, vertebrate type,PIRSF036518:globin,																						transport,polymorphism,phosphoprotein,oxygen transport,oxygen carrier,metalloprotein,metal-binding,iron,heterotetramer,heme,erythrocyte,direct protein sequencing,complete proteome,chromoprotein,blood,acetylation,3d-structure,						turn,sequence variant,modified residue,metal ion-binding site:Iron (heme proximal ligand),metal ion-binding site:Iron (heme distal ligand),helix,chain:Hemoglobin subunit delta,										
40735_at	histidine ammonia-lyase	Homo sapiens						GO:0046700~heterocycle catabolic process,GO:0046395~carboxylic acid catabolic process,GO:0016054~organic acid catabolic process,GO:0009310~amine catabolic process,GO:0009077~histidine family amino acid catabolic process,GO:0009075~histidine family amino acid metabolic process,GO:0009063~cellular amino acid catabolic process,GO:0006548~histidine catabolic process,GO:0006547~histidine metabolic process,												GO:0005829~cytosol,GO:0005625~soluble fraction,GO:0000267~cell fraction,																GO:0016880~acid-ammonia (or amide) ligase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016841~ammonia-lyase activity,GO:0016840~carbon-nitrogen lyase activity,GO:0016211~ammonia ligase activity,GO:0004397~histidine ammonia-lyase activity,							IPR005921:Histidine ammonia-lyase,IPR001106:Phenylalanine/histidine ammonia-lyase,																				hsa00910:Nitrogen metabolism,hsa00340:Histidine metabolism,								Histidinemia,																			polymorphism,phosphoprotein,Phenylpropanoid metabolism,lyase,histidine metabolism,histidine catabolism,disease mutation,cytoplasm,complete proteome,carbon-nitrogen lyase,ammonia-lyase,						sequence variant,modified residue,cross-link:5-imidazolinone (Ala-Gly),chain:Histidine ammonia-lyase,										
35566_f_at	immunoglobulin heavy constant gamma 1 (G1m marker); immunoglobulin heavy constant mu; immunoglobulin heavy variable 3-7; immunoglobulin heavy constant gamma 3 (G3m marker); immunoglobulin heavy variable 3-11 (gene/pseudogene); immunoglobulin heavy variable 4-31; immunoglobulin heavy locus	Homo sapiens							79.B_cell_Activation,78.B_Cell_Development,												GO:0006955~immune response,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005886~plasma membrane,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0005576~extracellular region,GO:0000267~cell fraction,																GO:0003823~antigen binding,							IPR018062:Helix-turn-helix, AraC type, subdomain 2,IPR013783:Immunoglobulin-like fold,IPR013151:Immunoglobulin,IPR013106:Immunoglobulin V-set,IPR007110:Immunoglobulin-like,IPR003597:Immunoglobulin C1-set,IPR003596:Immunoglobulin V-set, subgroup,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,															Agammaglobulinemia,																					SM00407:IGc1,SM00406:IGv,											transmembrane,signal,Secreted,repeat,receptor,Pyrrolidone carboxylic acid,pyroglutamic acid,polymorphism,membrane protein,membrane,Immunoglobulin domain,immunoglobulin c region,immunoglobulin,heterotetramer,glycoprotein,duplication,disulfide bond,direct protein sequencing,complete proteome,chromosomal rearrangement,cell membrane,alternative splicing,3d-structure,						turn,strand,splice variant,signal peptide,sequence variant,sequence conflict,region of interest:Hinge,region of interest:CH4,region of interest:CH3,region of interest:CH2,region of interest:CH1,helix,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Ig mu chain C region,chain:Ig gamma-3 chain C region,chain:Ig gamma-1 chain C region,chain:anti-RhD monoclonal T125 gamma1 heavy chain,										
35915_at	inhibin, beta C	Homo sapiens					GO:0005576~extracellular region,																GO:0008083~growth factor activity,GO:0005179~hormone activity,GO:0005160~transforming growth factor beta receptor binding,							IPR017948:Transforming growth factor beta, conserved site,IPR015615:Transforming growth factor-beta-related,IPR001839:Transforming growth factor beta,IPR001318:Inhibin, beta C subunit,																				hsa04350:TGF-beta signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,					PIRSF800009:TGF-beta-like cysteine-knot cytokine,PIRSF500818:activin/inhibin, beta C subunit,PIRSF037268:activin/inhibin, beta subunit,																								SM00204:TGFB,											signal,Secreted,polymorphism,hormone,growth factor,glycoprotein,disulfide bond,complete proteome,cleavage on pair of basic residues,						signal peptide,sequence variant,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Inhibin beta C chain,										
38926_at	integrin, beta 5	Homo sapiens						GO:0031589~cell-substrate adhesion,GO:0022610~biological adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0007160~cell-matrix adhesion,GO:0007155~cell adhesion,												GO:0044459~plasma membrane part,GO:0043235~receptor complex,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0008305~integrin complex,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,										IPR015812:Integrin beta subunit,IPR015435:Integrin beta-3 subunit, C-terminal,IPR014836:Integrin beta subunit, cytoplasmic,IPR013111:EGF, extracellular,IPR013032:EGF-like region, conserved site,IPR012896:Integrin beta subunit, tail,IPR012012:Integrin beta subunit, subgroup,IPR006210:EGF-like,IPR003659:Plexin/semaphorin/integrin,IPR002369:Integrin beta subunit, N-terminal,IPR002035:von Willebrand factor, type A,IPR001169:Integrin beta subunit, C-terminal,																				hsa05414:Dilated cardiomyopathy,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05410:Hypertrophic cardiomyopathy (HCM),hsa04810:Regulation of actin cytoskeleton,hsa04512:ECM-receptor interaction,hsa04510:Focal adhesion,					PIRSF002512:Integrin_B,PIRSF002512:integrin, beta subunit,																								SM00423:PSI,SM00327:VWA,SM00187:INB,SM00181:EGF,											transmembrane protein,transmembrane,signal,repeat,receptor,polymorphism,membrane,integrin,heterodimer,glycoprotein,extracellular matrix,duplication,disulfide bond,cytoskeleton,complete proteome,cell adhesion,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,signal peptide,sequence variant,sequence conflict,repeat:IV,repeat:III,repeat:II,repeat:I,region of interest:Cysteine-rich tandem repeats,glycosylation site:N-linked (GlcNAc...),domain:VWFA,domain:PSI,disulfide bond,chain:Integrin beta-5,										
38674_at	kelch-like 9 (Drosophila)	Homo sapiens						GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0030163~protein catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0006508~proteolysis,									IPR017096:Kelch-like protein, gigaxonin,IPR015915:Kelch-type beta propeller,IPR013089:Kelch related,IPR013069:BTB/POZ,IPR011705:BTB/Kelch-associated,IPR011333:BTB/POZ fold,IPR006652:Kelch repeat type 1,IPR000210:BTB/POZ-like,																				hsa04120:Ubiquitin mediated proteolysis,					PIRSF037037:Kelch-like_protein_gigaxonin,PIRSF037037:kelch-like protein, gigaxonin type,																								SM00612:Kelch,SM00225:BTB,											ubl conjugation pathway,repeat,phosphoprotein,kelch repeat,complete proteome,						repeat:Kelch 6,repeat:Kelch 5,repeat:Kelch 4,repeat:Kelch 3,repeat:Kelch 2,repeat:Kelch 1,modified residue,domain:BTB,domain:BACK,chain:Kelch-like protein 9,										
34012_at	keratin 34	Homo sapiens						GO:0008544~epidermis development,GO:0007398~ectoderm development,												GO:0045111~intermediate filament cytoskeleton,GO:0044430~cytoskeletal part,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0005882~intermediate filament,GO:0005856~cytoskeleton,																GO:0005198~structural molecule activity,							IPR018039:Intermediate filament protein, conserved site,IPR016044:Filament,IPR002957:Keratin, type I,IPR001664:Intermediate filament protein,												PIRSF002282:cytoskeletal keratin,																						polymorphism,keratin,Intermediate filament,complete proteome,coiled coil,						site:Stutter,sequence variant,sequence conflict,region of interest:Tail,region of interest:Rod,region of interest:Linker 12,region of interest:Linker 1,region of interest:Head,region of interest:Coil 2,region of interest:Coil 1B,region of interest:Coil 1A,chain:Keratin, type I cuticular Ha4,										
31987_at	kin of IRRE like (Drosophila)	Homo sapiens						GO:0046903~secretion,GO:0007588~excretion,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005886~plasma membrane,										IPR013783:Immunoglobulin-like fold,IPR013162:CD80-like, immunoglobulin C2-set,IPR013151:Immunoglobulin,IPR013106:Immunoglobulin V-set,IPR013098:Immunoglobulin I-set,IPR007110:Immunoglobulin-like,IPR003599:Immunoglobulin subtype,IPR003598:Immunoglobulin subtype 2,																							SM00409:IG,SM00408:IGc2,											transmembrane,signal,repeat,polymorphism,phosphoprotein,membrane,Immunoglobulin domain,glycoprotein,disulfide bond,complete proteome,cell membrane,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,signal peptide,short sequence motif:Cell attachment site,sequence variant,sequence conflict,modified residue,glycosylation site:N-linked (GlcNAc...),domain:Ig-like C2-type 5,domain:Ig-like C2-type 4,domain:Ig-like C2-type 3,domain:Ig-like C2-type 2,domain:Ig-like C2-type 1,disulfide bond,chain:Kin of IRRE-like protein 1,										
35367_at	lectin, galactoside-binding, soluble, 3	Homo sapiens						GO:0043062~extracellular structure organization,GO:0030198~extracellular matrix organization,GO:0001501~skeletal system development,												GO:0044421~extracellular region part,GO:0031012~extracellular matrix,GO:0005886~plasma membrane,GO:0005578~proteinaceous extracellular matrix,GO:0005576~extracellular region,																GO:0032403~protein complex binding,GO:0030246~carbohydrate binding,GO:0019865~immunoglobulin binding,GO:0019863~IgE binding,GO:0005529~sugar binding,							IPR015534:Galectin-3,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR001079:Galectin, carbohydrate recognition domain,												PIRSF037626:galectin 3,																								SM00276:GLECT,											repeat,polymorphism,phosphoprotein,nucleus,Lectin,ige-binding protein,disulfide bond,differentiation,complete proteome,acetylation,3d-structure,						strand,sequence variant,sequence conflict,repeat:8; approximate,repeat:7; approximate,repeat:6; approximate,repeat:5,repeat:4; approximate,repeat:3,repeat:2,repeat:1,region of interest:Beta-galactoside binding,region of interest:8 X 9 AA tandem repeats of Y-P-G-X(3)-P- G-A,modified residue,helix,domain:Galectin,disulfide bond,chain:Galectin-3,										
36436_at	leukocyte cell-derived chemotaxin 2	Homo sapiens						GO:0042330~taxis,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0010648~negative regulation of cell communication,GO:0009968~negative regulation of signal transduction,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0006935~chemotaxis,GO:0001501~skeletal system development,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,										IPR017381:Leukocyte cell-derived chemotaxin 2, chordata,IPR016047:Peptidase M23,IPR008663:Leukocyte cell-derived chemotaxin 2,												PIRSF038085:LECT3,																						signal,Secreted,polymorphism,cytoplasm,complete proteome,chemotaxis,						signal peptide,sequence variant,chain:Leukocyte cell-derived chemotaxin-2,										
32073_at	lysine (K)-specific demethylase 4A	Homo sapiens													General function prediction only,						GO:0055114~oxidation reduction,GO:0051276~chromosome organization,GO:0045449~regulation of transcription,GO:0016577~histone demethylation,GO:0016570~histone modification,GO:0016569~covalent chromatin modification,GO:0016568~chromatin modification,GO:0008214~protein amino acid dealkylation,GO:0006730~one-carbon metabolic process,GO:0006482~protein amino acid demethylation,GO:0006350~transcription,GO:0006325~chromatin organization,												GO:0070013~intracellular organelle lumen,GO:0043233~organelle lumen,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0005730~nucleolus,																GO:0051864~histone demethylase activity (H3-K36 specific),GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0032452~histone demethylase activity,GO:0032451~demethylase activity,GO:0030528~transcription regulator activity,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016564~transcription repressor activity,GO:0008270~zinc ion binding,GO:0005506~iron ion binding,							IPR019787:Zinc finger, PHD-finger,IPR019786:Zinc finger, PHD-type, conserved site,IPR013129:Transcription factor jumonji,IPR003349:Transcription factor jumonji, JmjN,IPR003347:Transcription factor jumonji/aspartyl beta-hydroxylase,IPR002999:Tudor domain,IPR001965:Zinc finger, PHD-type,																							SM00558:JmjC,SM00545:JmjN,SM00333:TUDOR,SM00249:PHD,											zinc-finger,zinc,transcription regulation,Transcription,repeat,polymorphism,phosphoprotein,oxidoreductase,nucleus,metal-binding,iron,host-virus interaction,dioxygenase,complete proteome,chromatin regulator,3d-structure,						zinc finger region:PHD-type 2,zinc finger region:PHD-type 1,turn,strand,sequence variant,region of interest:Interaction with NCOR1,mutagenesis site,modified residue,metal ion-binding site:Zinc,metal ion-binding site:Iron; catalytic,helix,domain:Tudor 2,domain:Tudor 1,domain:JmjN,domain:JmjC,chain:Lysine-specific demethylase 4A,binding site:Histone H3-K4Me3,binding site:Alpha-ketoglutarate,										
37408_at	mannose receptor, C type 2	Homo sapiens						GO:0016192~vesicle-mediated transport,GO:0016044~membrane organization,GO:0010324~membrane invagination,GO:0006897~endocytosis,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,																GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0030246~carbohydrate binding,GO:0005529~sugar binding,GO:0005509~calcium ion binding,							IPR018378:C-type lectin, conserved site,IPR016186:C-type lectin-like,IPR002353:Type II antifreeze protein,IPR001304:C-type lectin,IPR000772:Ricin B lectin,IPR000562:Type II fibronectin, collagen-binding,												PIRSF002427:mannose receptor,																								SM00458:RICIN,SM00059:FN2,SM00034:CLECT,											transmembrane,signal,repeat,receptor,polymorphism,phosphoprotein,membrane,Lectin,glycoprotein,Endocytosis,disulfide bond,direct protein sequencing,complete proteome,calcium,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,signal peptide,sequence variant,mutagenesis site,glycosylation site:N-linked (GlcNAc...),domain:Ricin B-type lectin,domain:Fibronectin type-II,domain:C-type lectin 8,domain:C-type lectin 7,domain:C-type lectin 6,domain:C-type lectin 5,domain:C-type lectin 4,domain:C-type lectin 3,domain:C-type lectin 2,domain:C-type lectin 1,disulfide bond,chain:C-type mannose receptor 2,										
34577_at	melanoma antigen family A, 9; melanoma antigen family A, 9B	Homo sapiens		IPR002190:MAGE protein,												PIRSF005491:tumor associated protein MAGE,																						tumor antigen,complete proteome,						sequence conflict,domain:MAGE,compositionally biased region:Poly-Glu,chain:Melanoma-associated antigen 9,										
38945_at	metal-regulatory transcription factor 1	Homo sapiens													Transcription / Cell division and chromosome partitioning,General function prediction only,						GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0046686~response to cadmium ion,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045941~positive regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0031328~positive regulation of cellular biosynthetic process,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0009891~positive regulation of biosynthetic process,GO:0006979~response to oxidative stress,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,															GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042156~zinc-mediated transcriptional activator activity,GO:0030528~transcription regulator activity,GO:0016563~transcription activator activity,GO:0008270~zinc ion binding,GO:0008134~transcription factor binding,GO:0003713~transcription coactivator activity,GO:0003712~transcription cofactor activity,GO:0003700~transcription factor activity,GO:0003677~DNA binding,							IPR015880:Zinc finger, C2H2-like,IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding,IPR007087:Zinc finger, C2H2-type,																							SM00355:ZnF_C2H2,											zinc-finger,zinc,transcription regulation,Transcription,repeat,nucleus,metal-binding,dna-binding,complete proteome,activator,						zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 1,short sequence motif:Nuclear localization signal,sequence conflict,compositionally biased region:Pro-rich,chain:Metal regulatory transcription factor 1,										
31576_at	mevalonate kinase	Homo sapiens						GO:0016310~phosphorylation,GO:0016126~sterol biosynthetic process,GO:0016125~sterol metabolic process,GO:0008610~lipid biosynthetic process,GO:0008299~isoprenoid biosynthetic process,GO:0008203~cholesterol metabolic process,GO:0008202~steroid metabolic process,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006720~isoprenoid metabolic process,GO:0006695~cholesterol biosynthetic process,GO:0006694~steroid biosynthetic process,												GO:0042579~microbody,GO:0005777~peroxisome,																GO:0042802~identical protein binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0005524~ATP binding,GO:0004496~mevalonate kinase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR014721:Ribosomal protein S5 domain 2-type fold,IPR013750:GHMP kinase, C-terminal,IPR006206:Mevalonate and galactokinase,IPR006205:Mevalonate kinase,IPR006204:GHMP kinase,IPR006203:GHMP kinase, ATP-binding, conserved site,																				hsa00900:Terpenoid backbone biosynthesis,								Newly identified loci that influence lipid concentrations and risk of coronary artery disease,Mevalonicaciduria,Mevalonic aciduria,Hyper-IgD syndrome,Common variants at 30 loci contribute to polygenic dyslipidemia,										PIRSF500058:mevalonate kinase,PIRSF000546:mevalonate kinase/phosphomevalonate kinase,																						transferase,sterol biosynthesis,Steroid biosynthesis,polymorphism,phosphotransferase,peroxisome,nucleotide-binding,lipid synthesis,kinase,isoprenoid biosynthesis,disease mutation,cytoplasm,complete proteome,Cholesterol biosynthesis,cataract,atp-binding,ATP,3d-structure,						turn,strand,sequence variant,nucleotide phosphate-binding region:ATP,helix,chain:Mevalonate kinase,binding site:ATP,										
33246_at	mitogen-activated protein kinase 13	Homo sapiens											h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_mapkPathway:MAPKinase Signaling Pathway,h_keratinocytePathway:Keratinocyte Differentiation,								GO:0016310~phosphorylation,GO:0007265~Ras protein signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007243~protein kinase cascade,GO:0007242~intracellular signaling cascade,GO:0007049~cell cycle,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein amino acid phosphorylation,												GO:0005625~soluble fraction,GO:0000267~cell fraction,																GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016909~SAP kinase activity,GO:0005524~ATP binding,GO:0004707~MAP kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004672~protein kinase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR017442:Serine/threonine protein kinase-related,IPR017441:Protein kinase, ATP binding site,IPR008352:MAP kinase, p38,IPR008271:Serine/threonine protein kinase, active site,IPR003527:MAP kinase, conserved site,IPR002290:Serine/threonine protein kinase,IPR000719:Protein kinase, core,																				hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa04914:Progesterone-mediated oocyte maturation,hsa04912:GnRH signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04664:Fc epsilon RI signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04370:VEGF signaling pathway,hsa04010:MAPK signaling pathway,					PIRSF000564:kinase-related transforming protein,																								SM00220:S_TKc,											transferase,serine/threonine-protein kinase,polymorphism,phosphotransferase,phosphoprotein,nucleotide-binding,kinase,complete proteome,cell cycle,atp-binding,3d-structure,						turn,strand,short sequence motif:TXY,sequence variant,sequence conflict,nucleotide phosphate-binding region:ATP,mutagenesis site,modified residue,helix,domain:Protein kinase,chain:Mitogen-activated protein kinase 13,binding site:ATP,active site:Proton acceptor,										
41280_r_at	mitogen-activated protein kinase 8 interacting protein 1	Homo sapiens						GO:0080135~regulation of cellular response to stress,GO:0070303~negative regulation of stress-activated protein kinase signaling pathway,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0060548~negative regulation of cell death,GO:0051348~negative regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051252~regulation of RNA metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0048585~negative regulation of response to stimulus,GO:0046329~negative regulation of JNK cascade,GO:0046328~regulation of JNK cascade,GO:0045859~regulation of protein kinase activity,GO:0045449~regulation of transcription,GO:0044092~negative regulation of molecular function,GO:0043549~regulation of kinase activity,GO:0043508~negative regulation of JUN kinase activity,GO:0043506~regulation of JUN kinase activity,GO:0043409~negative regulation of MAPKKK cascade,GO:0043408~regulation of MAPKKK cascade,GO:0043407~negative regulation of MAP kinase activity,GO:0043405~regulation of MAP kinase activity,GO:0043086~negative regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptosis,GO:0042981~regulation of apoptosis,GO:0042325~regulation of phosphorylation,GO:0033673~negative regulation of kinase activity,GO:0033554~cellular response to stress,GO:0032268~regulation of cellular protein metabolic process,GO:0031399~regulation of protein modification process,GO:0031098~stress-activated protein kinase signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0010941~regulation of cell death,GO:0010741~negative regulation of protein kinase cascade,GO:0010648~negative regulation of cell communication,GO:0010627~regulation of protein kinase cascade,GO:0009968~negative regulation of signal transduction,GO:0007258~JUN phosphorylation,GO:0007254~JNK cascade,GO:0007243~protein kinase cascade,GO:0007242~intracellular signaling cascade,GO:0006916~anti-apoptosis,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006469~negative regulation of protein kinase activity,GO:0006468~protein amino acid phosphorylation,GO:0006355~regulation of transcription, DNA-dependent,GO:0001932~regulation of protein amino acid phosphorylation,GO:0000165~MAPKKK cascade,												GO:0048471~perinuclear region of cytoplasm,GO:0043005~neuron projection,GO:0042995~cell projection,GO:0005829~cytosol,																GO:0032947~protein complex scaffold,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0030159~receptor signaling complex scaffold activity,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0019894~kinesin binding,GO:0019887~protein kinase regulator activity,GO:0019210~kinase inhibitor activity,GO:0019207~kinase regulator activity,GO:0008432~JUN kinase binding,GO:0008092~cytoskeletal protein binding,GO:0005198~structural molecule activity,GO:0005078~MAP-kinase scaffold activity,GO:0004860~protein kinase inhibitor activity,GO:0004857~enzyme inhibitor activity,							IPR011993:Pleckstrin homology-type,IPR006020:Phosphotyrosine interaction region,IPR001452:Src homology-3 domain,																				hsa04010:MAPK signaling pathway,								Diabetes mellitus, noninsulin-dependent,																					SM00462:PTB,SM00326:SH3,											ubl conjugation,sh3 domain,repeat,polymorphism,phosphoprotein,nucleus,kinase,disease mutation,diabetes mellitus,cytoplasm,complete proteome,3d-structure,						short sequence motif:D-box 2,short sequence motif:D-box 1,sequence variant,region of interest:Minimal inhibitory domain (MID),region of interest:JNK-binding domain (JBD),mutagenesis site,modified residue,domain:SH3,domain:PID,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Glu,compositionally biased region:Asp/Glu-rich (acidic),chain:C-jun-amino-terminal kinase-interacting protein 1,										
33284_at	myeloperoxidase	Homo sapiens						GO:0070301~cellular response to hydrogen peroxide,GO:0060548~negative regulation of cell death,GO:0055114~oxidation reduction,GO:0043933~macromolecular complex subunit organization,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptosis,GO:0042981~regulation of apoptosis,GO:0042744~hydrogen peroxide catabolic process,GO:0042743~hydrogen peroxide metabolic process,GO:0042542~response to hydrogen peroxide,GO:0034614~cellular response to reactive oxygen species,GO:0034599~cellular response to oxidative stress,GO:0034374~low-density lipoprotein particle remodeling,GO:0034369~plasma lipoprotein particle remodeling,GO:0034368~protein-lipid complex remodeling,GO:0034367~macromolecular complex remodeling,GO:0033554~cellular response to stress,GO:0010941~regulation of cell death,GO:0010035~response to inorganic substance,GO:0006979~response to oxidative stress,GO:0006952~defense response,GO:0006916~anti-apoptosis,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0000302~response to reactive oxygen species,												GO:0044421~extracellular region part,GO:0005773~vacuole,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,																GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0020037~heme binding,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016209~antioxidant activity,GO:0005509~calcium ion binding,GO:0005506~iron ion binding,GO:0004601~peroxidase activity,GO:0003682~chromatin binding,							IPR019794:Peroxidase, active site,IPR019793:Peroxidases heam-ligand binding site,IPR019791:Haem peroxidase, animal, subgroup,IPR002007:Haem peroxidase, animal,															Myeloperoxidase deficiency,Lung cancer, protection against, in smokers,Alzheimer disease, susceptibility to,										PIRSF000299:myeloperoxidase,																						signal,polymorphism,peroxidase,oxidoreductase,oxidation,metalloprotein,metal-binding,lysosome,iron,hydrogen peroxide,heme,glycoprotein,disulfide bond,disease mutation,direct protein sequencing,complete proteome,chromoprotein,calcium,alternative splicing,3d-structure,						turn,strand,splice variant,site:Transition state stabilizer,signal peptide,sequence variant,sequence conflict,modified residue,metal ion-binding site:Iron (heme axial ligand),metal ion-binding site:Calcium; via carbonyl oxygen,metal ion-binding site:Calcium,helix,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Myeloperoxidase light chain,chain:Myeloperoxidase heavy chain,chain:Myeloperoxidase,chain:89 kDa myeloperoxidase,chain:84 kDa myeloperoxidase,binding site:Heme (covalent; via 3 links),active site:Proton acceptor,										
37711_at	myocyte enhancer factor 2C	Homo sapiens											h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_alkPathway:ALK in cardiac myocytes,															Transcription,						GO:0060548~negative regulation of cell death,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045941~positive regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045885~positive regulation of survival gene product expression,GO:0045884~regulation of survival gene product expression,GO:0045449~regulation of transcription,GO:0043193~positive regulation of gene-specific transcription,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptosis,GO:0042981~regulation of apoptosis,GO:0032583~regulation of gene-specific transcription,GO:0032582~negative regulation of gene-specific transcription,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0016481~negative regulation of transcription,GO:0016265~death,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0008219~cell death,GO:0007517~muscle organ development,GO:0006916~anti-apoptosis,GO:0006915~apoptosis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,												GO:0070013~intracellular organelle lumen,GO:0044451~nucleoplasm part,GO:0043233~organelle lumen,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0016607~nuclear speck,GO:0016604~nuclear body,GO:0005654~nucleoplasm,																GO:0043565~sequence-specific DNA binding,GO:0030528~transcription regulator activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003700~transcription factor activity,GO:0003677~DNA binding,							IPR002100:Transcription factor, MADS-box,																				hsa04010:MAPK signaling pathway,								Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness,																					SM00432:MADS,											ubl conjugation,transcription regulation,transcription factor,Transcription,skeletal muscle,phosphoprotein,nucleus,neurogenesis,isopeptide bond,dna-binding,DNA binding,differentiation,developmental protein,complete proteome,brain,Apoptosis,alternative splicing,activator,acetylation,						splice variant,site:Cleavage,region of interest:Transcription repressor,region of interest:Beta domain,mutagenesis site,modified residue,domain:MADS-box,DNA-binding region:Mef2-type,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),compositionally biased region:Ser-rich,compositionally biased region:Lys-rich (basic),chain:Myocyte-specific enhancer factor 2C,										
35038_at	myosin binding protein C, cardiac	Homo sapiens						GO:0060537~muscle tissue development,GO:0060415~muscle tissue morphogenesis,GO:0060341~regulation of cellular localization,GO:0060048~cardiac muscle contraction,GO:0060047~heart contraction,GO:0055010~ventricular cardiac muscle morphogenesis,GO:0055008~cardiac muscle tissue morphogenesis,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0048738~cardiac muscle tissue development,GO:0048729~tissue morphogenesis,GO:0044093~positive regulation of molecular function,GO:0044057~regulation of system process,GO:0043462~regulation of ATPase activity,GO:0043085~positive regulation of catalytic activity,GO:0032971~regulation of muscle filament sliding,GO:0032970~regulation of actin filament-based process,GO:0032781~positive regulation of ATPase activity,GO:0032386~regulation of intracellular transport,GO:0022610~biological adhesion,GO:0014706~striated muscle tissue development,GO:0008015~blood circulation,GO:0007517~muscle organ development,GO:0007507~heart development,GO:0007155~cell adhesion,GO:0006942~regulation of striated muscle contraction,GO:0006941~striated muscle contraction,GO:0006937~regulation of muscle contraction,GO:0006936~muscle contraction,GO:0003015~heart process,GO:0003013~circulatory system process,GO:0003012~muscle system process,GO:0003007~heart morphogenesis,												GO:0044449~contractile fiber part,GO:0044430~cytoskeletal part,GO:0043292~contractile fiber,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0032982~myosin filament,GO:0031672~A band,GO:0030017~sarcomere,GO:0030016~myofibril,GO:0016460~myosin II complex,GO:0016459~myosin complex,GO:0015629~actin cytoskeleton,GO:0014705~C zone,GO:0005863~striated muscle thick filament,GO:0005859~muscle myosin complex,GO:0005856~cytoskeleton,																GO:0060590~ATPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0032036~myosin heavy chain binding,GO:0031432~titin binding,GO:0017022~myosin binding,GO:0008307~structural constituent of muscle,GO:0008092~cytoskeletal protein binding,GO:0008047~enzyme activator activity,GO:0005198~structural molecule activity,GO:0003779~actin binding,GO:0001671~ATPase activator activity,							IPR013783:Immunoglobulin-like fold,IPR013151:Immunoglobulin,IPR013098:Immunoglobulin I-set,IPR008957:Fibronectin, type III-like fold,IPR007110:Immunoglobulin-like,IPR003961:Fibronectin, type III,IPR003599:Immunoglobulin subtype,IPR003598:Immunoglobulin subtype 2,																				hsa05414:Dilated cardiomyopathy,hsa05410:Hypertrophic cardiomyopathy (HCM),								Cardiomyopathy, familial hypertrophic, 4,?Cardiomyopathy, dilated,																					SM00409:IG,SM00408:IGc2,SM00060:FN3,											thick filament,repeat,polymorphism,phosphoprotein,muscle protein,Immunoglobulin domain,heart,disease mutation,complete proteome,cell adhesion,Cardiomyopathy,cardiac muscle,actin-binding,3d-structure,						turn,strand,sequence variant,sequence conflict,modified residue,helix,domain:Ig-like C2-type 7,domain:Ig-like C2-type 6,domain:Ig-like C2-type 5,domain:Ig-like C2-type 4,domain:Ig-like C2-type 3,domain:Ig-like C2-type 2,domain:Ig-like C2-type 1,domain:Fibronectin type-III 3,domain:Fibronectin type-III 2,domain:Fibronectin type-III 1,compositionally biased region:Pro-rich,chain:Myosin-binding protein C, cardiac-type,										
37968_at	natural cytotoxicity triggering receptor 3	Homo sapiens						GO:0050778~positive regulation of immune response,GO:0048584~positive regulation of response to stimulus,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0045089~positive regulation of innate immune response,GO:0045088~regulation of innate immune response,GO:0042269~regulation of natural killer cell mediated cytotoxicity,GO:0031349~positive regulation of defense response,GO:0031343~positive regulation of cell killing,GO:0031341~regulation of cell killing,GO:0009611~response to wounding,GO:0008037~cell recognition,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0002717~positive regulation of natural killer cell mediated immunity,GO:0002715~regulation of natural killer cell mediated immunity,GO:0002708~positive regulation of lymphocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002705~positive regulation of leukocyte mediated immunity,GO:0002703~regulation of leukocyte mediated immunity,GO:0002699~positive regulation of immune effector process,GO:0002697~regulation of immune effector process,GO:0002684~positive regulation of immune system process,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0001910~regulation of leukocyte mediated cytotoxicity,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,										IPR013783:Immunoglobulin-like fold,IPR013106:Immunoglobulin V-set,IPR007110:Immunoglobulin-like,IPR003599:Immunoglobulin subtype,																				hsa04650:Natural killer cell mediated cytotoxicity,								Malaria, mild, susceptibility to,Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity,										PIRSF038040:Natural cytotoxicity triggering receptor 3,																								SM00409:IG,											transmembrane,signal,receptor,polymorphism,membrane,Immunoglobulin domain,glycoprotein,disulfide bond,complete proteome,cell membrane,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,signal peptide,sequence variant,glycosylation site:N-linked (GlcNAc...),domain:Ig-like,disulfide bond,chain:Natural cytotoxicity triggering receptor 3,										
34233_i_at	natural killer-tumor recognition sequence	Homo sapiens						GO:0006457~protein folding,												GO:0019898~extrinsic to membrane,																GO:0042277~peptide binding,GO:0016859~cis-trans isomerase activity,GO:0016018~cyclosporin A binding,GO:0008144~drug binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,							IPR002130:Peptidyl-prolyl cis-trans isomerase, cyclophilin-type,																					ubl conjugation,Rotamase,repeat,polymorphism,phosphoprotein,membrane,lymphocyte,isopeptide bond,Isomerase,Cyclosporin,complete proteome,alternative splicing,3d-structure,						turn,strand,sequence variant,region of interest:Arg/Ser tandem repeat-rich,modified residue,helix,domain:PPIase cyclophilin-type,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),compositionally biased region:Arg/Ser-rich,compositionally biased region:Arg/Lys-rich (basic),chain:NK-tumor recognition protein,										
1112_g_at	neural cell adhesion molecule 1	Homo sapiens											h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,								GO:0050850~positive regulation of calcium-mediated signaling,GO:0050848~regulation of calcium-mediated signaling,GO:0034109~homotypic cell-cell adhesion,GO:0022610~biological adhesion,GO:0016337~cell-cell adhesion,GO:0010647~positive regulation of cell communication,GO:0009967~positive regulation of signal transduction,GO:0007166~cell surface receptor linked signal transduction,GO:0007155~cell adhesion,												GO:0044459~plasma membrane part,GO:0043005~neuron projection,GO:0042995~cell projection,GO:0031225~anchored to membrane,GO:0031224~intrinsic to membrane,GO:0030424~axon,GO:0016021~integral to membrane,GO:0009986~cell surface,GO:0009897~external side of plasma membrane,GO:0005886~plasma membrane,GO:0005576~extracellular region,										IPR013783:Immunoglobulin-like fold,IPR013151:Immunoglobulin,IPR013098:Immunoglobulin I-set,IPR009138:Neural cell adhesion,IPR008957:Fibronectin, type III-like fold,IPR007110:Immunoglobulin-like,IPR003961:Fibronectin, type III,IPR003598:Immunoglobulin subtype 2,																				hsa05020:Prion diseases,hsa04514:Cell adhesion molecules (CAMs),					PIRSF501037:neural cell adhesion molecule,PIRSF002507:cell adhesion molecule, NCAM/Fasciclin-2 types,																								SM00408:IGc2,SM00060:FN3,											transmembrane,skeletal muscle,signal,sialoglycoprotein,Secreted,repeat,polymorphism,phosphoprotein,phosphatidylinositol linkage,membrane protein,membrane,lipoprotein,Immunoglobulin domain,heparin binding,gpi-anchor,glycoprotein,duplication,disulfide bond,complete proteome,cell membrane,cell adhesion,alternative splicing,3d-structure,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,strand,splice variant,signal peptide,sequence variant,sequence conflict,modified residue,helix,glycosylation site:N-linked (GlcNAc...),domain:Ig-like C2-type 5,domain:Ig-like C2-type 4,domain:Ig-like C2-type 3,domain:Ig-like C2-type 2,domain:Ig-like C2-type 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 1,disulfide bond,chain:Neural cell adhesion molecule 1,										
32717_at	neuralized homolog (Drosophila)	Homo sapiens						GO:0051674~localization of cell,GO:0048870~cell motility,GO:0048732~gland development,GO:0048610~reproductive cellular process,GO:0048609~reproductive process in a multicellular organism,GO:0048515~spermatid differentiation,GO:0048232~male gamete generation,GO:0043064~flagellum organization,GO:0035084~flagellar axoneme assembly,GO:0035082~axoneme assembly,GO:0032989~cellular component morphogenesis,GO:0032504~multicellular organism reproduction,GO:0030879~mammary gland development,GO:0030317~sperm motility,GO:0030031~cell projection assembly,GO:0030030~cell projection organization,GO:0019953~sexual reproduction,GO:0010927~cellular component assembly involved in morphogenesis,GO:0009296~flagellum assembly,GO:0007595~lactation,GO:0007288~sperm axoneme assembly,GO:0007286~spermatid development,GO:0007283~spermatogenesis,GO:0007281~germ cell development,GO:0007276~gamete generation,GO:0007017~microtubule-based process,GO:0007010~cytoskeleton organization,GO:0006928~cell motion,GO:0003006~reproductive developmental process,GO:0001578~microtubule bundle formation,GO:0000226~microtubule cytoskeleton organization,												GO:0048471~perinuclear region of cytoplasm,GO:0005886~plasma membrane,																GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0008270~zinc ion binding,							IPR017907:Zinc finger, RING-type, conserved site,IPR006573:NEUZ,IPR001841:Zinc finger, RING-type,																							SM00588:NEUZ,SM00184:RING,											zinc-finger,zinc,repeat,metal-binding,cytoplasm,complete proteome,alternative splicing,						zinc finger region:RING-type,splice variant,sequence conflict,domain:NHR 2,domain:NHR 1,chain:Neuralized-like protein 1A,										
35090_g_at	neuregulin 2	Homo sapiens											h_erbB4pathway:g-Secretase mediated ErbB4 Signaling Pathway ,h_agrPathway:Agrin in Postsynaptic Differentiation,							GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005886~plasma membrane,GO:0005576~extracellular region,																GO:0008083~growth factor activity,							IPR013783:Immunoglobulin-like fold,IPR013098:Immunoglobulin I-set,IPR013032:EGF-like region, conserved site,IPR007110:Immunoglobulin-like,IPR006210:EGF-like,IPR006209:EGF,IPR003598:Immunoglobulin subtype 2,IPR002154:Neuregulin 1-related, C-terminal,IPR000742:EGF-like, type 3,																				hsa04012:ErbB signaling pathway,					PIRSF036337:pro-neuregulin-2,																								SM00408:IGc2,SM00181:EGF,											transmembrane,Secreted,phosphoprotein,membrane,Immunoglobulin domain,growth factor,glycoprotein,egf-like domain,disulfide bond,complete proteome,cell membrane,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,modified residue,glycosylation site:N-linked (GlcNAc...),domain:Ig-like C2-type,domain:EGF-like,disulfide bond,compositionally biased region:Ser/Thr-rich,compositionally biased region:Poly-Ser,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ala,chain:Pro-neuregulin-2, membrane-bound isoform,chain:Neuregulin-2,										
38604_at	neuropeptide Y	Homo sapiens						GO:0050909~sensory perception of taste,GO:0050890~cognition,GO:0050877~neurological system process,GO:0048584~positive regulation of response to stimulus,GO:0048015~phosphoinositide-mediated signaling,GO:0045776~negative regulation of blood pressure,GO:0032109~positive regulation of response to nutrient levels,GO:0032107~regulation of response to nutrient levels,GO:0032106~positive regulation of response to extracellular stimulus,GO:0032104~regulation of response to extracellular stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0032100~positive regulation of appetite,GO:0032098~regulation of appetite,GO:0032097~positive regulation of response to food,GO:0032095~regulation of response to food,GO:0031667~response to nutrient levels,GO:0030534~adult behavior,GO:0030001~metal ion transport,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0019932~second-messenger-mediated signaling,GO:0019226~transmission of nerve impulse,GO:0015674~di-, tri-valent inorganic cation transport,GO:0009991~response to extracellular stimulus,GO:0008343~adult feeding behavior,GO:0008283~cell proliferation,GO:0008217~regulation of blood pressure,GO:0008015~blood circulation,GO:0007631~feeding behavior,GO:0007610~behavior,GO:0007606~sensory perception of chemical stimulus,GO:0007600~sensory perception,GO:0007586~digestion,GO:0007268~synaptic transmission,GO:0007267~cell-cell signaling,GO:0007242~intracellular signaling cascade,GO:0007218~neuropeptide signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0006928~cell motion,GO:0006816~calcium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0003013~circulatory system process,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,																GO:0031841~neuropeptide Y receptor binding,GO:0016247~channel regulator activity,GO:0005246~calcium channel regulator activity,GO:0005184~neuropeptide hormone activity,GO:0005179~hormone activity,							IPR001955:Pancreatic hormone-like,IPR001955:Pancreatic hormone,																				hsa04920:Adipocytokine signaling pathway,					PIRSF001845:pancreatic hormone,																								SM00309:PAH,											signal,Secreted,polymorphism,neuropeptide,complete proteome,cleavage on pair of basic residues,amidation,3d-structure,						strand,signal peptide,sequence variant,sequence conflict,peptide:Neuropeptide Y,peptide:C-flanking peptide of NPY,modified residue,helix,										
1355_g_at	neurotrophic tyrosine kinase, receptor, type 2	Homo sapiens						GO:0060341~regulation of cellular localization,GO:0060284~regulation of cell development,GO:0051971~positive regulation of transmission of nerve impulse,GO:0051969~regulation of transmission of nerve impulse,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051960~regulation of nervous system development,GO:0051588~regulation of neurotransmitter transport,GO:0051349~positive regulation of lyase activity,GO:0051339~regulation of lyase activity,GO:0051240~positive regulation of multicellular organismal process,GO:0051046~regulation of secretion,GO:0050806~positive regulation of synaptic transmission,GO:0050804~regulation of synaptic transmission,GO:0050773~regulation of dendrite development,GO:0050767~regulation of neurogenesis,GO:0048666~neuron development,GO:0048592~eye morphogenesis,GO:0048514~blood vessel morphogenesis,GO:0046928~regulation of neurotransmitter secretion,GO:0046903~secretion,GO:0046777~protein amino acid autophosphorylation,GO:0046548~retinal rod cell development,GO:0046530~photoreceptor cell differentiation,GO:0045762~positive regulation of adenylate cyclase activity,GO:0045761~regulation of adenylate cyclase activity,GO:0045664~regulation of neuron differentiation,GO:0044093~positive regulation of molecular function,GO:0044057~regulation of system process,GO:0043085~positive regulation of catalytic activity,GO:0042490~mechanoreceptor differentiation,GO:0042462~eye photoreceptor cell development,GO:0042461~photoreceptor cell development,GO:0032940~secretion by cell,GO:0031646~positive regulation of neurological system process,GO:0031644~regulation of neurological system process,GO:0031547~brain-derived neurotrophic factor receptor signaling pathway,GO:0031344~regulation of cell projection organization,GO:0031281~positive regulation of cyclase activity,GO:0031279~regulation of cyclase activity,GO:0030817~regulation of cAMP biosynthetic process,GO:0030814~regulation of cAMP metabolic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030182~neuron differentiation,GO:0016310~phosphorylation,GO:0014047~glutamate secretion,GO:0010975~regulation of neuron projection development,GO:0010647~positive regulation of cell communication,GO:0007631~feeding behavior,GO:0007610~behavior,GO:0007423~sensory organ development,GO:0007267~cell-cell signaling,GO:0007190~activation of adenylate cyclase activity,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein amino acid phosphorylation,GO:0006140~regulation of nucleotide metabolic process,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0001944~vasculature development,GO:0001754~eye photoreceptor cell differentiation,GO:0001654~eye development,GO:0001570~vasculogenesis,GO:0001568~blood vessel development,												GO:0060076~excitatory synapse,GO:0048786~presynaptic active zone,GO:0045202~synapse,GO:0044463~cell projection part,GO:0044459~plasma membrane part,GO:0044456~synapse part,GO:0044430~cytoskeletal part,GO:0043679~nerve terminal,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0043195~terminal button,GO:0043025~cell soma,GO:0043005~neuron projection,GO:0042995~cell projection,GO:0033267~axon part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0030427~site of polarized growth,GO:0030426~growth cone,GO:0030425~dendrite,GO:0030424~axon,GO:0016021~integral to membrane,GO:0014069~postsynaptic density,GO:0009986~cell surface,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,GO:0005856~cytoskeleton,GO:0005829~cytosol,																GO:0048403~brain-derived neurotrophic factor binding,GO:0043121~neurotrophin binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0019838~growth factor binding,GO:0017076~purine nucleotide binding,GO:0005524~ATP binding,GO:0005030~neurotrophin receptor activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004672~protein kinase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR017441:Protein kinase, ATP binding site,IPR013783:Immunoglobulin-like fold,IPR013098:Immunoglobulin I-set,IPR008266:Tyrosine protein kinase, active site,IPR007110:Immunoglobulin-like,IPR003598:Immunoglobulin subtype 2,IPR002011:Receptor tyrosine kinase, class II, conserved site,IPR001611:Leucine-rich repeat,IPR001245:Tyrosine protein kinase,IPR000719:Protein kinase, core,IPR000483:Cysteine-rich flanking region, C-terminal,IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal,																				hsa04722:Neurotrophin signaling pathway,hsa04010:MAPK signaling pathway,								Obesity, hyperphagia, and developmental delay,										PIRSF000623:tyrosine-protein kinase, BDNF/NT/NGF receptor type,																								SM00408:IGc2,SM00219:TyrKc,SM00082:LRRCT,SM00013:LRRNT,											tyrosine-specific protein kinase,tyrosine-protein kinase,transmembrane protein,transmembrane,transferase,tandem repeat,signal,repeat,receptor,polymorphism,phosphotransferase,phosphoprotein,nucleotide-binding,neurogenesis,membrane,leucine-rich repeat,kinase,Immunoglobulin domain,growth factor receptor,glycoprotein,disulfide bond,differentiation,developmental protein,complete proteome,autophosphorylation,atp-binding,ATP,alternative splicing,3d-structure,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,strand,splice variant,site:Interaction with SHC1,site:Interaction with PLC-gamma-1,signal peptide,sequence variant,repeat:LRR 2,repeat:LRR 1,nucleotide phosphate-binding region:ATP,modified residue,helix,glycosylation site:N-linked (GlcNAc...),domain:Protein kinase,domain:Ig-like C2-type 2,domain:Ig-like C2-type 1,disulfide bond,chain:BDNF/NT-3 growth factors receptor,binding site:ATP,active site:Proton acceptor,										
1419_g_at	nitric oxide synthase 2, inducible	Homo sapiens							8.MonocytesIFNF_IL4,																	h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,															Inorganic ion transport and metabolism,						GO:0070482~response to oxygen levels,GO:0060341~regulation of cellular localization,GO:0055114~oxidation reduction,GO:0051712~positive regulation of killing of cells of another organism,GO:0051709~regulation of killing of cells of another organism,GO:0051046~regulation of secretion,GO:0050829~defense response to Gram-negative bacterium,GO:0050796~regulation of insulin secretion,GO:0048771~tissue remodeling,GO:0048514~blood vessel morphogenesis,GO:0048384~retinoic acid receptor signaling pathway,GO:0046883~regulation of hormone secretion,GO:0046395~carboxylic acid catabolic process,GO:0046209~nitric oxide metabolic process,GO:0045087~innate immune response,GO:0044271~nitrogen compound biosynthetic process,GO:0044057~regulation of system process,GO:0043902~positive regulation of multi-organism process,GO:0043900~regulation of multi-organism process,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043457~regulation of cellular respiration,GO:0042742~defense response to bacterium,GO:0042127~regulation of cell proliferation,GO:0031343~positive regulation of cell killing,GO:0031341~regulation of cell killing,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0019934~cGMP-mediated signaling,GO:0019932~second-messenger-mediated signaling,GO:0016054~organic acid catabolic process,GO:0009617~response to bacterium,GO:0009310~amine catabolic process,GO:0009065~glutamine family amino acid catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009063~cellular amino acid catabolic process,GO:0008283~cell proliferation,GO:0008217~regulation of blood pressure,GO:0008016~regulation of heart contraction,GO:0008015~blood circulation,GO:0007243~protein kinase cascade,GO:0007242~intracellular signaling cascade,GO:0007199~G-protein signaling, coupled to cGMP nucleotide second messenger,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0006955~immune response,GO:0006952~defense response,GO:0006809~nitric oxide biosynthetic process,GO:0006801~superoxide metabolic process,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006527~arginine catabolic process,GO:0006525~arginine metabolic process,GO:0003013~circulatory system process,GO:0002791~regulation of peptide secretion,GO:0002699~positive regulation of immune effector process,GO:0002697~regulation of immune effector process,GO:0002684~positive regulation of immune system process,GO:0002385~mucosal immune response,GO:0002251~organ or tissue specific immune response,GO:0002227~innate immune response in mucosa,GO:0001974~blood vessel remodeling,GO:0001944~vasculature development,GO:0001935~endothelial cell proliferation,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001666~response to hypoxia,GO:0001568~blood vessel development,												GO:0048471~perinuclear region of cytoplasm,GO:0044448~cell cortex part,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0042579~microbody,GO:0030863~cortical cytoskeleton,GO:0005938~cell cortex,GO:0005856~cytoskeleton,GO:0005829~cytosol,GO:0005777~peroxisome,																GO:0050662~coenzyme binding,GO:0050661~NADP or NADPH binding,GO:0050660~FAD binding,GO:0048037~cofactor binding,GO:0046983~protein dimerization activity,GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043176~amine binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0034618~arginine binding,GO:0034617~tetrahydrobiopterin binding,GO:0031406~carboxylic acid binding,GO:0030554~adenyl nucleotide binding,GO:0020037~heme binding,GO:0019887~protein kinase regulator activity,GO:0019207~kinase regulator activity,GO:0017076~purine nucleotide binding,GO:0016597~amino acid binding,GO:0010181~FMN binding,GO:0009055~electron carrier activity,GO:0008603~cAMP-dependent protein kinase regulator activity,GO:0008270~zinc ion binding,GO:0005516~calmodulin binding,GO:0005509~calcium ion binding,GO:0005506~iron ion binding,GO:0004517~nitric-oxide synthase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR012144:Nitric-oxide synthase,IPR008254:Flavodoxin/nitric oxide synthase,IPR004030:Nitric oxide synthase, oxygenase region,IPR003097:FAD-binding, type 1,IPR001709:Flavoprotein pyridine nucleotide cytochrome reductase,IPR001433:Oxidoreductase FAD/NAD(P)-binding,IPR001094:Flavodoxin-like,																				hsa05222:Small cell lung cancer,hsa05200:Pathways in cancer,hsa04020:Calcium signaling pathway,hsa00330:Arginine and proline metabolism,								Malaria, resistance to,Hypertension, susceptibility to,										PIRSF000333:NOS,PIRSF000333:nitric-oxide synthase, inducible,																						zinc,polymorphism,phosphoprotein,oxidoreductase,nadp,metal-binding,iron,heme,fmn,FAD,complete proteome,calmodulin-binding,calcium,alternative splicing,3d-structure,						turn,strand,splice variant,sequence variant,sequence conflict,region of interest:Calmodulin-binding,nucleotide phosphate-binding region:NADP,nucleotide phosphate-binding region:FMN,nucleotide phosphate-binding region:FAD,modified residue,metal ion-binding site:Zinc,metal ion-binding site:Iron (heme axial ligand),helix,domain:Flavodoxin-like,domain:FAD-binding FR-type,chain:Nitric oxide synthase, inducible,										
34720_at	nuclear factor I/B	Homo sapiens						GO:0060541~respiratory system development,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045941~positive regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0042127~regulation of cell proliferation,GO:0035295~tube development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0030902~hindbrain development,GO:0030900~forebrain development,GO:0030324~lung development,GO:0030323~respiratory tube development,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0008285~negative regulation of cell proliferation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,GO:0006260~DNA replication,GO:0006259~DNA metabolic process,												GO:0070013~intracellular organelle lumen,GO:0043233~organelle lumen,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0005730~nucleolus,																GO:0043566~structure-specific DNA binding,GO:0030528~transcription regulator activity,GO:0016563~transcription activator activity,GO:0003700~transcription factor activity,GO:0003690~double-stranded DNA binding,GO:0003677~DNA binding,							IPR019739:CTF transcription factor/nuclear factor 1, conserved site,IPR019548:CTF transcription factor/nuclear factor 1, N-terminal,IPR003619:MAD homology 1, Dwarfin-type,IPR000647:CTF transcription factor/nuclear factor 1,												PIRSF018476:nuclear factor 1,																								SM00523:DWA,											transcription regulation,Transcription,phosphoprotein,nucleus,dna-binding,dna replication,complete proteome,alternative splicing,activator,						splice variant,sequence conflict,modified residue,DNA-binding region:CTF/NF-I,chain:Nuclear factor 1 B-type,										
40271_at	nucleoporin 93kDa	Homo sapiens						GO:0055085~transmembrane transport,GO:0051236~establishment of RNA localization,GO:0051028~mRNA transport,GO:0050658~RNA transport,GO:0050657~nucleic acid transport,GO:0045184~establishment of protein localization,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0015031~protein transport,GO:0008104~protein localization,GO:0006403~RNA localization,												GO:0046930~pore complex,GO:0031975~envelope,GO:0031967~organelle envelope,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0012505~endomembrane system,GO:0005643~nuclear pore,GO:0005635~nuclear envelope,										IPR007231:Nucleoporin interacting component Nup93/Nic96,																					transport,translocation,protein transport,polymorphism,phosphoprotein,nucleus,nuclear pore complex,mRNA transport,complete proteome,acetylation,						sequence variant,modified residue,chain:Nuclear pore complex protein Nup93,										
34539_at	olfactory receptor, family 7, subfamily E, member 35 pseudogene	Homo sapiens						GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,																GO:0004984~olfactory receptor activity,							IPR017452:GPCR, rhodopsin-like superfamily,IPR000725:Olfactory receptor,IPR000276:7TM GPCR, rhodopsin-like,																					receptor,			
35903_at	oligodendrocyte myelin glycoprotein	Homo sapiens													Function unknown,						GO:0060284~regulation of cell development,GO:0051960~regulation of nervous system development,GO:0051129~negative regulation of cellular component organization,GO:0050771~negative regulation of axonogenesis,GO:0050770~regulation of axonogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0045664~regulation of neuron differentiation,GO:0045596~negative regulation of cell differentiation,GO:0031345~negative regulation of cell projection organization,GO:0031344~regulation of cell projection organization,GO:0022610~biological adhesion,GO:0022604~regulation of cell morphogenesis,GO:0010975~regulation of neuron projection development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010721~negative regulation of cell development,GO:0007155~cell adhesion,												GO:0031225~anchored to membrane,GO:0031224~intrinsic to membrane,GO:0005886~plasma membrane,										IPR003591:Leucine-rich repeat, typical subtype,IPR001611:Leucine-rich repeat,IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal,																							SM00369:LRR_TYP,SM00013:LRRNT,											tandem repeat,signal,repeat,polymorphism,phosphoprotein,phosphatidylinositol linkage,membrane,lipoprotein,leucine-rich repeat,gpi-anchor,glycoprotein,direct protein sequencing,complete proteome,cell membrane,cell adhesion,blocked carboxyl end,						signal peptide,sequence variant,repeat:Ser/Thr-rich,repeat:LRR 8; truncated,repeat:LRR 7,repeat:LRR 6,repeat:LRR 5,repeat:LRR 4,repeat:LRR 3,repeat:LRR 2,repeat:LRR 1,propeptide:Removed in mature form,lipid moiety-binding region:GPI-anchor amidated serine,glycosylation site:N-linked (GlcNAc...),chain:Oligodendrocyte-myelin glycoprotein,										
36696_at	phosphatidylinositol glycan anchor biosynthesis, class C	Homo sapiens						GO:0046489~phosphoinositide biosynthetic process,GO:0046486~glycerolipid metabolic process,GO:0046474~glycerophospholipid biosynthetic process,GO:0045017~glycerolipid biosynthetic process,GO:0042158~lipoprotein biosynthetic process,GO:0042157~lipoprotein metabolic process,GO:0030384~phosphoinositide metabolic process,GO:0019637~organophosphate metabolic process,GO:0016254~preassembly of GPI anchor in ER membrane,GO:0008654~phospholipid biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0006650~glycerophospholipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006506~GPI anchor biosynthetic process,GO:0006505~GPI anchor metabolic process,GO:0006497~protein amino acid lipidation,												GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0031224~intrinsic to membrane,GO:0031090~organelle membrane,GO:0016021~integral to membrane,GO:0012505~endomembrane system,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,																GO:0017176~phosphatidylinositol N-acetylglucosaminyltransferase activity,GO:0008375~acetylglucosaminyltransferase activity,							IPR009450:Phosphatidylinositol N-acetylglucosaminyltransferase,																				hsa00563:Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,					PIRSF016104:GPI2,																						transmembrane,transferase,polymorphism,membrane,gpi-anchor biosynthesis,glycosyltransferase,endoplasmic reticulum,complete proteome,						transmembrane region,sequence variant,chain:Phosphatidylinositol N- acetylglucosaminyltransferase subunit C,										
32418_at	phosphodiesterase 1C, calmodulin-dependent 70kDa	Homo sapiens						GO:0050890~cognition,GO:0050877~neurological system process,GO:0007608~sensory perception of smell,GO:0007606~sensory perception of chemical stimulus,GO:0007600~sensory perception,												GO:0005829~cytosol,																GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030552~cAMP binding,GO:0030551~cyclic nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016208~AMP binding,GO:0008081~phosphoric diester hydrolase activity,GO:0005516~calmodulin binding,GO:0004117~calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR013706:3'5'-cyclic nucleotide phosphodiesterase N-terminal,IPR003607:Metal-dependent phosphohydrolase, HD region,IPR002073:3'5'-cyclic nucleotide phosphodiesterase,																				hsa04740:Olfactory transduction,hsa04020:Calcium signaling pathway,hsa00230:Purine metabolism,																SM00471:HDc,											phosphoprotein,metal-binding,hydrolase,complete proteome,cGMP,camp,calmodulin-binding,alternative splicing,3d-structure,						turn,strand,splice variant,region of interest:Catalytic,modified residue,metal ion-binding site:Divalent metal cation 2,metal ion-binding site:Divalent metal cation 1,helix,chain:Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C,active site:Proton donor,										
35373_at	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	Homo sapiens							63.LAT_couples_T-cell_receptor,37.Akt-PKB_Effector_of_P13K_in_Vivo,2.Cytokine_Receptors,107.mRNA_translation-protein_synthesis,106.Glycogen_synthase-synthesis,105.Signaling_glucose_uptake,104.Insulin_signaling,																	h_trkaPathway:Trka Receptor Signaling Pathway,h_RacCycDPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_mTORPathway:mTOR Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_egfPathway:EGF Signaling Pathway,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_aktPathway:AKT Signaling Pathway,															Cell division and chromosome partitioning,						GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:0070201~regulation of establishment of protein localization,GO:0060416~response to growth hormone stimulus,GO:0060396~growth hormone receptor signaling pathway,GO:0051272~positive regulation of cell motion,GO:0051270~regulation of cell motion,GO:0051130~positive regulation of cellular component organization,GO:0051050~positive regulation of transport,GO:0048534~hemopoietic or lymphoid organ development,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0046854~phosphoinositide phosphorylation,GO:0046834~lipid phosphorylation,GO:0046649~lymphocyte activation,GO:0046486~glycerolipid metabolic process,GO:0046326~positive regulation of glucose import,GO:0046324~regulation of glucose import,GO:0045321~leukocyte activation,GO:0043434~response to peptide hormone stimulus,GO:0042113~B cell activation,GO:0040017~positive regulation of locomotion,GO:0040012~regulation of locomotion,GO:0032880~regulation of protein localization,GO:0032870~cellular response to hormone stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032868~response to insulin stimulus,GO:0030384~phosphoinositide metabolic process,GO:0030335~positive regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030258~lipid modification,GO:0030183~B cell differentiation,GO:0030155~regulation of cell adhesion,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0019637~organophosphate metabolic process,GO:0016310~phosphorylation,GO:0014065~phosphoinositide 3-kinase cascade,GO:0010828~positive regulation of glucose transport,GO:0010827~regulation of glucose transport,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010810~regulation of cell-substrate adhesion,GO:0010033~response to organic substance,GO:0009725~response to hormone stimulus,GO:0009719~response to endogenous stimulus,GO:0008286~insulin receptor signaling pathway,GO:0007243~protein kinase cascade,GO:0007242~intracellular signaling cascade,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0007162~negative regulation of cell adhesion,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0001953~negative regulation of cell-matrix adhesion,GO:0001952~regulation of cell-matrix adhesion,GO:0001775~cell activation,												GO:0044445~cytosolic part,GO:0005943~1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex,GO:0005942~phosphoinositide 3-kinase complex,GO:0005829~cytosol,																GO:0043560~insulin receptor substrate binding,GO:0043559~insulin binding,GO:0043125~ErbB-3 class receptor binding,GO:0042562~hormone binding,GO:0042277~peptide binding,GO:0035091~phosphoinositide binding,GO:0035014~phosphoinositide 3-kinase regulator activity,GO:0032403~protein complex binding,GO:0019903~protein phosphatase binding,GO:0019902~phosphatase binding,GO:0019899~enzyme binding,GO:0019207~kinase regulator activity,GO:0017046~peptide hormone binding,GO:0008289~lipid binding,GO:0005545~phosphatidylinositol binding,GO:0005543~phospholipid binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005158~insulin receptor binding,							IPR001720:PI3 kinase, P85 regulatory subunit,IPR001452:Src homology-3 domain,IPR000980:SH2 motif,IPR000198:RhoGAP,																				hsa05223:Non-small cell lung cancer,hsa05222:Small cell lung cancer,hsa05221:Acute myeloid leukemia,hsa05220:Chronic myeloid leukemia,hsa05218:Melanoma,hsa05215:Prostate cancer,hsa05214:Glioma,hsa05213:Endometrial cancer,hsa05212:Pancreatic cancer,hsa05211:Renal cell carcinoma,hsa05210:Colorectal cancer,hsa05200:Pathways in cancer,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04930:Type II diabetes mellitus,hsa04914:Progesterone-mediated oocyte maturation,hsa04910:Insulin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04722:Neurotrophin signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04666:Fc gamma R-mediated phagocytosis,hsa04664:Fc epsilon RI signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04630:Jak-STAT signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04510:Focal adhesion,hsa04370:VEGF signaling pathway,hsa04210:Apoptosis,hsa04150:mTOR signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04062:Chemokine signaling pathway,hsa04012:ErbB signaling pathway,					PIRSF038271:phosphatidylinositol 3-kinase, regulatory subunit, p85 type,																								SM00326:SH3,SM00324:RhoGAP,SM00252:SH2,											ubl conjugation,sh3 domain,SH2 domain,repeat,polymorphism,phosphotransferase,phosphoprotein,host-virus interaction,disease mutation,complete proteome,alternative splicing,acetylation,3d-structure,						turn,strand,splice variant,sequence variant,sequence conflict,modified residue,helix,domain:SH3,domain:SH2 2,domain:SH2 1,domain:Rho-GAP,chain:Phosphatidylinositol 3-kinase regulatory subunit alpha,										
40959_at	pleckstrin homology domain containing, family G (with RhoGef domain) member 3	Homo sapiens						GO:0051056~regulation of small GTPase mediated signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,															GO:0060589~nucleoside-triphosphatase regulator activity,GO:0030695~GTPase regulator activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005083~small GTPase regulator activity,							IPR011993:Pleckstrin homology-type,IPR001849:Pleckstrin homology,IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site,IPR000219:Dbl homology (DH) domain,																							SM00325:RhoGEF,SM00233:PH,											polymorphism,phosphoprotein,complete proteome,alternative splicing,						splice variant,sequence variant,sequence conflict,modified residue,domain:PH,domain:DH,compositionally biased region:Ser-rich,compositionally biased region:Poly-Glu,chain:Pleckstrin homology domain-containing family G member 3,										
35956_s_at	pregnancy specific beta-1-glycoprotein 7; pregnancy specific beta-1-glycoprotein 8; pregnancy specific beta-1-glycoprotein 4	Homo sapiens						GO:0007565~female pregnancy,GO:0006952~defense response,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005576~extracellular region,										IPR013783:Immunoglobulin-like fold,IPR013151:Immunoglobulin,IPR013106:Immunoglobulin V-set,IPR007110:Immunoglobulin-like,IPR003599:Immunoglobulin subtype,IPR003598:Immunoglobulin subtype 2,																							SM00409:IG,SM00408:IGc2,											tandem repeat,signal,Secreted,repeat,Pregnancy,polymorphism,plasma,Immunoglobulin domain,glycoprotein,duplication,disulfide bond,complete proteome,alternative splicing,						splice variant,signal peptide,short sequence motif:Cell attachment site,sequence variant,sequence conflict,glycosylation site:N-linked (GlcNAc...),domain:Ig-like V-type,domain:Ig-like C2-type 3,domain:Ig-like C2-type 2,domain:Ig-like C2-type 1,disulfide bond,chain:Putative pregnancy-specific beta-1- glycoprotein 7,chain:Pregnancy-specific beta-1-glycoprotein 8,chain:Pregnancy-specific beta-1-glycoprotein 4,										
38948_at	protein phosphatase 1, regulatory (inhibitor) subunit 3D	Homo sapiens						GO:0044264~cellular polysaccharide metabolic process,GO:0044042~glucan metabolic process,GO:0019318~hexose metabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0006112~energy reserve metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006073~cellular glucan metabolic process,GO:0006006~glucose metabolic process,GO:0005996~monosaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005976~polysaccharide metabolic process,															GO:0016791~phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004721~phosphoprotein phosphatase activity,							IPR017434:Protein phosphatase 1, glycogen targeting subunit, Metazoa.,IPR005036:Putative phosphatase regulatory subunit,																				hsa04910:Insulin signaling pathway,					PIRSF038207:protein phosphatase 1, glycogen targeting subunit, animal type,PIRSF038207:PP1_GT_animal,																						phosphoprotein,glycogen metabolism,complete proteome,carbohydrate metabolism,						short sequence motif:PP1-binding motif,modified residue,domain:CBM21,chain:Protein phosphatase 1 regulatory subunit 3D,										
38646_s_at	regenerating islet-derived 1 alpha; regenerating islet-derived 1 pseudogene	Homo sapiens						GO:0042127~regulation of cell proliferation,GO:0008284~positive regulation of cell proliferation,															GO:0030246~carbohydrate binding,GO:0008083~growth factor activity,GO:0005529~sugar binding,							IPR018378:C-type lectin, conserved site,IPR016186:C-type lectin-like,IPR003990:Pancreatitis-associated protein,IPR001304:C-type lectin,												PIRSF002422:tetranectin,																								SM00034:CLECT,											signal,Pyrrolidone carboxylic acid,pyroglutamic acid,pancreas,Lectin,glycoprotein,down syndrome,disulfide bond,direct protein sequencing,complete proteome,alzheimer disease,3d-structure,						strand,signal peptide,sequence conflict,modified residue,helix,glycosylation site:O-linked (GlcNAc...),domain:C-type lectin,disulfide bond,chain:Lithostathine-1-alpha,										
36766_at	ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)	Homo sapiens						GO:0044265~cellular macromolecule catabolic process,GO:0042330~taxis,GO:0009057~macromolecule catabolic process,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0006935~chemotaxis,GO:0006401~RNA catabolic process,												GO:0005773~vacuole,GO:0005764~lysosome,GO:0005576~extracellular region,GO:0000323~lytic vacuole,																GO:0016894~endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,GO:0016892~endoribonuclease activity, producing 3'-phosphomonoesters,GO:0004540~ribonuclease activity,GO:0004522~pancreatic ribonuclease activity,GO:0004521~endoribonuclease activity,GO:0004519~endonuclease activity,GO:0004518~nuclease activity,							IPR001427:Pancreatic ribonuclease,												PIRSF001015:pyrimidine-specific ribonuclease/angiogenin,																								SM00092:RNAse_Pc,											signal,polymorphism,nuclease,nitration,neurotoxin,lysosome,hydrolase,glycoprotein,Endonuclease,disulfide bond,direct protein sequencing,complete proteome,chemotaxis,3d-structure,						turn,strand,signal peptide,sequence variant,sequence conflict,region of interest:Substrate binding,modified residue,helix,glycosylation site:N-linked (GlcNAc...),glycosylation site:C-linked (Man),disulfide bond,chain:Non-secretory ribonuclease,active site:Proton donor,active site:Proton acceptor,										
33979_at	ribonuclease, RNase A family, 3 (eosinophil cationic protein)	Homo sapiens						GO:0044265~cellular macromolecule catabolic process,GO:0042742~defense response to bacterium,GO:0009617~response to bacterium,GO:0009057~macromolecule catabolic process,GO:0006952~defense response,GO:0006401~RNA catabolic process,												GO:0005625~soluble fraction,GO:0005576~extracellular region,GO:0000267~cell fraction,																GO:0016894~endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,GO:0016892~endoribonuclease activity, producing 3'-phosphomonoesters,GO:0004540~ribonuclease activity,GO:0004522~pancreatic ribonuclease activity,GO:0004521~endoribonuclease activity,GO:0004519~endonuclease activity,GO:0004518~nuclease activity,							IPR001427:Pancreatic ribonuclease,																				hsa05310:Asthma,																SM00092:RNAse_Pc,											signal,polymorphism,nuclease,nitration,hydrolase,glycoprotein,Endonuclease,disulfide bond,direct protein sequencing,complete proteome,Antimicrobial,antibiotic,3d-structure,						strand,signal peptide,sequence variant,region of interest:Substrate binding,modified residue,helix,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Eosinophil cationic protein,active site:Proton donor,active site:Proton acceptor,										
39187_at	runt-related transcription factor 2	Homo sapiens						GO:0060350~endochondral bone morphogenesis,GO:0060349~bone morphogenesis,GO:0060348~bone development,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051216~cartilage development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051094~positive regulation of developmental process,GO:0048705~skeletal system morphogenesis,GO:0048469~cell maturation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045941~positive regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045778~positive regulation of ossification,GO:0045669~positive regulation of osteoblast differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045449~regulation of transcription,GO:0045165~cell fate commitment,GO:0042487~regulation of odontogenesis of dentine-containing tooth,GO:0042481~regulation of odontogenesis,GO:0042127~regulation of cell proliferation,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032330~regulation of chondrocyte differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0030278~regulation of ossification,GO:0021700~developmental maturation,GO:0016481~negative regulation of transcription,GO:0010648~negative regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0008589~regulation of smoothened signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,GO:0002063~chondrocyte development,GO:0002062~chondrocyte differentiation,GO:0002051~osteoblast fate commitment,GO:0001958~endochondral ossification,GO:0001649~osteoblast differentiation,GO:0001503~ossification,GO:0001501~skeletal system development,												GO:0070013~intracellular organelle lumen,GO:0044451~nucleoplasm part,GO:0043233~organelle lumen,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0005667~transcription factor complex,GO:0005654~nucleoplasm,																GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030528~transcription regulator activity,GO:0017076~purine nucleotide binding,GO:0016563~transcription activator activity,GO:0005524~ATP binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0003700~transcription factor activity,GO:0003682~chromatin binding,GO:0003677~DNA binding,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR016554:Transcription factor, Runt-related, RUNX,IPR013711:Runx inhibition,IPR013524:Acute myeloid leukemia 1 (AML 1)/Runt,IPR012346:p53 and RUNT-type transcription factor, DNA-binding,IPR000040:Acute myeloid leukemia 1 protein (AML 1)/Runt,															Many sequence variants affecting diversity of adult human height,Dental anomalies, isolated,Cleidocranial dysplasia,										PIRSF009374:TF_Runt-rel_RUNX,PIRSF009374:runt-related transcription factor RUNX,																						transcription regulation,Transcription,polymorphism,phosphoprotein,nucleus,dna-binding,disease mutation,complete proteome,alternative splicing,						splice variant,sequence variant,sequence conflict,region of interest:Interaction with MYST4,region of interest:Interaction with MYST3,domain:Runt,compositionally biased region:Pro/Ser/Thr-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Ala,chain:Runt-related transcription factor 2,										
36328_at	sex hormone-binding globulin	Homo sapiens						GO:0048610~reproductive cellular process,GO:0048609~reproductive process in a multicellular organism,GO:0048589~developmental growth,GO:0048588~developmental cell growth,GO:0048232~male gamete generation,GO:0040007~growth,GO:0032535~regulation of cellular component size,GO:0032504~multicellular organism reproduction,GO:0019953~sexual reproduction,GO:0016049~cell growth,GO:0010817~regulation of hormone levels,GO:0009914~hormone transport,GO:0008361~regulation of cell size,GO:0007285~primary spermatocyte growth,GO:0007283~spermatogenesis,GO:0007276~gamete generation,GO:0003006~reproductive developmental process,												GO:0005576~extracellular region,																GO:0046983~protein dimerization activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0042562~hormone binding,GO:0008289~lipid binding,GO:0005497~androgen binding,GO:0005496~steroid binding,							IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR012679:Laminin G, subdomain 1,IPR001791:Laminin G,															A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs),										PIRSF002538:sex steroid-binding protein,																								SM00282:LamG,											steroid-binding,steroid binding,signal,Secreted,repeat,polymorphism,plasma,lipid-binding,homodimer,glycoprotein,disulfide bond,direct protein sequencing,complete proteome,alternative splicing,3d-structure,						turn,strand,splice variant,signal peptide,sequence variant,sequence conflict,helix,glycosylation site:O-linked (GalNAc...),glycosylation site:N-linked (GlcNAc...); when associated with variant N-356,glycosylation site:N-linked (GlcNAc...),domain:Laminin G-like 2,domain:Laminin G-like 1,disulfide bond,chain:Sex hormone-binding globulin,										
33077_at	sidekick homolog 1, cell adhesion molecule (chicken); hypothetical LOC730351	Homo sapiens						GO:0022610~biological adhesion,GO:0007155~cell adhesion,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,										IPR013783:Immunoglobulin-like fold,IPR013151:Immunoglobulin,IPR013098:Immunoglobulin I-set,IPR008957:Fibronectin, type III-like fold,IPR007110:Immunoglobulin-like,IPR003962:Fibronectin, type III subdomain,IPR003961:Fibronectin, type III,IPR003599:Immunoglobulin subtype,IPR003598:Immunoglobulin subtype 2,																							SM00409:IG,SM00408:IGc2,SM00060:FN3,											transmembrane,signal,repeat,polymorphism,membrane,Immunoglobulin domain,glycoprotein,disulfide bond,complete proteome,cell adhesion,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,signal peptide,sequence variant,sequence conflict,glycosylation site:N-linked (GlcNAc...),domain:Ig-like C2-type 6,domain:Ig-like C2-type 5,domain:Ig-like C2-type 4,domain:Ig-like C2-type 3,domain:Ig-like C2-type 2,domain:Ig-like C2-type 1,domain:Fibronectin type-III 9,domain:Fibronectin type-III 8,domain:Fibronectin type-III 7,domain:Fibronectin type-III 6,domain:Fibronectin type-III 5,domain:Fibronectin type-III 4,domain:Fibronectin type-III 3,domain:Fibronectin type-III 2,domain:Fibronectin type-III 13,domain:Fibronectin type-III 12,domain:Fibronectin type-III 11,domain:Fibronectin type-III 10,domain:Fibronectin type-III 1,disulfide bond,compositionally biased region:Pro-rich,chain:Protein sidekick-1,										
39511_at	similar to Afadin (Protein AF-6); myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4	Homo sapiens						GO:0022610~biological adhesion,GO:0007267~cell-cell signaling,GO:0007155~cell adhesion,												GO:0070161~anchoring junction,GO:0044459~plasma membrane part,GO:0030054~cell junction,GO:0005912~adherens junction,GO:0005911~cell-cell junction,GO:0005886~plasma membrane,GO:0005829~cytosol,																GO:0008022~protein C-terminus binding,							IPR018444:Dil domain,IPR002710:Dilute,IPR001478:PDZ/DHR/GLGF,IPR000253:Forkhead-associated,IPR000159:Ras-association,																				hsa04670:Leukocyte transendothelial migration,hsa04530:Tight junction,hsa04520:Adherens junction,																SM00314:RA,SM00240:FHA,SM00228:PDZ,											repeat,Proto-oncogene,phosphoprotein,complete proteome,coiled coil,chromosomal rearrangement,cell junction,cell adhesion,alternative splicing,3d-structure,						strand,splice variant,site:Breakpoint for translocation to form MLL- MLLT4,sequence conflict,modified residue,helix,domain:Ras-associating 2,domain:Ras-associating 1,domain:PDZ,domain:FHA,domain:Dilute,compositionally biased region:Pro-rich,compositionally biased region:Glu/Lys-rich,compositionally biased region:Asp/Glu-rich (acidic),chain:Afadin,										
36234_at	similar to eukaryotic translation initiation factor 4A; small nucleolar RNA, H/ACA box 67; eukaryotic translation initiation factor 4A, isoform 1	Homo sapiens											h_mTORPathway:mTOR Signaling Pathway,h_iresPathway:Internal Ribosome entry pathway,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,								GO:0006412~translation,												GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0005829~cytosol,																GO:0070035~purine NTP-dependent helicase activity,GO:0042623~ATPase activity, coupled,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0008026~ATP-dependent helicase activity,GO:0005524~ATP binding,GO:0004386~helicase activity,GO:0003743~translation initiation factor activity,GO:0003729~mRNA binding,GO:0003723~RNA binding,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000339~RNA cap binding,GO:0000166~nucleotide binding,							IPR014021:Helicase, superfamily 1 and 2, ATP-binding,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR014001:DEAD-like helicase, N-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR001650:DNA/RNA helicase, C-terminal,IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,												PIRSF003023:translation initiation factor eIF-4A,																								SM00490:HELICc,SM00487:DEXDc,											rna-binding,RNA binding,protein biosynthesis,phosphoprotein,P-loop,nucleotide-binding,nucleotide binding,Initiation factor,hydrolase,helicase,complete proteome,atp-binding,ATP,acetylation,3d-structure,						turn,strand,short sequence motif:Q motif,short sequence motif:DEAD box,nucleotide phosphate-binding region:ATP,modified residue,helix,domain:Helicase C-terminal,domain:Helicase ATP-binding,chain:Eukaryotic initiation factor 4A-I,										
31512_at	similar to hCG26659; immunoglobulin kappa constant; similar to Ig kappa chain V-I region HK102 precursor	Homo sapiens						GO:0006955~immune response,												GO:0005576~extracellular region,																GO:0003823~antigen binding,							IPR013783:Immunoglobulin-like fold,IPR013106:Immunoglobulin V-set,IPR007110:Immunoglobulin-like,IPR003597:Immunoglobulin C1-set,IPR003596:Immunoglobulin V-set, subgroup,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,															Kappa light chain deficiency,										PIRSF001974:immunoglobulin V region,																								SM00407:IGc1,SM00406:IGv,											signal,immunoglobulin v region,Immunoglobulin domain,immunoglobulin c region,immunoglobulin,heterotetramer,disulfide bond,direct protein sequencing,complete proteome,3d-structure,						turn,strand,signal peptide,sequence variant,sequence conflict,region of interest:Framework-4,region of interest:Framework-3,region of interest:Framework-2,region of interest:Framework-1,region of interest:Complementarity-determining-3,region of interest:Complementarity-determining-2,region of interest:Complementarity-determining-1,helix,domain:Ig-like,disulfide bond,chain:Ig kappa chain V-I region Walker,chain:Ig kappa chain V-I region HK101,chain:Ig kappa chain C region,chain:anti-RhD monoclonal T125 kappa light chain,										
41489_at	similar to transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila); transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)	Homo sapiens											h_wntPathway:WNT Signaling Pathway,								GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0016481~negative regulation of transcription,GO:0016055~Wnt receptor signaling pathway,GO:0010648~negative regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0009890~negative regulation of biosynthetic process,GO:0007166~cell surface receptor linked signal transduction,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,												GO:0070013~intracellular organelle lumen,GO:0044451~nucleoplasm part,GO:0043233~organelle lumen,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0005667~transcription factor complex,GO:0005654~nucleoplasm,																GO:0030528~transcription regulator activity,GO:0016564~transcription repressor activity,GO:0008134~transcription factor binding,GO:0003714~transcription corepressor activity,GO:0003712~transcription cofactor activity,GO:0003682~chromatin binding,							IPR019782:WD40 repeat 2,IPR019781:WD40 repeat, subgroup,IPR019775:WD40 repeat, conserved site,IPR017986:WD40 repeat, region,IPR015943:WD40/YVTN repeat-like,IPR009146:Groucho/transducin-like enhancer,IPR005617:Groucho/TLE, N-terminal Q-rich region,IPR001680:WD40 repeat,																							SM00320:WD40,											wnt signaling pathway,wd repeat,transcription regulation,Transcription,repressor,repeat,phosphoprotein,nucleus,direct protein sequencing,complete proteome,3d-structure,						turn,strand,short sequence motif:Nuclear localization signal,sequence conflict,repeat:WD 6,repeat:WD 5,repeat:WD 4,repeat:WD 3,repeat:WD 2,repeat:WD 1,region of interest:CCN domain,mutagenesis site,modified residue,compositionally biased region:Pro/Ser-rich,compositionally biased region:Gly/Pro-rich,compositionally biased region:Gln-rich,chain:Transducin-like enhancer protein 1,										
37097_at	solute carrier family 17 (sodium phosphate), member 1	Homo sapiens						GO:0055085~transmembrane transport,GO:0030001~metal ion transport,GO:0015698~inorganic anion transport,GO:0015672~monovalent inorganic cation transport,GO:0006820~anion transport,GO:0006817~phosphate transport,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,																GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0031420~alkali metal ion binding,GO:0031402~sodium ion binding,GO:0015293~symporter activity,GO:0015114~phosphate transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,							IPR011701:Major facilitator superfamily MFS-1,IPR004745:Na-dependent inorganic phosphate cotransporter,															Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels,																			transport,transmembrane,Symport,Sodium transport,Sodium,polymorphism,membrane,ion transport,glycoprotein,complete proteome,alternative splicing,						transmembrane region,splice variant,sequence variant,sequence conflict,glycosylation site:N-linked (GlcNAc...),chain:Sodium-dependent phosphate transport protein 1,										
34436_at	solute carrier family 17 (sodium phosphate), member 3	Homo sapiens						GO:0055085~transmembrane transport,GO:0030001~metal ion transport,GO:0015672~monovalent inorganic cation transport,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,GO:0005783~endoplasmic reticulum,GO:0005626~insoluble fraction,GO:0005624~membrane fraction,GO:0000267~cell fraction,																GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0031420~alkali metal ion binding,GO:0031402~sodium ion binding,GO:0015296~anion:cation symporter activity,GO:0015294~solute:cation symporter activity,GO:0015293~symporter activity,GO:0015114~phosphate transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0005436~sodium:phosphate symporter activity,							IPR017373:Sodium-dependent phosphate transport protein 4 , predicted,IPR011701:Major facilitator superfamily MFS-1,															Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study,										PIRSF038072:Na(+)/PI_cotransporter4_prd,																						transport,transmembrane,Symport,Sodium transport,Sodium,polymorphism,phosphoprotein,membrane,ion transport,glycoprotein,endoplasmic reticulum,complete proteome,						transmembrane region,sequence variant,sequence conflict,glycosylation site:N-linked (GlcNAc...),chain:Sodium-dependent phosphate transport protein 4,										
32084_at	solute carrier family 22 (organic cation/carnitine transporter), member 5	Homo sapiens						GO:0070715~sodium-dependent organic cation transport,GO:0060731~positive regulation of intestinal epithelial structure maintenance,GO:0060730~regulation of intestinal epithelial structure maintenance,GO:0060456~positive regulation of digestive system process,GO:0055085~transmembrane transport,GO:0052106~quorum sensing during interaction with host,GO:0052097~interspecies quorum sensing,GO:0051240~positive regulation of multicellular organismal process,GO:0051181~cofactor transport,GO:0051180~vitamin transport,GO:0048874~homeostasis of number of cells in a free-living population,GO:0048872~homeostasis of number of cells,GO:0046942~carboxylic acid transport,GO:0044058~regulation of digestive system process,GO:0044057~regulation of system process,GO:0042592~homeostatic process,GO:0042493~response to drug,GO:0032846~positive regulation of homeostatic process,GO:0032844~regulation of homeostatic process,GO:0030001~metal ion transport,GO:0015893~drug transport,GO:0015879~carnitine transport,GO:0015849~organic acid transport,GO:0015838~betaine transport,GO:0015837~amine transport,GO:0015697~quaternary ammonium group transport,GO:0015695~organic cation transport,GO:0015672~monovalent inorganic cation transport,GO:0009372~quorum sensing,GO:0006865~amino acid transport,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,												GO:0045177~apical part of cell,GO:0044463~cell projection part,GO:0044459~plasma membrane part,GO:0042995~cell projection,GO:0031526~brush border membrane,GO:0031253~cell projection membrane,GO:0031224~intrinsic to membrane,GO:0016324~apical plasma membrane,GO:0016021~integral to membrane,GO:0005903~brush border,GO:0005886~plasma membrane,																GO:0051184~cofactor transporter activity,GO:0051183~vitamin transporter activity,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0031420~alkali metal ion binding,GO:0031402~sodium ion binding,GO:0030554~adenyl nucleotide binding,GO:0030165~PDZ domain binding,GO:0022890~inorganic cation transmembrane transporter activity,GO:0019904~protein domain specific binding,GO:0017076~purine nucleotide binding,GO:0015651~quaternary ammonium group transmembrane transporter activity,GO:0015293~symporter activity,GO:0015238~drug transporter activity,GO:0015226~carnitine transporter activity,GO:0015101~organic cation transmembrane transporter activity,GO:0005524~ATP binding,GO:0005275~amine transmembrane transporter activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR011701:Major facilitator superfamily MFS-1,IPR005829:Sugar transporter, conserved site,IPR004749:Organic cation transport protein,															Carnitine deficiency, systemic primary,																			transport,transmembrane,Symport,Sodium transport,Sodium,polymorphism,phosphoprotein,nucleotide-binding,membrane,ion transport,glycoprotein,disease mutation,complete proteome,atp-binding,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,sequence variant,sequence conflict,nucleotide phosphate-binding region:ATP,mutagenesis site,modified residue,glycosylation site:N-linked (GlcNAc...),chain:Solute carrier family 22 member 5,										
35121_at	solute carrier family 6 (neurotransmitter transporter, taurine), member 6	Homo sapiens													General function prediction only,						GO:0046942~carboxylic acid transport,GO:0015849~organic acid transport,GO:0015837~amine transport,GO:0015804~neutral amino acid transport,GO:0015734~taurine transport,GO:0015718~monocarboxylic acid transport,GO:0006865~amino acid transport,GO:0006836~neurotransmitter transport,GO:0001762~beta-alanine transport,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,																GO:0043176~amine binding,GO:0030977~taurine binding,GO:0015370~solute:sodium symporter activity,GO:0015294~solute:cation symporter activity,GO:0015293~symporter activity,GO:0015175~neutral amino acid transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0005369~taurine:sodium symporter activity,GO:0005368~taurine transmembrane transporter activity,GO:0005343~organic acid:sodium symporter activity,GO:0005328~neurotransmitter:sodium symporter activity,GO:0005326~neurotransmitter transporter activity,GO:0005275~amine transmembrane transporter activity,GO:0001761~beta-alanine transmembrane transporter activity,							IPR002434:Sodium:neurotransmitter symporter, taurine,IPR000175:Sodium:neurotransmitter symporter,												PIRSF002444:gamma-aminobutyric acid transporter,																						transport,transmembrane protein,transmembrane,Symport,polymorphism,phosphoprotein,neurotransmitter transport,membrane,glycoprotein,complete proteome,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,sequence variant,sequence conflict,modified residue,glycosylation site:N-linked (GlcNAc...),chain:Sodium- and chloride-dependent taurine transporter,										
35439_at	splicing factor 1	Homo sapiens													RNA processing and modification,						GO:0065003~macromolecular complex assembly,GO:0050810~regulation of steroid biosynthetic process,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048610~reproductive cellular process,GO:0048608~reproductive structure development,GO:0046890~regulation of lipid biosynthetic process,GO:0046661~male sex differentiation,GO:0046546~development of primary male sexual characteristics,GO:0045449~regulation of transcription,GO:0045137~development of primary sexual characteristics,GO:0043933~macromolecular complex subunit organization,GO:0042127~regulation of cell proliferation,GO:0034622~cellular macromolecular complex assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0033327~Leydig cell differentiation,GO:0030238~male sex determination,GO:0022618~ribonucleoprotein complex assembly,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022402~cell cycle process,GO:0019218~regulation of steroid metabolic process,GO:0019216~regulation of lipid metabolic process,GO:0016071~mRNA metabolic process,GO:0008584~male gonad development,GO:0008406~gonad development,GO:0008380~RNA splicing,GO:0008285~negative regulation of cell proliferation,GO:0007548~sex differentiation,GO:0007530~sex determination,GO:0007049~cell cycle,GO:0006397~mRNA processing,GO:0006396~RNA processing,GO:0006376~mRNA splice site selection,GO:0006350~transcription,GO:0003006~reproductive developmental process,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0000389~nuclear mRNA 3'-splice site recognition,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000375~RNA splicing, via transesterification reactions,GO:0000245~spliceosome assembly,												GO:0070013~intracellular organelle lumen,GO:0043233~organelle lumen,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0030529~ribonucleoprotein complex,GO:0005840~ribosome,GO:0005730~nucleolus,GO:0005681~spliceosome,																GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0030528~transcription regulator activity,GO:0016564~transcription repressor activity,GO:0008270~zinc ion binding,GO:0008134~transcription factor binding,GO:0003723~RNA binding,GO:0003714~transcription corepressor activity,GO:0003712~transcription cofactor activity,GO:0003702~RNA polymerase II transcription factor activity,							IPR018111:K Homology, type 1, subgroup,IPR004088:K Homology, type 1,IPR004087:K Homology,IPR001878:Zinc finger, CCHC-type,																							SM00343:ZnF_C2HC,SM00322:KH,											zinc-finger,zinc,transcription regulation,Transcription,Spliceosome,rna-binding,repressor,polymorphism,phosphoprotein,nucleus,mrna splicing,mrna processing,metal-binding,direct protein sequencing,complete proteome,alternative splicing,acetylation,3d-structure,						zinc finger region:CCHC-type,turn,strand,splice variant,short sequence motif:Nuclear localization signal,sequence variant,sequence conflict,mutagenesis site,modified residue,helix,domain:KH,compositionally biased region:Pro-rich,chain:Splicing factor 1,										
38691_s_at	surfactant protein C	Homo sapiens						GO:0007585~respiratory gaseous exchange,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,										IPR018051:Surfactant-associated polypeptide, palmitoylation site,IPR015091:Surfactant protein C, N-terminal propeptide,IPR007084:BRICHOS,IPR001729:Surfactant-associated polypeptide,															Surfactant protein C deficiency,Surfactant metabolism dysfunction, pulmonary, 2,Pulmonary fibrosis, idiopathic, familial,Pulmonary alveolar proteinosis,										PIRSF002432:pulmonary surfactant protein C,																								SM00019:SF_P,											thiolester bond,surface film,Secreted,respiratory distress syndrome,pulmonary surfactant,polymorphism,phosphoprotein,palmitate,lung,lipoprotein,gaseous exchange,disease mutation,direct protein sequencing,complete proteome,alternative splicing,						splice variant,sequence variant,sequence conflict,modified residue,lipid moiety-binding region:S-palmitoyl cysteine,domain:BRICHOS,chain:Pulmonary surfactant-associated protein C,										
38508_s_at	tenascin XB; tenascin XA pseudogene	Homo sapiens						GO:0048251~elastic fiber assembly,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0044236~multicellular organismal metabolic process,GO:0043062~extracellular structure organization,GO:0032963~collagen metabolic process,GO:0030198~extracellular matrix organization,GO:0030036~actin cytoskeleton organization,GO:0030029~actin filament-based process,GO:0022610~biological adhesion,GO:0007155~cell adhesion,GO:0007010~cytoskeleton organization,												GO:0044421~extracellular region part,GO:0044420~extracellular matrix part,GO:0031012~extracellular matrix,GO:0005615~extracellular space,GO:0005583~fibrillar collagen,GO:0005581~collagen,GO:0005578~proteinaceous extracellular matrix,GO:0005576~extracellular region,																GO:0032403~protein complex binding,GO:0030247~polysaccharide binding,GO:0030246~carbohydrate binding,GO:0008201~heparin binding,GO:0005539~glycosaminoglycan binding,GO:0005201~extracellular matrix structural constituent,GO:0005198~structural molecule activity,GO:0005178~integrin binding,GO:0001871~pattern binding,							IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR013111:EGF, extracellular,IPR013032:EGF-like region, conserved site,IPR008957:Fibronectin, type III-like fold,IPR006210:EGF-like,IPR003961:Fibronectin, type III,IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular,IPR000742:EGF-like, type 3,																				hsa04512:ECM-receptor interaction,hsa04510:Focal adhesion,								Ehlers-Danlos syndrome, hypermobility type,Ehlers-Danlos due to tenascin X deficiency,										PIRSF002500:tenascin-X,																								SM00186:FBG,SM00181:EGF,SM00060:FN3,											signal,Secreted,repeat,pseudogene,polymorphism,phosphoprotein,glycoprotein,extracellular matrix,Ehlers-Danlos syndrome,egf-like domain,disulfide bond,direct protein sequencing,complete proteome,coiled coil,cell adhesion,alternative splicing,3d-structure,						turn,strand,splice variant,signal peptide,short sequence motif:Cell attachment site,sequence variant,sequence conflict,modified residue,glycosylation site:N-linked (GlcNAc...),domain:Fibronectin type-III 9,domain:Fibronectin type-III 8,domain:Fibronectin type-III 7,domain:Fibronectin type-III 6,domain:Fibronectin type-III 5,domain:Fibronectin type-III 4,domain:Fibronectin type-III 32,domain:Fibronectin type-III 31,domain:Fibronectin type-III 30,domain:Fibronectin type-III 3,domain:Fibronectin type-III 29,domain:Fibronectin type-III 28,domain:Fibronectin type-III 27,domain:Fibronectin type-III 26,domain:Fibronectin type-III 25,domain:Fibronectin type-III 24,domain:Fibronectin type-III 23,domain:Fibronectin type-III 22,domain:Fibronectin type-III 21,domain:Fibronectin type-III 20,domain:Fibronectin type-III 2,domain:Fibronectin type-III 19,domain:Fibronectin type-III 18,domain:Fibronectin type-III 17,domain:Fibronectin type-III 16,domain:Fibronectin type-III 15,domain:Fibronectin type-III 14,domain:Fibronectin type-III 13,domain:Fibronectin type-III 12,domain:Fibronectin type-III 11,domain:Fibronectin type-III 10,domain:Fibronectin type-III 1,domain:Fibrinogen C-terminal,domain:EGF-like 9,domain:EGF-like 8,domain:EGF-like 7,domain:EGF-like 6,domain:EGF-like 5,domain:EGF-like 4,domain:EGF-like 3,domain:EGF-like 2,domain:EGF-like 1; incomplete,domain:EGF-like 19,domain:EGF-like 18,domain:EGF-like 17,domain:EGF-like 16,domain:EGF-like 15,domain:EGF-like 14,domain:EGF-like 13,domain:EGF-like 12,domain:EGF-like 11,domain:EGF-like 10,disulfide bond,chain:Tenascin-X,chain:Putative tenascin-XA,										
31715_at	testis expressed 28; testis expressed 28 pseudogene 1; testis expressed 28 pseudogene 2	Homo sapiens					GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,										IPR019394:Predicted transmembrane and coiled-coil 2 protein,IPR017387:Testis-specific TEX28,												PIRSF038100:Testis-specific_TEX28,PIRSF038100:testis-specific protein TEX28,																						transmembrane,membrane,complete proteome,coiled coil,						transmembrane region,chain:Testis-specific protein TEX28,										
39198_s_at	tetratricopeptide repeat domain 15	Homo sapiens		IPR019734:Tetratricopeptide repeat,IPR013026:Tetratricopeptide region,IPR011990:Tetratricopeptide-like helical,IPR001440:Tetratricopeptide TPR-1,																							SM00028:TPR,											tpr repeat,repeat,polymorphism,phosphoprotein,complete proteome,						sequence variant,sequence conflict,repeat:TPR 4,repeat:TPR 3,repeat:TPR 2,repeat:TPR 1,modified residue,chain:Tetratricopeptide repeat protein 15,										
38816_at	transforming, acidic coiled-coil containing protein 2	Homo sapiens						GO:0051647~nucleus localization,GO:0051640~organelle localization,GO:0032886~regulation of microtubule-based process,GO:0031122~cytoplasmic microtubule organization,GO:0030953~spindle astral microtubule organization,GO:0030900~forebrain development,GO:0022403~cell cycle phase,GO:0022402~cell cycle process,GO:0022027~interkinetic nuclear migration,GO:0021987~cerebral cortex development,GO:0021846~cell proliferation in forebrain,GO:0021543~pallium development,GO:0021537~telencephalon development,GO:0008283~cell proliferation,GO:0007051~spindle organization,GO:0007049~cell cycle,GO:0007017~microtubule-based process,GO:0007010~cytoskeleton organization,GO:0000279~M phase,GO:0000226~microtubule cytoskeleton organization,												GO:0044430~cytoskeletal part,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0015630~microtubule cytoskeleton,GO:0005856~cytoskeleton,GO:0005815~microtubule organizing center,GO:0005813~centrosome,																GO:0051427~hormone receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0019904~protein domain specific binding,							IPR007707:Transforming acidic coiled-coil-containing,																					polymorphism,phosphoprotein,nucleus,cytoskeleton,cytoplasm,complete proteome,coiled coil,alternative splicing,acetylation,						splice variant,sequence variant,sequence conflict,modified residue,domain:SPAZ,compositionally biased region:Pro-rich,compositionally biased region:Poly-Lys,chain:Transforming acidic coiled-coil- containing protein 2,										
37898_r_at	trefoil factor 3 (intestinal)	Homo sapiens											h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,								GO:0043434~response to peptide hormone stimulus,GO:0010033~response to organic substance,GO:0009725~response to hormone stimulus,GO:0009719~response to endogenous stimulus,GO:0007586~digestion,GO:0006952~defense response,												GO:0044421~extracellular region part,GO:0044420~extracellular matrix part,GO:0033166~hyaline layer,GO:0032579~apical lamina of hyaline layer,GO:0031988~membrane-bounded vesicle,GO:0031982~vesicle,GO:0031410~cytoplasmic vesicle,GO:0031012~extracellular matrix,GO:0030141~secretory granule,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0005578~proteinaceous extracellular matrix,GO:0005576~extracellular region,										IPR017994:P-type trefoil, chordata,IPR017957:P-type trefoil, conserved site,IPR000519:P-type trefoil,												PIRSF001853:trefoil factor, types 1 and 3,																								SM00018:PD,											signal,Secreted,intestine,extracellular matrix,disulfide bond,direct protein sequencing,complete proteome,3d-structure,						turn,strand,signal peptide,sequence conflict,helix,domain:P-type,disulfide bond,chain:Trefoil factor 3,										
36713_at	tripartite motif-containing 58	Homo sapiens								GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0008270~zinc ion binding,							IPR018957:Zinc finger, C3HC4 RING-type,IPR018355:SPla/RYanodine receptor subgroup,IPR017907:Zinc finger, RING-type, conserved site,IPR006574:SPRY-associated,IPR003879:Butyrophylin-like,IPR003877:SPla/RYanodine receptor SPRY,IPR001870:B302 (SPRY)-like,IPR001841:Zinc finger, RING-type,IPR000315:Zinc finger, B-box,																							SM00589:PRY,SM00449:SPRY,SM00336:BBOX,SM00184:RING,											zinc-finger,zinc,polymorphism,metal-binding,complete proteome,coiled coil,						zinc finger region:RING-type,zinc finger region:B box-type,sequence variant,sequence conflict,domain:B30.2/SPRY,chain:Tripartite motif-containing protein 58,										
1331_s_at	tumor necrosis factor receptor superfamily, member 25	Homo sapiens											h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,								GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043065~positive regulation of apoptosis,GO:0042981~regulation of apoptosis,GO:0016265~death,GO:0012502~induction of programmed cell death,GO:0012501~programmed cell death,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0008219~cell death,GO:0007166~cell surface receptor linked signal transduction,GO:0006917~induction of apoptosis,GO:0006915~apoptosis,												GO:0044459~plasma membrane part,GO:0031226~intrinsic to plasma membrane,GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005887~integral to plasma membrane,GO:0005886~plasma membrane,GO:0005829~cytosol,GO:0005576~extracellular region,																GO:0043120~tumor necrosis factor binding,GO:0019955~cytokine binding,GO:0005031~tumor necrosis factor receptor activity,							IPR011029:DEATH-like,IPR001368:TNFR/CD27/30/40/95 cysteine-rich region,IPR000488:Death,																				hsa04060:Cytokine-cytokine receptor interaction,																SM00208:TNFR,SM00005:DEATH,											transmembrane,signal,Secreted,repeat,receptor,polymorphism,membrane,glycoprotein,disulfide bond,complete proteome,cell membrane,Apoptosis,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,signal peptide,sequence variant,sequence conflict,repeat:TNFR-Cys 4,repeat:TNFR-Cys 3,repeat:TNFR-Cys 2,repeat:TNFR-Cys 1,mutagenesis site,glycosylation site:N-linked (GlcNAc...),domain:Death,disulfide bond,chain:Tumor necrosis factor receptor superfamily member 25,										
1372_at	tumor necrosis factor, alpha-induced protein 6	Homo sapiens						GO:0022610~biological adhesion,GO:0009611~response to wounding,GO:0007267~cell-cell signaling,GO:0007155~cell adhesion,GO:0006954~inflammatory response,GO:0006952~defense response,															GO:0030247~polysaccharide binding,GO:0030246~carbohydrate binding,GO:0005540~hyaluronic acid binding,GO:0005539~glycosaminoglycan binding,GO:0001871~pattern binding,							IPR000859:CUB,IPR000538:Link,																							SM00445:LINK,SM00042:CUB,											signal,polymorphism,phosphoprotein,glycoprotein,disulfide bond,direct protein sequencing,complete proteome,cell adhesion,3d-structure,						strand,signal peptide,sequence variant,modified residue,helix,glycosylation site:N-linked (GlcNAc...),domain:Link,domain:CUB,disulfide bond,chain:Tumor necrosis factor-inducible gene 6 protein,										
1974_s_at	tumor protein p53	Homo sapiens							99.NF-kB_activation,94.E2F_transcriptional_activity_cell_cycle,38.Cell_cycle_arrest_and_apoptosis_ceramide,157.14-3-3_Cell_Cycle,152.altered_synaptic_signalling-neurodegenerative_disorders,1.RBphosphoE2F,																	h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tertpathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_pmlPathway:Regulation of transcriptional activity by PML,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_p53Pathway:p53 Signaling Pathway,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_atmPathway:ATM Signaling Pathway,h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,								GO:0070727~cellular macromolecule localization,GO:0070661~leukocyte proliferation,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0060548~negative regulation of cell death,GO:0060284~regulation of cell development,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0052548~regulation of endopeptidase activity,GO:0052547~regulation of peptidase activity,GO:0051960~regulation of nervous system development,GO:0051726~regulation of cell cycle,GO:0051453~regulation of intracellular pH,GO:0051346~negative regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051276~chromosome organization,GO:0051262~protein tetramerization,GO:0051259~protein oligomerization,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051170~nuclear import,GO:0051169~nuclear transport,GO:0051097~negative regulation of helicase activity,GO:0051095~regulation of helicase activity,GO:0051053~negative regulation of DNA metabolic process,GO:0051052~regulation of DNA metabolic process,GO:0050801~ion homeostasis,GO:0050768~negative regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0048878~chemical homeostasis,GO:0048598~embryonic morphogenesis,GO:0048534~hemopoietic or lymphoid organ development,GO:0048147~negative regulation of fibroblast proliferation,GO:0048145~regulation of fibroblast proliferation,GO:0046907~intracellular transport,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045941~positive regulation of transcription,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045926~negative regulation of growth,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045792~negative regulation of cell size,GO:0045786~negative regulation of cell cycle,GO:0045596~negative regulation of cell differentiation,GO:0045449~regulation of transcription,GO:0045321~leukocyte activation,GO:0045184~establishment of protein localization,GO:0045165~cell fate commitment,GO:0044093~positive regulation of molecular function,GO:0044092~negative regulation of molecular function,GO:0043933~macromolecular complex subunit organization,GO:0043525~positive regulation of neuron apoptosis,GO:0043523~regulation of neuron apoptosis,GO:0043281~regulation of caspase activity,GO:0043280~positive regulation of caspase activity,GO:0043193~positive regulation of gene-specific transcription,GO:0043086~negative regulation of catalytic activity,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0042981~regulation of apoptosis,GO:0042771~DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,GO:0042770~DNA damage response, signal transduction,GO:0042594~response to starvation,GO:0042592~homeostatic process,GO:0042493~response to drug,GO:0042149~cellular response to glucose starvation,GO:0042127~regulation of cell proliferation,GO:0042113~B cell activation,GO:0042110~T cell activation,GO:0042098~T cell proliferation,GO:0040008~regulation of growth,GO:0034976~response to endoplasmic reticulum stress,GO:0034644~cellular response to UV,GO:0034613~cellular protein localization,GO:0034504~protein localization in nucleus,GO:0033554~cellular response to stress,GO:0033365~protein localization in organelle,GO:0033077~T cell differentiation in the thymus,GO:0032943~mononuclear cell proliferation,GO:0032774~RNA biosynthetic process,GO:0032583~regulation of gene-specific transcription,GO:0032535~regulation of cellular component size,GO:0031669~cellular response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031667~response to nutrient levels,GO:0031575~G1/S transition checkpoint,GO:0031571~G1 DNA damage checkpoint,GO:0031570~DNA integrity checkpoint,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0030641~regulation of cellular pH,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030308~negative regulation of cell growth,GO:0030217~T cell differentiation,GO:0030183~B cell differentiation,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0030004~cellular monovalent inorganic cation homeostasis,GO:0030003~cellular cation homeostasis,GO:0022402~cell cycle process,GO:0019725~cellular homeostasis,GO:0017038~protein import,GO:0016481~negative regulation of transcription,GO:0016265~death,GO:0016044~membrane organization,GO:0015031~protein transport,GO:0012502~induction of programmed cell death,GO:0012501~programmed cell death,GO:0010952~positive regulation of peptidase activity,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010721~negative regulation of cell development,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010332~response to gamma radiation,GO:0010212~response to ionizing radiation,GO:0010165~response to X-ray,GO:0009991~response to extracellular stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009651~response to salt stress,GO:0009628~response to abiotic stimulus,GO:0009416~response to light stimulus,GO:0009411~response to UV,GO:0009314~response to radiation,GO:0009303~rRNA transcription,GO:0009267~cellular response to starvation,GO:0008637~apoptotic mitochondrial changes,GO:0008635~activation of caspase activity by cytochrome c,GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis,GO:0008629~induction of apoptosis by intracellular signals,GO:0008361~regulation of cell size,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0008156~negative regulation of DNA replication,GO:0008104~protein localization,GO:0007569~cell aging,GO:0007568~aging,GO:0007406~negative regulation of neuroblast proliferation,GO:0007369~gastrulation,GO:0007346~regulation of mitotic cell cycle,GO:0007242~intracellular signaling cascade,GO:0007093~mitotic cell cycle checkpoint,GO:0007050~cell cycle arrest,GO:0007049~cell cycle,GO:0007006~mitochondrial membrane organization,GO:0007005~mitochondrion organization,GO:0006984~ER-nuclear signaling pathway,GO:0006983~ER overload response,GO:0006974~response to DNA damage stimulus,GO:0006970~response to osmotic stress,GO:0006955~immune response,GO:0006919~activation of caspase activity,GO:0006917~induction of apoptosis,GO:0006915~apoptosis,GO:0006913~nucleocytoplasmic transport,GO:0006886~intracellular protein transport,GO:0006885~regulation of pH,GO:0006873~cellular ion homeostasis,GO:0006839~mitochondrial transport,GO:0006606~protein import into nucleus,GO:0006605~protein targeting,GO:0006461~protein complex assembly,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-dependent,GO:0006351~transcription, DNA-dependent,GO:0006350~transcription,GO:0006302~double-strand break repair,GO:0006289~nucleotide-excision repair,GO:0006284~base-excision repair,GO:0006281~DNA repair,GO:0006275~regulation of DNA replication,GO:0006259~DNA metabolic process,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002366~leukocyte activation during immune response,GO:0002360~T cell lineage commitment,GO:0002347~response to tumor cell,GO:0002326~B cell lineage commitment,GO:0002309~T cell proliferation during immune response,GO:0002286~T cell activation during immune response,GO:0002285~lymphocyte activation during immune response,GO:0002263~cell activation during immune response,GO:0001836~release of cytochrome c from mitochondria,GO:0001775~cell activation,GO:0001701~in utero embryonic development,GO:0001558~regulation of cell growth,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000077~DNA damage checkpoint,GO:0000075~cell cycle checkpoint,GO:0000060~protein import into nucleus, translocation,												GO:0070013~intracellular organelle lumen,GO:0044451~nucleoplasm part,GO:0044427~chromosomal part,GO:0043233~organelle lumen,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043228~non-membrane-bounded organelle,GO:0034399~nuclear periphery,GO:0031981~nuclear lumen,GO:0031974~membrane-enclosed lumen,GO:0016605~PML body,GO:0016604~nuclear body,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0016363~nuclear matrix,GO:0005829~cytosol,GO:0005783~endoplasmic reticulum,GO:0005739~mitochondrion,GO:0005730~nucleolus,GO:0005694~chromosome,GO:0005669~transcription factor TFIID complex,GO:0005667~transcription factor complex,GO:0005657~replication fork,GO:0005654~nucleoplasm,GO:0005626~insoluble fraction,GO:0000267~cell fraction,																GO:0051087~chaperone binding,GO:0047485~protein N-terminus binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043566~structure-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030528~transcription regulator activity,GO:0019899~enzyme binding,GO:0017076~purine nucleotide binding,GO:0010843~promoter binding,GO:0008270~zinc ion binding,GO:0008134~transcription factor binding,GO:0005524~ATP binding,GO:0005507~copper ion binding,GO:0003700~transcription factor activity,GO:0003697~single-stranded DNA binding,GO:0003690~double-stranded DNA binding,GO:0003682~chromatin binding,GO:0003677~DNA binding,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000739~DNA strand annealing activity,GO:0000166~nucleotide binding,							IPR015551:Cellular tumour antigen p53,IPR013872:p53 transactivation domain,IPR012346:p53 and RUNT-type transcription factor, DNA-binding,IPR011615:p53, DNA-binding,IPR010991:p53, tetramerisation,IPR002117:p53 tumour antigen,																				hsa05223:Non-small cell lung cancer,hsa05222:Small cell lung cancer,hsa05220:Chronic myeloid leukemia,hsa05219:Bladder cancer,hsa05218:Melanoma,hsa05217:Basal cell carcinoma,hsa05216:Thyroid cancer,hsa05215:Prostate cancer,hsa05214:Glioma,hsa05213:Endometrial cancer,hsa05212:Pancreatic cancer,hsa05210:Colorectal cancer,hsa05200:Pathways in cancer,hsa05016:Huntington's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa04722:Neurotrophin signaling pathway,hsa04310:Wnt signaling pathway,hsa04210:Apoptosis,hsa04115:p53 signaling pathway,hsa04110:Cell cycle,hsa04010:MAPK signaling pathway,								Thyroid carcinoma,Pancreatic cancer,Osteosarcoma,Nasopharyngeal carcinoma,Multiple malignancy syndrome,Li-Fraumeni-like syndrome,Li-Fraumeni syndrome,Histiocytoma,Hepatocellular carcinoma,Colorectal cancer,Choroid plexus papilloma,Breast cancer,Adrenal cortical carcinoma,										PIRSF002089:tumor suppressor p53,																						zinc,ubl conjugation,tumor suppressor,transcription regulation,Transcription,polymorphism,phosphoprotein,nucleus,methylation,metal-binding,Li-Fraumeni syndrome,isopeptide bond,host-virus interaction,homotetramer,glycoprotein,endoplasmic reticulum,dna-binding,DNA binding,disease mutation,cytoplasm,complete proteome,cell division control,cell cycle,Apoptosis,alternative splicing,activator,acetylation,3d-structure,						turn,strand,splice variant,short sequence motif:[KR]-[STA]-K motif,short sequence motif:Nuclear export signal,short sequence motif:Bipartite nuclear localization signal,sequence variant,region of interest:Transcription activation (acidic),region of interest:Required for interaction with FBXO42,region of interest:Oligomerization,region of interest:Interacts with the 53BP2 SH3 domain,region of interest:Interaction with WWOX,region of interest:Interaction with USP7,region of interest:Interaction with HRMT1L2,region of interest:Interaction with HIPK2,region of interest:Interaction with HIPK1,region of interest:Interaction with E4F1,region of interest:Interaction with CARM1,region of interest:Interaction with AXIN1,region of interest:Basic (repression of DNA-binding),mutagenesis site,modified residue,metal ion-binding site:Zinc,helix,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),chain:Cellular tumor antigen p53,										
34629_at	tumor protein p53 inducible protein 11	Homo sapiens						GO:0042127~regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,							
36378_at	uroplakin 1A	Homo sapiens						GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0060429~epithelium development,GO:0051259~protein oligomerization,GO:0043933~macromolecular complex subunit organization,GO:0030855~epithelial cell differentiation,GO:0006461~protein complex assembly,												GO:0031224~intrinsic to membrane,GO:0016021~integral to membrane,GO:0005886~plasma membrane,GO:0005783~endoplasmic reticulum,																GO:0048029~monosaccharide binding,GO:0046983~protein dimerization activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0030246~carbohydrate binding,GO:0005529~sugar binding,							IPR018499:Tetraspanin,IPR000301:Tetraspanin, subgroup,												PIRSF005764:uroplakin,																						transmembrane,polymorphism,membrane,glycoprotein,disulfide bond,complete proteome,alternative splicing,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,splice variant,sequence variant,glycosylation site:N-linked (GlcNAc...),chain:Uroplakin-1a,										
1901_s_at	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)	Homo sapiens											h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,								GO:0070664~negative regulation of leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0060548~negative regulation of cell death,GO:0060538~skeletal muscle organ development,GO:0060537~muscle tissue development,GO:0060443~mammary gland morphogenesis,GO:0060209~estrus,GO:0060206~estrous cycle phase,GO:0060056~mammary gland involution,GO:0055082~cellular chemical homeostasis,GO:0055002~striated muscle cell development,GO:0055001~muscle cell development,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051250~negative regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051174~regulation of phosphorus metabolic process,GO:0051146~striated muscle cell differentiation,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0050877~neurological system process,GO:0050868~negative regulation of T cell activation,GO:0050866~negative regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050863~regulation of T cell activation,GO:0050808~synapse organization,GO:0050801~ion homeostasis,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050670~regulation of lymphocyte proliferation,GO:0048878~chemical homeostasis,GO:0048858~cell projection morphogenesis,GO:0048812~neuron projection morphogenesis,GO:0048771~tissue remodeling,GO:0048747~muscle fiber development,GO:0048741~skeletal muscle fiber development,GO:0048732~gland development,GO:0048678~response to axon injury,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048609~reproductive process in a multicellular organism,GO:0048545~response to steroid hormone stimulus,GO:0048511~rhythmic process,GO:0048485~sympathetic nervous system development,GO:0048483~autonomic nervous system development,GO:0048015~phosphoinositide-mediated signaling,GO:0046777~protein amino acid autophosphorylation,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045785~positive regulation of cell adhesion,GO:0045765~regulation of angiogenesis,GO:0045619~regulation of lymphocyte differentiation,GO:0045580~regulation of T cell differentiation,GO:0044093~positive regulation of molecular function,GO:0043586~tongue development,GO:0043549~regulation of kinase activity,GO:0043410~positive regulation of MAPKKK cascade,GO:0043408~regulation of MAPKKK cascade,GO:0043406~positive regulation of MAP kinase activity,GO:0043405~regulation of MAP kinase activity,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptosis,GO:0043062~extracellular structure organization,GO:0042981~regulation of apoptosis,GO:0042698~ovulation cycle,GO:0042692~muscle cell differentiation,GO:0042592~homeostatic process,GO:0042552~myelination,GO:0042493~response to drug,GO:0042391~regulation of membrane potential,GO:0042325~regulation of phosphorylation,GO:0042130~negative regulation of T cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042127~regulation of cell proliferation,GO:0042063~gliogenesis,GO:0042060~wound healing,GO:0033674~positive regulation of kinase activity,GO:0033088~negative regulation of immature T cell proliferation in the thymus,GO:0033087~negative regulation of immature T cell proliferation,GO:0033084~regulation of immature T cell proliferation in the thymus,GO:0033083~regulation of immature T cell proliferation,GO:0033081~regulation of T cell differentiation in the thymus,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032570~response to progesterone stimulus,GO:0032504~multicellular organism reproduction,GO:0031175~neuron projection development,GO:0030879~mammary gland development,GO:0030182~neuron differentiation,GO:0030155~regulation of cell adhesion,GO:0030030~cell projection organization,GO:0022612~gland morphogenesis,GO:0022602~ovulation cycle process,GO:0019932~second-messenger-mediated signaling,GO:0019725~cellular homeostasis,GO:0019228~regulation of action potential in neuron,GO:0019226~transmission of nerve impulse,GO:0019220~regulation of phosphate metabolic process,GO:0018212~peptidyl-tyrosine modification,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0016310~phosphorylation,GO:0014706~striated muscle tissue development,GO:0014068~positive regulation of phosphoinositide 3-kinase cascade,GO:0014066~regulation of phosphoinositide 3-kinase cascade,GO:0014065~phosphoinositide 3-kinase cascade,GO:0010941~regulation of cell death,GO:0010740~positive regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010627~regulation of protein kinase cascade,GO:0010033~response to organic substance,GO:0010001~glial cell differentiation,GO:0009967~positive regulation of signal transduction,GO:0009725~response to hormone stimulus,GO:0009719~response to endogenous stimulus,GO:0009611~response to wounding,GO:0008366~axon ensheathment,GO:0008285~negative regulation of cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008045~motor axon guidance,GO:0007528~neuromuscular junction development,GO:0007519~skeletal muscle tissue development,GO:0007517~muscle organ development,GO:0007507~heart development,GO:0007423~sensory organ development,GO:0007422~peripheral nervous system development,GO:0007411~axon guidance,GO:0007409~axonogenesis,GO:0007272~ensheathment of neurons,GO:0007243~protein kinase cascade,GO:0007242~intracellular signaling cascade,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor linked signal transduction,GO:0006928~cell motion,GO:0006873~cellular ion homeostasis,GO:0006796~phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein amino acid phosphorylation,GO:0002695~negative regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002683~negative regulation of immune system process,GO:0001889~liver development,GO:0001508~regulation of action potential,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,												GO:0048471~perinuclear region of cytoplasm,GO:0045211~postsynaptic membrane,GO:0045202~synapse,GO:0045178~basal part of cell,GO:0045177~apical part of cell,GO:0045121~membrane raft,GO:0044459~plasma membrane part,GO:0044456~synapse part,GO:0043235~receptor complex,GO:0043219~lateral loop,GO:0043209~myelin sheath,GO:0042995~cell projection,GO:0031224~intrinsic to membrane,GO:0016324~apical plasma membrane,GO:0016323~basolateral plasma membrane,GO:0016021~integral to membrane,GO:0009925~basal plasma membrane,GO:0005902~microvillus,GO:0005886~plasma membrane,GO:0005576~extracellular region,																GO:0051879~Hsp90 protein binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0043125~ErbB-3 class receptor binding,GO:0042802~identical protein binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0031625~ubiquitin protein ligase binding,GO:0031072~heat shock protein binding,GO:0030554~adenyl nucleotide binding,GO:0019903~protein phosphatase binding,GO:0019902~phosphatase binding,GO:0019899~enzyme binding,GO:0019838~growth factor binding,GO:0017076~purine nucleotide binding,GO:0008022~protein C-terminus binding,GO:0005524~ATP binding,GO:0005006~epidermal growth factor receptor activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004672~protein kinase activity,GO:0001948~glycoprotein binding,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,							IPR017441:Protein kinase, ATP binding site,IPR016245:Tyrosine protein kinase, receptor-type, EGF/ERB/XmrK,IPR008266:Tyrosine protein kinase, active site,IPR006212:Furin-like repeat,IPR006211:Furin-like cysteine rich region,IPR004019:YLP motif,IPR001245:Tyrosine protein kinase,IPR000719:Protein kinase, core,IPR000494:EGF receptor, L domain,																				hsa05223:Non-small cell lung cancer,hsa05219:Bladder cancer,hsa05215:Prostate cancer,hsa05213:Endometrial cancer,hsa05212:Pancreatic cancer,hsa05200:Pathways in cancer,hsa04520:Adherens junction,hsa04510:Focal adhesion,hsa04020:Calcium signaling pathway,hsa04012:ErbB signaling pathway,								Ovarian cancer, somatic,Glioblastoma, somatic,Gastric cancer, somatic,Adenocarcinoma of lung, somatic,										PIRSF000619:TyrPK_EGF-R,PIRSF000619:tyrosine-protein kinase, EGF receptor type,																								SM00261:FU,SM00219:TyrKc,											tyrosine-specific protein kinase,tyrosine-protein kinase,transmembrane protein,transmembrane,transforming protein,transferase,signal,receptor,Proto-oncogene,polymorphism,phosphotransferase,phosphoprotein,nucleotide-binding,membrane,kinase,glycoprotein,duplication,disulfide bond,complete proteome,autophosphorylation,atp-binding,ATP,3d-structure,						turn,transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,strand,signal peptide,sequence variant,region of interest:Interaction with PIK3C2B,nucleotide phosphate-binding region:ATP,modified residue,helix,glycosylation site:N-linked (GlcNAc...),domain:Protein kinase,disulfide bond,chain:Receptor tyrosine-protein kinase erbB-2,binding site:ATP,active site:Proton acceptor,										
33684_at	wingless-type MMTV integration site family, member 2B	Homo sapiens						GO:0016055~Wnt receptor signaling pathway,GO:0007223~Wnt receptor signaling pathway, calcium modulating pathway,GO:0007166~cell surface receptor linked signal transduction,												GO:0044421~extracellular region part,GO:0031012~extracellular matrix,GO:0005615~extracellular space,GO:0005578~proteinaceous extracellular matrix,GO:0005576~extracellular region,										IPR018161:Secreted growth factor Wnt protein, conserved site,IPR009140:Wnt-2 protein,IPR005817:Wnt superfamily,IPR005816:Secreted growth factor Wnt protein,																				hsa05217:Basal cell carcinoma,hsa05200:Pathways in cancer,hsa04916:Melanogenesis,hsa04340:Hedgehog signaling pathway,hsa04310:Wnt signaling pathway,					PIRSF001784:int-1 transforming protein,																								SM00097:WNT1,											wnt signaling pathway,signal,Secreted,glycoprotein,extracellular matrix,developmental protein,complete proteome,alternative splicing,						splice variant,signal peptide,sequence conflict,glycosylation site:N-linked (GlcNAc...),chain:Protein Wnt-2b,										
2090_i_at	wingless-type MMTV integration site family, member 6	Homo sapiens						GO:0016055~Wnt receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007223~Wnt receptor signaling pathway, calcium modulating pathway,GO:0007166~cell surface receptor linked signal transduction,												GO:0044421~extracellular region part,GO:0031012~extracellular matrix,GO:0005578~proteinaceous extracellular matrix,GO:0005576~extracellular region,																GO:0005201~extracellular matrix structural constituent,GO:0005198~structural molecule activity,							IPR018161:Secreted growth factor Wnt protein, conserved site,IPR009143:Wnt-6 protein,IPR005817:Wnt superfamily,IPR005816:Secreted growth factor Wnt protein,																				hsa05217:Basal cell carcinoma,hsa05200:Pathways in cancer,hsa04916:Melanogenesis,hsa04340:Hedgehog signaling pathway,hsa04310:Wnt signaling pathway,					PIRSF001784:int-1 transforming protein,																								SM00097:WNT1,											wnt signaling pathway,signal,Secreted,glycoprotein,extracellular matrix,developmental protein,complete proteome,carcinogenesis,						signal peptide,glycosylation site:N-linked (GlcNAc...),chain:Protein Wnt-6,										
41113_at	zinc finger protein 500	Homo sapiens													General function prediction only,						GO:0051252~regulation of RNA metabolic process,GO:0045449~regulation of transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006350~transcription,															GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0030528~transcription regulator activity,GO:0008270~zinc ion binding,GO:0003700~transcription factor activity,GO:0003677~DNA binding,							IPR015880:Zinc finger, C2H2-like,IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding,IPR007087:Zinc finger, C2H2-type,IPR003309:Transcriptional regulator SCAN,IPR001909:Krueppel-associated  box,																							SM00431:SCAN,SM00355:ZnF_C2H2,SM00349:KRAB,											zinc-finger,zinc,transcription regulation,Transcription,repeat,nucleus,metal-binding,dna-binding,complete proteome,						zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 1,domain:SCAN box,domain:KRAB,chain:Zinc finger protein 500,										